Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the musculature (HP:0003011)help
Parent Node:
expand
Abnormal skeletal muscle morphology (HP:0011805)help
..Starting node
..expand
Myopathy (HP:0003198)help
Term ID: 3198
Name: Myopathy
Synonym: Muscle tissue disease; Myopathic changes
Definition: A disorder of muscle unrelated to impairment of innervation or neuromuscular junction.
Comments:
Reference: HP:0003198
Genes and Diseases:
 
       Child Nodes:
........expandEMG: myopathic abnormalities (HP:0003458) help
........expandMyofibrillar myopathy (HP:0003715) help
........expandSkeletal myopathy (HP:0003756) help
........expandMinicore myopathy (HP:0003789) help
................... HP:0003787 Type 1 and type 2 muscle fiber minicore regions
........expandNecrotizing myopathy (HP:0008978) help
........expandInflammatory myopathy (HP:0009071) help

 Sister Nodes: 
..expandAbnormal muscle fiber morphology (HP:0004303) help
..expandAbnormality of muscle size (HP:0030236) help
..expandCalcinosis (HP:0003761) help
..expandDecreased muscle mass (HP:0003199) help
..expandFatty replacement of skeletal muscle (HP:0012548) help
..expandFirm muscles (HP:0003725) help
..expandFlexion contracture (HP:0001371) help
..expandGeneralized muscular appearance from birth (HP:0003716) help
..expandIntramuscular hematoma (HP:0012233) help
..expandLevator palpebrae superioris atrophy (HP:0012241) help
..expandMuscular dystrophy (HP:0003560) help
..expandMuscular edema (HP:0100748) help
..expandMyositis (HP:0100614) help
..expandRhabdomyolysis (HP:0003201) help
..expandSkeletal muscle fibrosis (HP:0030951) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0003198HP:0003198Myopathy0ABHD5 CL E G H51099275630Triglyceride storage disease with ichthyosis275630C0268238OMIM129121396604780
HP:0003198HP:0003198Myopathy0ACACA CL E G H31613933Acetyl-CoA: carboxylase deficiency613933C0268603OMIM130784200350
HP:0003198HP:0003198Myopathy0ACADS CL E G H35201470Deficiency of butyryl-CoA dehydrogenase201470C0342783OMIM140690606885
HP:0003198HP:0003198Myopathy0ACTA1 CL E G H5897244ORPHA1506129102610
HP:0003198HP:0003198Myopathy0ADGRG6 CL E G H57211616503Lethal congenital contracture syndrome 9616503C4225303OMIM115313841612243
HP:0003198HP:0003198Myopathy0ADSSL1 CL E G H122622617030Myopathy, distal, 5617030C4310754OMIM120093612498
HP:0003198HP:0003198Myopathy0AGK CL E G H557501369ORPHA134721869610345
HP:0003198HP:0003198Myopathy0AGK CL E G H55750212350Cataract and cardiomyopathy212350C1859317OMIM134721869610345
HP:0003198HP:0003198Myopathy0AGL CL E G H178366Arnold Stickler Bourne syndromeORPHA12263321610860
HP:0003198HP:0003198Myopathy0AGL CL E G H178232400Glycogen storage disease type III232400C0017922OMIM12263321610860
HP:0003198HP:0003198Myopathy0AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1242325603100
HP:0003198HP:0003198Myopathy0ALG14 CL E G H199857353327ORPHA114428287612866
HP:0003198HP:0003198Myopathy0ALG2 CL E G H85365353327ORPHA133523159607905
HP:0003198HP:0003198Myopathy0ALPL CL E G H249241510Childhood hypophosphatasia241510C0220743OMIM1934438171760
HP:0003198HP:0003198Myopathy0AP1S2 CL E G H890585329ORPHA1241560300629
HP:0003198HP:0003198Myopathy0B3GALNT2 CL E G H148789588ORPHA158728596610194
HP:0003198HP:0003198Myopathy0B4GALT1 CL E G H268379332ORPHA1184924137060
HP:0003198HP:0003198Myopathy0B4GALT1 CL E G H2683607091Congenital disorder of glycosylation type 2D607091C1846816OMIM1184924137060
HP:0003198HP:0003198Myopathy0BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA151015832606158
HP:0003198HP:0003198Myopathy0C1QBP CL E G H708617713COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33617713C4540209OMIM11371243601269
HP:0003198HP:0003198Myopathy0CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003198HP:0003198Myopathy0CASQ1 CL E G H84488635ORPHA12491512114250
HP:0003198HP:0003198Myopathy0CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA11351527601047
HP:0003198HP:0003198Myopathy0CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11289688603198
HP:0003198HP:0003198Myopathy0CCDC174 CL E G H51244616816Hypotonia, infantile, with psychomotor retardation616816C4225196OMIM18728033616735
HP:0003198HP:0003198Myopathy0CENPF CL E G H1063243605Stromme syndrome243605C1855705OMIM15541857600236
HP:0003198HP:0003198Myopathy0CHKB CL E G H1120602541Muscular dystrophy, congenital, megaconial type602541C1865233OMIM15021938612395
HP:0003198HP:0003198Myopathy0CHRNB1 CL E G H1140616313Myasthenic syndrome, congenital, 2a, slow-channel616313C4225374OMIM14541961100710
HP:0003198HP:0003198Myopathy0CHRNB1 CL E G H1140616314Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency616314C4225373OMIM14541961100710
HP:0003198HP:0003198Myopathy0CHRND CL E G H1144616321Myasthenic syndrome, congenital, 3a, slow-channel616321C4225372OMIM15051965100720
HP:0003198HP:0003198Myopathy0CHRNE CL E G H1145605809Myasthenic syndrome, congenital, 4a, slow-channel605809C1853949OMIM110111966100725
HP:0003198HP:0003198Myopathy0COL12A1 CL E G H1303616471Bethlem myopathy 2616471C4225313OMIM125482188120320
HP:0003198HP:0003198Myopathy0COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003198HP:0003198Myopathy0COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003198HP:0003198Myopathy0COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003198HP:0003198Myopathy0COLQ CL E G H829298915ORPHA15422226603033
HP:0003198HP:0003198Myopathy0COLQ CL E G H8292603034Endplate acetylcholinesterase deficiency603034C1864233OMIM15422226603033
HP:0003198HP:0003198Myopathy0CPT2 CL E G H1376228302ORPHA18762330600650
HP:0003198HP:0003198Myopathy0CPT2 CL E G H1376228305ORPHA18762330600650
HP:0003198HP:0003198Myopathy0DNA2 CL E G H1763352470ORPHA16012939601810
HP:0003198HP:0003198Myopathy0DPAGT1 CL E G H1798353327ORPHA13122995191350
HP:0003198HP:0003198Myopathy0DYSF CL E G H8291606768Myopathy, distal, with anterior tibial onset606768C1847532OMIM133553097603009
HP:0003198HP:0003198Myopathy0EMD CL E G H2010310300Emery-Dreifuss muscular dystrophy 1, X-linked310300C0751337OMIM16953331300384
HP:0003198HP:0003198Myopathy0EPG5 CL E G H57724242840Vici syndrome242840C1855772OMIM1164029331615068
HP:0003198HP:0003198Myopathy0ERGIC1 CL E G H57222208100Arthrogryposis multiplex congenita neurogenic type208100C1859721OMIM13929205617946
HP:0003198HP:0003198Myopathy0FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003198HP:0003198Myopathy0FKBP14 CL E G H55033300179ORPHA122018625614505
HP:0003198HP:0003198Myopathy0FKBP14 CL E G H55033614557Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss614557C3281160OMIM122018625614505
HP:0003198HP:0003198Myopathy0FKRP CL E G H79147588ORPHA195017997606596
HP:0003198HP:0003198Myopathy0FKTN CL E G H2218588ORPHA19143622607440
HP:0003198HP:0003198Myopathy0FKTN CL E G H2218272VACTERL hydrocephalyORPHA19143622607440
HP:0003198HP:0003198Myopathy0FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003198HP:0003198Myopathy0FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003198HP:0003198Myopathy0FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1403796164810
HP:0003198HP:0003198Myopathy0GCLC CL E G H2729230450Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to230450C1856603OMIM11284311606857
HP:0003198HP:0003198Myopathy0GFER CL E G H2671613076Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay613076C2751320OMIM12004236600924
HP:0003198HP:0003198Myopathy0GFPT1 CL E G H2673353327ORPHA15244241138292
HP:0003198HP:0003198Myopathy0GK CL E G H2710307030Deficiency of glycerol kinase307030C0268418OMIM12334289300474
HP:0003198HP:0003198Myopathy0GMPPB CL E G H29925588ORPHA136422932615320
HP:0003198HP:0003198Myopathy0GMPPB CL E G H29925353327ORPHA136422932615320
HP:0003198HP:0003198Myopathy0HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003198HP:0003198Myopathy0HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003198HP:0003198Myopathy0HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003198HP:0003198Myopathy0HNRNPA2B1 CL E G H3181615422Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2615422C3809468OMIM12955033600124
HP:0003198HP:0003198Myopathy0HNRNPDL CL E G H9987609115Limb-girdle muscular dystrophy, type 1G609115C1836765OMIM13545037607137
HP:0003198HP:0003198Myopathy0HSPG2 CL E G H3339800ORPHA124975273142461
HP:0003198HP:0003198Myopathy0INPP5K CL E G H51763559ORPHA118733882607875
HP:0003198HP:0003198Myopathy0ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM116029882611911
HP:0003198HP:0003198Myopathy0ITGA7 CL E G H3679613204Muscular dystrophy, congenital, due to integrin alpha-7 deficiency613204C2750786OMIM18986143600536
HP:0003198HP:0003198Myopathy0KBTBD13 CL E G H390594609273Nemaline myopathy 6609273C1836472OMIM153037227613727
HP:0003198HP:0003198Myopathy0LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003198HP:0003198Myopathy0LARGE1 CL E G H9215588ORPHA17866511603590
HP:0003198HP:0003198Myopathy0LMNA CL E G H4000157973ORPHA118146636150330
HP:0003198HP:0003198Myopathy0LMNB2 CL E G H8482379087ORPHA15486638150341
HP:0003198HP:0003198Myopathy0MGME1 CL E G H92667352447ORPHA115716205615076
HP:0003198HP:0003198Myopathy0MT-ATP6 CL E G H4508535000Leber's optic atrophy535000C0917796OMIM17414516060
HP:0003198HP:0003198Myopathy0MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003198HP:0003198Myopathy0MT-CO1 CL E G H4512540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17419516030
HP:0003198HP:0003198Myopathy0MT-CO2 CL E G H4513540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17421516040
HP:0003198HP:0003198Myopathy0MT-CO3 CL E G H4514540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17422516050
HP:0003198HP:0003198Myopathy0MT-CO3 CL E G H4514535000Leber's optic atrophy535000C0917796OMIM17422516050
HP:0003198HP:0003198Myopathy0MT-CYB CL E G H4519540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17427516020
HP:0003198HP:0003198Myopathy0MT-CYB CL E G H4519535000Leber's optic atrophy535000C0917796OMIM17427516020
HP:0003198HP:0003198Myopathy0MT-ND1 CL E G H4535540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17455516000
HP:0003198HP:0003198Myopathy0MT-ND1 CL E G H4535535000Leber's optic atrophy535000C0917796OMIM17455516000
HP:0003198HP:0003198Myopathy0MT-ND2 CL E G H4536535000Leber's optic atrophy535000C0917796OMIM17456516001
HP:0003198HP:0003198Myopathy0MT-ND4 CL E G H4538535000Leber's optic atrophy535000C0917796OMIM17459516003
HP:0003198HP:0003198Myopathy0MT-ND4L CL E G H4539535000Leber's optic atrophy535000C0917796OMIM17460516004
HP:0003198HP:0003198Myopathy0MT-ND5 CL E G H4540551ORPHA17461516005
HP:0003198HP:0003198Myopathy0MT-ND5 CL E G H4540540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17461516005
HP:0003198HP:0003198Myopathy0MT-ND5 CL E G H4540535000Leber's optic atrophy535000C0917796OMIM17461516005
HP:0003198HP:0003198Myopathy0MT-ND6 CL E G H4541540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17462516006
HP:0003198HP:0003198Myopathy0MT-ND6 CL E G H4541535000Leber's optic atrophy535000C0917796OMIM17462516006
HP:0003198HP:0003198Myopathy0MT-RNR1 CL E G H4549551ORPHA117470180450
HP:0003198HP:0003198Myopathy0MT-TC CL E G H4511540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17477590020
HP:0003198HP:0003198Myopathy0MT-TE CL E G H4556254864ORPHA17479590025
HP:0003198HP:0003198Myopathy0MT-TF CL E G H4558551ORPHA17481590070
HP:0003198HP:0003198Myopathy0MT-TF CL E G H4558540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17481590070
HP:0003198HP:0003198Myopathy0MT-TF CL E G H4558545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17481590070
HP:0003198HP:0003198Myopathy0MT-TH CL E G H4564551ORPHA17487590040
HP:0003198HP:0003198Myopathy0MT-TI CL E G H4565545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17488590045
HP:0003198HP:0003198Myopathy0MT-TK CL E G H4566551ORPHA17489590060
HP:0003198HP:0003198Myopathy0MT-TK CL E G H4566540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17489590060
HP:0003198HP:0003198Myopathy0MT-TK CL E G H4566545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17489590060
HP:0003198HP:0003198Myopathy0MT-TL1 CL E G H4567551ORPHA17490590050
HP:0003198HP:0003198Myopathy0MT-TL1 CL E G H4567540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17490590050
HP:0003198HP:0003198Myopathy0MT-TL1 CL E G H4567545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17490590050
HP:0003198HP:0003198Myopathy0MT-TP CL E G H4571551ORPHA17494590075
HP:0003198HP:0003198Myopathy0MT-TP CL E G H4571545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17494590075
HP:0003198HP:0003198Myopathy0MT-TQ CL E G H4572551ORPHA17495590030
HP:0003198HP:0003198Myopathy0MT-TQ CL E G H4572540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17495590030
HP:0003198HP:0003198Myopathy0MT-TS1 CL E G H4574551ORPHA17497590080
HP:0003198HP:0003198Myopathy0MT-TS1 CL E G H4574540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17497590080
HP:0003198HP:0003198Myopathy0MT-TS2 CL E G H4575551ORPHA17498590085
HP:0003198HP:0003198Myopathy0MT-TS2 CL E G H4575540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17498590085
HP:0003198HP:0003198Myopathy0MT-TT CL E G H4576551000Lethal infantile mitochondrial myopathy551000C1838876OMIM17499590090
HP:0003198HP:0003198Myopathy0MT-TV CL E G H4577540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17500590105
HP:0003198HP:0003198Myopathy0MT-TW CL E G H4578540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17501590095
HP:0003198HP:0003198Myopathy0MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003198HP:0003198Myopathy0MYMK CL E G H389827254940Congenital nonprogressive myopathy with Moebius and Robin sequences254940C1850746OMIM18633778615345
HP:0003198HP:0003198Myopathy0MYO18B CL E G H84700616549Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism616549C4225285OMIM1181018150607295
HP:0003198HP:0003198Myopathy0MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003198HP:0003198Myopathy0NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003198HP:0003198Myopathy0NDUFA11 CL E G H126328618236MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14618236OMIM113120371612638
HP:0003198HP:0003198Myopathy0NDUFAF1 CL E G H51103618234MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11618234OMIM115418828606934
HP:0003198HP:0003198Myopathy0NDUFAF4 CL E G H29078618237MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15618237OMIM113621034611776
HP:0003198HP:0003198Myopathy0NDUFB3 CL E G H4709618246MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25618246OMIM1797698603839
HP:0003198HP:0003198Myopathy0NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM17147737162230
HP:0003198HP:0003198Myopathy0NUBPL CL E G H80224618242MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21618242OMIM128420278613621
HP:0003198HP:0003198Myopathy0OPA1 CL E G H4976125250Autosomal dominant optic atrophy plus syndrome125250C1852267OMIM112248140605290
HP:0003198HP:0003198Myopathy0ORAI1 CL E G H84876612782Immune dysfunction with T-cell inactivation due to calcium entry defect 1612782C2748568OMIM132625896610277
HP:0003198HP:0003198Myopathy0PABPN1 CL E G H8106270ORPHA1858565602279
HP:0003198HP:0003198Myopathy0PANK2 CL E G H80025234200Pigmentary pallidal degeneration234200C0018523OMIM149915894606157
HP:0003198HP:0003198Myopathy0PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003198HP:0003198Myopathy0PLEC CL E G H5339257ORPHA150689069601282
HP:0003198HP:0003198Myopathy0PNPLA2 CL E G H5710498908ORPHA156630802609059
HP:0003198HP:0003198Myopathy0PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003198HP:0003198Myopathy0POLG CL E G H5428254886ORPHA123249179174763
HP:0003198HP:0003198Myopathy0POMGNT1 CL E G H55624588ORPHA1117419139606822
HP:0003198HP:0003198Myopathy0POMT1 CL E G H10585588ORPHA19069202607423
HP:0003198HP:0003198Myopathy0POMT2 CL E G H29954588ORPHA193619743607439
HP:0003198HP:0003198Myopathy0PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11669236601487
HP:0003198HP:0003198Myopathy0PRKAG2 CL E G H51422261740Glycogen storage disease of heart, lethal congenital261740C1849813OMIM110799386602743
HP:0003198HP:0003198Myopathy0PUS1 CL E G H803242598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA147815508608109
HP:0003198HP:0003198Myopathy0PYGM CL E G H5837368ORPHA110559726608455
HP:0003198HP:0003198Myopathy0RET CL E G H5979162300Multiple endocrine neoplasia, type 2b162300C0025269OMIM131659967164761
HP:0003198HP:0003198Myopathy0RMND1 CL E G H55005614922Combined oxidative phosphorylation deficiency 11614922C3554067OMIM126221176614917
HP:0003198HP:0003198Myopathy0RRM2B CL E G H50484613077Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5613077C2751319OMIM135417296604712
HP:0003198HP:0003198Myopathy0RYR1 CL E G H6261597ORPHA1616410483180901
HP:0003198HP:0003198Myopathy0SCN4A CL E G H6329613345Hypokalemic periodic paralysis, type 2613345C2750061OMIM1176510591603967
HP:0003198HP:0003198Myopathy0SELENON CL E G H5719097244ORPHA165115999606210
HP:0003198HP:0003198Myopathy0SGCB CL E G H6443119ORPHA150010806600900
HP:0003198HP:0003198Myopathy0SIL1 CL E G H64374559ORPHA135224624608005
HP:0003198HP:0003198Myopathy0SIL1 CL E G H64374248800Marinesco-Sjögren syndrome248800C0024814OMIM135224624608005
HP:0003198HP:0003198Myopathy0SLC22A5 CL E G H6584212140Renal carnitine transport defect212140C0342788OMIM1102710969603377
HP:0003198HP:0003198Myopathy0SLC25A3 CL E G H525091130ORPHA117610989600370
HP:0003198HP:0003198Myopathy0SLC25A4 CL E G H2911369ORPHA133310990103220
HP:0003198HP:0003198Myopathy0STIM1 CL E G H6786612783Immune dysfunction with T-cell inactivation due to calcium entry defect 2612783C2748557OMIM163511386605921
HP:0003198HP:0003198Myopathy0STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003198HP:0003198Myopathy0STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003198HP:0003198Myopathy0TIA1 CL E G H7072603ORPHA125011802603518
HP:0003198HP:0003198Myopathy0TK2 CL E G H7084254886ORPHA144211831188250
HP:0003198HP:0003198Myopathy0TK2 CL E G H7084254875ORPHA144211831188250
HP:0003198HP:0003198Myopathy0TNNT1 CL E G H7138605355Nemaline myopathy 5605355C1854380OMIM137211948191041
HP:0003198HP:0003198Myopathy0TPI1 CL E G H7167615512Triosephosphate isomerase deficiency615512C1860808OMIM118112009190450
HP:0003198HP:0003198Myopathy0TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003198HP:0003198Myopathy0TRAPPC11 CL E G H60684369847ORPHA198325751614138
HP:0003198HP:0003198Myopathy0TRIM32 CL E G H229541878Chromosome 1, uniparental disomy 1q12 q21CN035970ORPHA162716380602290
HP:0003198HP:0003198Myopathy0TRMU CL E G H55687254864ORPHA162325481610230
HP:0003198HP:0003198Myopathy0TTN CL E G H7273611705Myopathy, early-onset, with fatal cardiomyopathy611705C2673677OMIM12750312403188840
HP:0003198HP:0003198Myopathy0UBA1 CL E G H7317301830Spinal muscular atrophy, X-linked 2301830C1844934OMIM163112469314370
HP:0003198HP:0003198Myopathy0VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003198HP:0003198Myopathy0VMA21 CL E G H203547310440Myopathy, X-linked, with excessive autophagy310440C1839615OMIM125422082300913
HP:0003198HP:0003198Myopathy0VPS13A CL E G H232302388ORPHA123621908605978
HP:0003198HP:0003198Myopathy0XDH CL E G H7498278300Deficiency of xanthine oxidase278300C0268118OMIM169112805607633
HP:0003198HP:0003198Myopathy0XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM121812811314850
HP:0003198HP:0003198Myopathy0YARS2 CL E G H510672598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA127424249610957
HP:0003198HP:0003198Myopathy0ZBTB20 CL E G H261373042ORPHA125213503606025
HP:0003198HP:0003789Minicore myopathy1ABHD5 CL E G H51099275630Triglyceride storage disease with ichthyosis275630C0268238OMIM129121396604780
HP:0003198HP:0003756Skeletal myopathy1ABHD5 CL E G H51099275630Triglyceride storage disease with ichthyosis275630C0268238OMIM129121396604780
HP:0003198HP:0009071Inflammatory myopathy1ABHD5 CL E G H51099275630Triglyceride storage disease with ichthyosis275630C0268238OMIM129121396604780
HP:0003198HP:0008978Necrotizing myopathy1ABHD5 CL E G H51099275630Triglyceride storage disease with ichthyosis275630C0268238OMIM129121396604780
HP:0003198HP:0003458EMG: myopathic abnormalities1ABHD5 CL E G H51099275630Triglyceride storage disease with ichthyosis275630C0268238OMIM129121396604780
HP:0003198HP:0003715Myofibrillar myopathy1ABHD5 CL E G H51099275630Triglyceride storage disease with ichthyosis275630C0268238OMIM129121396604780
HP:0003198HP:0003789Minicore myopathy1ACACA CL E G H31613933Acetyl-CoA: carboxylase deficiency613933C0268603OMIM130784200350
HP:0003198HP:0003756Skeletal myopathy1ACACA CL E G H31613933Acetyl-CoA: carboxylase deficiency613933C0268603OMIM130784200350
HP:0003198HP:0009071Inflammatory myopathy1ACACA CL E G H31613933Acetyl-CoA: carboxylase deficiency613933C0268603OMIM130784200350
HP:0003198HP:0008978Necrotizing myopathy1ACACA CL E G H31613933Acetyl-CoA: carboxylase deficiency613933C0268603OMIM130784200350
HP:0003198HP:0003458EMG: myopathic abnormalities1ACACA CL E G H31613933Acetyl-CoA: carboxylase deficiency613933C0268603OMIM130784200350
HP:0003198HP:0003715Myofibrillar myopathy1ACACA CL E G H31613933Acetyl-CoA: carboxylase deficiency613933C0268603OMIM130784200350
HP:0003198HP:0003789Minicore myopathy1ACADS CL E G H35201470Deficiency of butyryl-CoA dehydrogenase201470C0342783OMIM140690606885
HP:0003198HP:0003756Skeletal myopathy1ACADS CL E G H35201470Deficiency of butyryl-CoA dehydrogenase201470C0342783OMIM140690606885
HP:0003198HP:0009071Inflammatory myopathy1ACADS CL E G H35201470Deficiency of butyryl-CoA dehydrogenase201470C0342783OMIM140690606885
HP:0003198HP:0008978Necrotizing myopathy1ACADS CL E G H35201470Deficiency of butyryl-CoA dehydrogenase201470C0342783OMIM140690606885
HP:0003198HP:0003458EMG: myopathic abnormalities1ACADS CL E G H35201470Deficiency of butyryl-CoA dehydrogenase201470C0342783OMIM140690606885
HP:0003198HP:0003715Myofibrillar myopathy1ACADS CL E G H35201470Deficiency of butyryl-CoA dehydrogenase201470C0342783OMIM140690606885
HP:0003198HP:0009071Inflammatory myopathy1ACTA1 CL E G H5897244ORPHA1506129102610
HP:0003198HP:0008978Necrotizing myopathy1ACTA1 CL E G H5897244ORPHA1506129102610
HP:0003198HP:0003458EMG: myopathic abnormalities1ACTA1 CL E G H5897244ORPHA1506129102610
HP:0003198HP:0003715Myofibrillar myopathy1ACTA1 CL E G H5897244ORPHA1506129102610
HP:0003198HP:0003789Minicore myopathy1ACTA1 CL E G H5897244ORPHA1506129102610
HP:0003198HP:0003756Skeletal myopathy1ACTA1 CL E G H5897244ORPHA1506129102610
HP:0003198HP:0003789Minicore myopathy1ADGRG6 CL E G H57211616503Lethal congenital contracture syndrome 9616503C4225303OMIM115313841612243
HP:0003198HP:0003756Skeletal myopathy1ADGRG6 CL E G H57211616503Lethal congenital contracture syndrome 9616503C4225303OMIM115313841612243
HP:0003198HP:0009071Inflammatory myopathy1ADGRG6 CL E G H57211616503Lethal congenital contracture syndrome 9616503C4225303OMIM115313841612243
HP:0003198HP:0008978Necrotizing myopathy1ADGRG6 CL E G H57211616503Lethal congenital contracture syndrome 9616503C4225303OMIM115313841612243
HP:0003198HP:0003458EMG: myopathic abnormalities1ADGRG6 CL E G H57211616503Lethal congenital contracture syndrome 9616503C4225303OMIM115313841612243
HP:0003198HP:0003715Myofibrillar myopathy1ADGRG6 CL E G H57211616503Lethal congenital contracture syndrome 9616503C4225303OMIM115313841612243
HP:0003198HP:0003789Minicore myopathy1ADSSL1 CL E G H122622617030Myopathy, distal, 5617030C4310754OMIM120093612498
HP:0003198HP:0003756Skeletal myopathy1ADSSL1 CL E G H122622617030Myopathy, distal, 5617030C4310754OMIM120093612498
HP:0003198HP:0009071Inflammatory myopathy1ADSSL1 CL E G H122622617030Myopathy, distal, 5617030C4310754OMIM120093612498
HP:0003198HP:0008978Necrotizing myopathy1ADSSL1 CL E G H122622617030Myopathy, distal, 5617030C4310754OMIM120093612498
HP:0003198HP:0003458EMG: myopathic abnormalities1ADSSL1 CL E G H122622617030Myopathy, distal, 5617030C4310754OMIM120093612498
HP:0003198HP:0003715Myofibrillar myopathy1ADSSL1 CL E G H122622617030Myopathy, distal, 5617030C4310754OMIM120093612498
HP:0003198HP:0003458EMG: myopathic abnormalities1AGK CL E G H557501369ORPHA134721869610345
HP:0003198HP:0003715Myofibrillar myopathy1AGK CL E G H557501369ORPHA134721869610345
HP:0003198HP:0003789Minicore myopathy1AGK CL E G H557501369ORPHA134721869610345
HP:0003198HP:0003756Skeletal myopathy1AGK CL E G H557501369ORPHA134721869610345
HP:0003198HP:0009071Inflammatory myopathy1AGK CL E G H557501369ORPHA134721869610345
HP:0003198HP:0008978Necrotizing myopathy1AGK CL E G H557501369ORPHA134721869610345
HP:0003198HP:0003789Minicore myopathy1AGK CL E G H55750212350Cataract and cardiomyopathy212350C1859317OMIM134721869610345
HP:0003198HP:0003756Skeletal myopathy1AGK CL E G H55750212350Cataract and cardiomyopathy212350C1859317OMIM134721869610345
HP:0003198HP:0009071Inflammatory myopathy1AGK CL E G H55750212350Cataract and cardiomyopathy212350C1859317OMIM134721869610345
HP:0003198HP:0008978Necrotizing myopathy1AGK CL E G H55750212350Cataract and cardiomyopathy212350C1859317OMIM134721869610345
HP:0003198HP:0003458EMG: myopathic abnormalities1AGK CL E G H55750212350Cataract and cardiomyopathy212350C1859317OMIM134721869610345
HP:0003198HP:0003715Myofibrillar myopathy1AGK CL E G H55750212350Cataract and cardiomyopathy212350C1859317OMIM134721869610345
HP:0003198HP:0003789Minicore myopathy1AGL CL E G H178366Arnold Stickler Bourne syndromeORPHA12263321610860
HP:0003198HP:0003756Skeletal myopathy1AGL CL E G H178366Arnold Stickler Bourne syndromeORPHA12263321610860
HP:0003198HP:0009071Inflammatory myopathy1AGL CL E G H178366Arnold Stickler Bourne syndromeORPHA12263321610860
HP:0003198HP:0008978Necrotizing myopathy1AGL CL E G H178366Arnold Stickler Bourne syndromeORPHA12263321610860
HP:0003198HP:0003458EMG: myopathic abnormalities1AGL CL E G H178366Arnold Stickler Bourne syndromeORPHA12263321610860
HP:0003198HP:0003715Myofibrillar myopathy1AGL CL E G H178366Arnold Stickler Bourne syndromeORPHA12263321610860
HP:0003198HP:0003789Minicore myopathy1AGL CL E G H178232400Glycogen storage disease type III232400C0017922OMIM12263321610860
HP:0003198HP:0003756Skeletal myopathy1AGL CL E G H178232400Glycogen storage disease type III232400C0017922OMIM12263321610860
HP:0003198HP:0008978Necrotizing myopathy1AGL CL E G H178232400Glycogen storage disease type III232400C0017922OMIM12263321610860
HP:0003198HP:0009071Inflammatory myopathy1AGL CL E G H178232400Glycogen storage disease type III232400C0017922OMIM12263321610860
HP:0003198HP:0003715Myofibrillar myopathy1AGL CL E G H178232400Glycogen storage disease type III232400C0017922OMIM12263321610860
HP:0003198HP:0003458EMG: myopathic abnormalities1AGL CL E G H178232400Glycogen storage disease type III232400C0017922OMIM12263321610860
HP:0003198HP:0003789Minicore myopathy1AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1242325603100
HP:0003198HP:0003756Skeletal myopathy1AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1242325603100
HP:0003198HP:0009071Inflammatory myopathy1AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1242325603100
HP:0003198HP:0008978Necrotizing myopathy1AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1242325603100
HP:0003198HP:0003458EMG: myopathic abnormalities1AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1242325603100
HP:0003198HP:0003715Myofibrillar myopathy1AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1242325603100
HP:0003198HP:0009071Inflammatory myopathy1ALG14 CL E G H199857353327ORPHA114428287612866
HP:0003198HP:0008978Necrotizing myopathy1ALG14 CL E G H199857353327ORPHA114428287612866
HP:0003198HP:0003458EMG: myopathic abnormalities1ALG14 CL E G H199857353327ORPHA114428287612866
HP:0003198HP:0003715Myofibrillar myopathy1ALG14 CL E G H199857353327ORPHA114428287612866
HP:0003198HP:0003789Minicore myopathy1ALG14 CL E G H199857353327ORPHA114428287612866
HP:0003198HP:0003756Skeletal myopathy1ALG14 CL E G H199857353327ORPHA114428287612866
HP:0003198HP:0008978Necrotizing myopathy1ALG2 CL E G H85365353327ORPHA133523159607905
HP:0003198HP:0009071Inflammatory myopathy1ALG2 CL E G H85365353327ORPHA133523159607905
HP:0003198HP:0003715Myofibrillar myopathy1ALG2 CL E G H85365353327ORPHA133523159607905
HP:0003198HP:0003458EMG: myopathic abnormalities1ALG2 CL E G H85365353327ORPHA133523159607905
HP:0003198HP:0003789Minicore myopathy1ALG2 CL E G H85365353327ORPHA133523159607905
HP:0003198HP:0003756Skeletal myopathy1ALG2 CL E G H85365353327ORPHA133523159607905
HP:0003198HP:0003756Skeletal myopathy1ALPL CL E G H249241510Childhood hypophosphatasia241510C0220743OMIM1934438171760
HP:0003198HP:0003789Minicore myopathy1ALPL CL E G H249241510Childhood hypophosphatasia241510C0220743OMIM1934438171760
HP:0003198HP:0008978Necrotizing myopathy1ALPL CL E G H249241510Childhood hypophosphatasia241510C0220743OMIM1934438171760
HP:0003198HP:0009071Inflammatory myopathy1ALPL CL E G H249241510Childhood hypophosphatasia241510C0220743OMIM1934438171760
HP:0003198HP:0003715Myofibrillar myopathy1ALPL CL E G H249241510Childhood hypophosphatasia241510C0220743OMIM1934438171760
HP:0003198HP:0003458EMG: myopathic abnormalities1ALPL CL E G H249241510Childhood hypophosphatasia241510C0220743OMIM1934438171760
HP:0003198HP:0003458EMG: myopathic abnormalities1AP1S2 CL E G H890585329ORPHA1241560300629
HP:0003198HP:0003715Myofibrillar myopathy1AP1S2 CL E G H890585329ORPHA1241560300629
HP:0003198HP:0003789Minicore myopathy1AP1S2 CL E G H890585329ORPHA1241560300629
HP:0003198HP:0003756Skeletal myopathy1AP1S2 CL E G H890585329ORPHA1241560300629
HP:0003198HP:0009071Inflammatory myopathy1AP1S2 CL E G H890585329ORPHA1241560300629
HP:0003198HP:0008978Necrotizing myopathy1AP1S2 CL E G H890585329ORPHA1241560300629
HP:0003198HP:0003458EMG: myopathic abnormalities1B3GALNT2 CL E G H148789588ORPHA158728596610194
HP:0003198HP:0003715Myofibrillar myopathy1B3GALNT2 CL E G H148789588ORPHA158728596610194
HP:0003198HP:0003789Minicore myopathy1B3GALNT2 CL E G H148789588ORPHA158728596610194
HP:0003198HP:0003756Skeletal myopathy1B3GALNT2 CL E G H148789588ORPHA158728596610194
HP:0003198HP:0009071Inflammatory myopathy1B3GALNT2 CL E G H148789588ORPHA158728596610194
HP:0003198HP:0008978Necrotizing myopathy1B3GALNT2 CL E G H148789588ORPHA158728596610194
HP:0003198HP:0003458EMG: myopathic abnormalities1B4GALT1 CL E G H268379332ORPHA1184924137060
HP:0003198HP:0003715Myofibrillar myopathy1B4GALT1 CL E G H268379332ORPHA1184924137060
HP:0003198HP:0003789Minicore myopathy1B4GALT1 CL E G H268379332ORPHA1184924137060
HP:0003198HP:0003756Skeletal myopathy1B4GALT1 CL E G H268379332ORPHA1184924137060
HP:0003198HP:0009071Inflammatory myopathy1B4GALT1 CL E G H268379332ORPHA1184924137060
HP:0003198HP:0008978Necrotizing myopathy1B4GALT1 CL E G H268379332ORPHA1184924137060
HP:0003198HP:0003756Skeletal myopathy1B4GALT1 CL E G H2683607091Congenital disorder of glycosylation type 2D607091C1846816OMIM1184924137060
HP:0003198HP:0003789Minicore myopathy1B4GALT1 CL E G H2683607091Congenital disorder of glycosylation type 2D607091C1846816OMIM1184924137060
HP:0003198HP:0008978Necrotizing myopathy1B4GALT1 CL E G H2683607091Congenital disorder of glycosylation type 2D607091C1846816OMIM1184924137060
HP:0003198HP:0009071Inflammatory myopathy1B4GALT1 CL E G H2683607091Congenital disorder of glycosylation type 2D607091C1846816OMIM1184924137060
HP:0003198HP:0003715Myofibrillar myopathy1B4GALT1 CL E G H2683607091Congenital disorder of glycosylation type 2D607091C1846816OMIM1184924137060
HP:0003198HP:0003458EMG: myopathic abnormalities1B4GALT1 CL E G H2683607091Congenital disorder of glycosylation type 2D607091C1846816OMIM1184924137060
HP:0003198HP:0003715Myofibrillar myopathy1BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA151015832606158
HP:0003198HP:0003789Minicore myopathy1BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA151015832606158
HP:0003198HP:0003756Skeletal myopathy1BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA151015832606158
HP:0003198HP:0009071Inflammatory myopathy1BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA151015832606158
HP:0003198HP:0008978Necrotizing myopathy1BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA151015832606158
HP:0003198HP:0003458EMG: myopathic abnormalities1BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA151015832606158
HP:0003198HP:0003789Minicore myopathy1C1QBP CL E G H708617713COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33617713C4540209OMIM11371243601269
HP:0003198HP:0003756Skeletal myopathy1C1QBP CL E G H708617713COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33617713C4540209OMIM11371243601269
HP:0003198HP:0009071Inflammatory myopathy1C1QBP CL E G H708617713COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33617713C4540209OMIM11371243601269
HP:0003198HP:0008978Necrotizing myopathy1C1QBP CL E G H708617713COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33617713C4540209OMIM11371243601269
HP:0003198HP:0003458EMG: myopathic abnormalities1C1QBP CL E G H708617713COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33617713C4540209OMIM11371243601269
HP:0003198HP:0003715Myofibrillar myopathy1C1QBP CL E G H708617713COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33617713C4540209OMIM11371243601269
HP:0003198HP:0003789Minicore myopathy1CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003198HP:0003756Skeletal myopathy1CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003198HP:0009071Inflammatory myopathy1CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003198HP:0008978Necrotizing myopathy1CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003198HP:0003458EMG: myopathic abnormalities1CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003198HP:0003715Myofibrillar myopathy1CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003198HP:0008978Necrotizing myopathy1CASQ1 CL E G H84488635ORPHA12491512114250
HP:0003198HP:0003458EMG: myopathic abnormalities1CASQ1 CL E G H84488635ORPHA12491512114250
HP:0003198HP:0003715Myofibrillar myopathy1CASQ1 CL E G H84488635ORPHA12491512114250
HP:0003198HP:0003789Minicore myopathy1CASQ1 CL E G H84488635ORPHA12491512114250
HP:0003198HP:0003756Skeletal myopathy1CASQ1 CL E G H84488635ORPHA12491512114250
HP:0003198HP:0009071Inflammatory myopathy1CASQ1 CL E G H84488635ORPHA12491512114250
HP:0003198HP:0003458EMG: myopathic abnormalities1CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA11351527601047
HP:0003198HP:0003715Myofibrillar myopathy1CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA11351527601047
HP:0003198HP:0003789Minicore myopathy1CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA11351527601047
HP:0003198HP:0003756Skeletal myopathy1CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA11351527601047
HP:0003198HP:0009071Inflammatory myopathy1CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA11351527601047
HP:0003198HP:0008978Necrotizing myopathy1CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA11351527601047
HP:0003198HP:0003715Myofibrillar myopathy1CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11289688603198
HP:0003198HP:0003458EMG: myopathic abnormalities1CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11289688603198
HP:0003198HP:0003756Skeletal myopathy1CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11289688603198
HP:0003198HP:0003789Minicore myopathy1CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11289688603198
HP:0003198HP:0008978Necrotizing myopathy1CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11289688603198
HP:0003198HP:0009071Inflammatory myopathy1CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11289688603198
HP:0003198HP:0003789Minicore myopathy1CCDC174 CL E G H51244616816Hypotonia, infantile, with psychomotor retardation616816C4225196OMIM18728033616735
HP:0003198HP:0003756Skeletal myopathy1CCDC174 CL E G H51244616816Hypotonia, infantile, with psychomotor retardation616816C4225196OMIM18728033616735
HP:0003198HP:0009071Inflammatory myopathy1CCDC174 CL E G H51244616816Hypotonia, infantile, with psychomotor retardation616816C4225196OMIM18728033616735
HP:0003198HP:0008978Necrotizing myopathy1CCDC174 CL E G H51244616816Hypotonia, infantile, with psychomotor retardation616816C4225196OMIM18728033616735
HP:0003198HP:0003458EMG: myopathic abnormalities1CCDC174 CL E G H51244616816Hypotonia, infantile, with psychomotor retardation616816C4225196OMIM18728033616735
HP:0003198HP:0003715Myofibrillar myopathy1CCDC174 CL E G H51244616816Hypotonia, infantile, with psychomotor retardation616816C4225196OMIM18728033616735
HP:0003198HP:0003789Minicore myopathy1CENPF CL E G H1063243605Stromme syndrome243605C1855705OMIM15541857600236
HP:0003198HP:0003756Skeletal myopathy1CENPF CL E G H1063243605Stromme syndrome243605C1855705OMIM15541857600236
HP:0003198HP:0009071Inflammatory myopathy1CENPF CL E G H1063243605Stromme syndrome243605C1855705OMIM15541857600236
HP:0003198HP:0008978Necrotizing myopathy1CENPF CL E G H1063243605Stromme syndrome243605C1855705OMIM15541857600236
HP:0003198HP:0003458EMG: myopathic abnormalities1CENPF CL E G H1063243605Stromme syndrome243605C1855705OMIM15541857600236
HP:0003198HP:0003715Myofibrillar myopathy1CENPF CL E G H1063243605Stromme syndrome243605C1855705OMIM15541857600236
HP:0003198HP:0003789Minicore myopathy1CHKB CL E G H1120602541Muscular dystrophy, congenital, megaconial type602541C1865233OMIM15021938612395
HP:0003198HP:0003756Skeletal myopathy1CHKB CL E G H1120602541Muscular dystrophy, congenital, megaconial type602541C1865233OMIM15021938612395
HP:0003198HP:0009071Inflammatory myopathy1CHKB CL E G H1120602541Muscular dystrophy, congenital, megaconial type602541C1865233OMIM15021938612395
HP:0003198HP:0008978Necrotizing myopathy1CHKB CL E G H1120602541Muscular dystrophy, congenital, megaconial type602541C1865233OMIM15021938612395
HP:0003198HP:0003458EMG: myopathic abnormalities1CHKB CL E G H1120602541Muscular dystrophy, congenital, megaconial type602541C1865233OMIM15021938612395
HP:0003198HP:0003715Myofibrillar myopathy1CHKB CL E G H1120602541Muscular dystrophy, congenital, megaconial type602541C1865233OMIM15021938612395
HP:0003198HP:0003756Skeletal myopathy1CHRNB1 CL E G H1140616313Myasthenic syndrome, congenital, 2a, slow-channel616313C4225374OMIM14541961100710
HP:0003198HP:0003789Minicore myopathy1CHRNB1 CL E G H1140616313Myasthenic syndrome, congenital, 2a, slow-channel616313C4225374OMIM14541961100710
HP:0003198HP:0008978Necrotizing myopathy1CHRNB1 CL E G H1140616313Myasthenic syndrome, congenital, 2a, slow-channel616313C4225374OMIM14541961100710
HP:0003198HP:0009071Inflammatory myopathy1CHRNB1 CL E G H1140616313Myasthenic syndrome, congenital, 2a, slow-channel616313C4225374OMIM14541961100710
HP:0003198HP:0003458EMG: myopathic abnormalities1CHRNB1 CL E G H1140616313Myasthenic syndrome, congenital, 2a, slow-channel616313C4225374OMIM14541961100710
HP:0003198HP:0003715Myofibrillar myopathy1CHRNB1 CL E G H1140616313Myasthenic syndrome, congenital, 2a, slow-channel616313C4225374OMIM14541961100710
HP:0003198HP:0003789Minicore myopathy1CHRNB1 CL E G H1140616314Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency616314C4225373OMIM14541961100710
HP:0003198HP:0003756Skeletal myopathy1CHRNB1 CL E G H1140616314Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency616314C4225373OMIM14541961100710
HP:0003198HP:0009071Inflammatory myopathy1CHRNB1 CL E G H1140616314Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency616314C4225373OMIM14541961100710
HP:0003198HP:0008978Necrotizing myopathy1CHRNB1 CL E G H1140616314Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency616314C4225373OMIM14541961100710
HP:0003198HP:0003458EMG: myopathic abnormalities1CHRNB1 CL E G H1140616314Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency616314C4225373OMIM14541961100710
HP:0003198HP:0003715Myofibrillar myopathy1CHRNB1 CL E G H1140616314Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency616314C4225373OMIM14541961100710
HP:0003198HP:0003789Minicore myopathy1CHRND CL E G H1144616321Myasthenic syndrome, congenital, 3a, slow-channel616321C4225372OMIM15051965100720
HP:0003198HP:0003756Skeletal myopathy1CHRND CL E G H1144616321Myasthenic syndrome, congenital, 3a, slow-channel616321C4225372OMIM15051965100720
HP:0003198HP:0009071Inflammatory myopathy1CHRND CL E G H1144616321Myasthenic syndrome, congenital, 3a, slow-channel616321C4225372OMIM15051965100720
HP:0003198HP:0008978Necrotizing myopathy1CHRND CL E G H1144616321Myasthenic syndrome, congenital, 3a, slow-channel616321C4225372OMIM15051965100720
HP:0003198HP:0003458EMG: myopathic abnormalities1CHRND CL E G H1144616321Myasthenic syndrome, congenital, 3a, slow-channel616321C4225372OMIM15051965100720
HP:0003198HP:0003715Myofibrillar myopathy1CHRND CL E G H1144616321Myasthenic syndrome, congenital, 3a, slow-channel616321C4225372OMIM15051965100720
HP:0003198HP:0003789Minicore myopathy1CHRNE CL E G H1145605809Myasthenic syndrome, congenital, 4a, slow-channel605809C1853949OMIM110111966100725
HP:0003198HP:0003756Skeletal myopathy1CHRNE CL E G H1145605809Myasthenic syndrome, congenital, 4a, slow-channel605809C1853949OMIM110111966100725
HP:0003198HP:0009071Inflammatory myopathy1CHRNE CL E G H1145605809Myasthenic syndrome, congenital, 4a, slow-channel605809C1853949OMIM110111966100725
HP:0003198HP:0008978Necrotizing myopathy1CHRNE CL E G H1145605809Myasthenic syndrome, congenital, 4a, slow-channel605809C1853949OMIM110111966100725
HP:0003198HP:0003458EMG: myopathic abnormalities1CHRNE CL E G H1145605809Myasthenic syndrome, congenital, 4a, slow-channel605809C1853949OMIM110111966100725
HP:0003198HP:0003715Myofibrillar myopathy1CHRNE CL E G H1145605809Myasthenic syndrome, congenital, 4a, slow-channel605809C1853949OMIM110111966100725
HP:0003198HP:0003789Minicore myopathy1COL12A1 CL E G H1303616471Bethlem myopathy 2616471C4225313OMIM125482188120320
HP:0003198HP:0003756Skeletal myopathy1COL12A1 CL E G H1303616471Bethlem myopathy 2616471C4225313OMIM125482188120320
HP:0003198HP:0009071Inflammatory myopathy1COL12A1 CL E G H1303616471Bethlem myopathy 2616471C4225313OMIM125482188120320
HP:0003198HP:0008978Necrotizing myopathy1COL12A1 CL E G H1303616471Bethlem myopathy 2616471C4225313OMIM125482188120320
HP:0003198HP:0003458EMG: myopathic abnormalities1COL12A1 CL E G H1303616471Bethlem myopathy 2616471C4225313OMIM125482188120320
HP:0003198HP:0003715Myofibrillar myopathy1COL12A1 CL E G H1303616471Bethlem myopathy 2616471C4225313OMIM125482188120320
HP:0003198HP:0003789Minicore myopathy1COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003198HP:0003756Skeletal myopathy1COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003198HP:0009071Inflammatory myopathy1COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003198HP:0008978Necrotizing myopathy1COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003198HP:0003458EMG: myopathic abnormalities1COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003198HP:0003715Myofibrillar myopathy1COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003198HP:0003789Minicore myopathy1COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003198HP:0003756Skeletal myopathy1COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003198HP:0009071Inflammatory myopathy1COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003198HP:0008978Necrotizing myopathy1COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003198HP:0003458EMG: myopathic abnormalities1COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003198HP:0003715Myofibrillar myopathy1COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003198HP:0003789Minicore myopathy1COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003198HP:0003756Skeletal myopathy1COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003198HP:0008978Necrotizing myopathy1COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003198HP:0009071Inflammatory myopathy1COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003198HP:0003715Myofibrillar myopathy1COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003198HP:0003458EMG: myopathic abnormalities1COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003198HP:0009071Inflammatory myopathy1COLQ CL E G H829298915ORPHA15422226603033
HP:0003198HP:0008978Necrotizing myopathy1COLQ CL E G H829298915ORPHA15422226603033
HP:0003198HP:0003458EMG: myopathic abnormalities1COLQ CL E G H829298915ORPHA15422226603033
HP:0003198HP:0003715Myofibrillar myopathy1COLQ CL E G H829298915ORPHA15422226603033
HP:0003198HP:0003789Minicore myopathy1COLQ CL E G H829298915ORPHA15422226603033
HP:0003198HP:0003756Skeletal myopathy1COLQ CL E G H829298915ORPHA15422226603033
HP:0003198HP:0003756Skeletal myopathy1COLQ CL E G H8292603034Endplate acetylcholinesterase deficiency603034C1864233OMIM15422226603033
HP:0003198HP:0003789Minicore myopathy1COLQ CL E G H8292603034Endplate acetylcholinesterase deficiency603034C1864233OMIM15422226603033
HP:0003198HP:0009071Inflammatory myopathy1COLQ CL E G H8292603034Endplate acetylcholinesterase deficiency603034C1864233OMIM15422226603033
HP:0003198HP:0008978Necrotizing myopathy1COLQ CL E G H8292603034Endplate acetylcholinesterase deficiency603034C1864233OMIM15422226603033
HP:0003198HP:0003458EMG: myopathic abnormalities1COLQ CL E G H8292603034Endplate acetylcholinesterase deficiency603034C1864233OMIM15422226603033
HP:0003198HP:0003715Myofibrillar myopathy1COLQ CL E G H8292603034Endplate acetylcholinesterase deficiency603034C1864233OMIM15422226603033
HP:0003198HP:0008978Necrotizing myopathy1CPT2 CL E G H1376228302ORPHA18762330600650
HP:0003198HP:0009071Inflammatory myopathy1CPT2 CL E G H1376228305ORPHA18762330600650
HP:0003198HP:0008978Necrotizing myopathy1CPT2 CL E G H1376228305ORPHA18762330600650
HP:0003198HP:0009071Inflammatory myopathy1CPT2 CL E G H1376228302ORPHA18762330600650
HP:0003198HP:0003458EMG: myopathic abnormalities1CPT2 CL E G H1376228305ORPHA18762330600650
HP:0003198HP:0003715Myofibrillar myopathy1CPT2 CL E G H1376228305ORPHA18762330600650
HP:0003198HP:0003458EMG: myopathic abnormalities1CPT2 CL E G H1376228302ORPHA18762330600650
HP:0003198HP:0003715Myofibrillar myopathy1CPT2 CL E G H1376228302ORPHA18762330600650
HP:0003198HP:0003756Skeletal myopathy1CPT2 CL E G H1376228302ORPHA18762330600650
HP:0003198HP:0003789Minicore myopathy1CPT2 CL E G H1376228305ORPHA18762330600650
HP:0003198HP:0003756Skeletal myopathy1CPT2 CL E G H1376228305ORPHA18762330600650
HP:0003198HP:0003789Minicore myopathy1CPT2 CL E G H1376228302ORPHA18762330600650
HP:0003198HP:0009071Inflammatory myopathy1DNA2 CL E G H1763352470ORPHA16012939601810
HP:0003198HP:0008978Necrotizing myopathy1DNA2 CL E G H1763352470ORPHA16012939601810
HP:0003198HP:0003458EMG: myopathic abnormalities1DNA2 CL E G H1763352470ORPHA16012939601810
HP:0003198HP:0003715Myofibrillar myopathy1DNA2 CL E G H1763352470ORPHA16012939601810
HP:0003198HP:0003789Minicore myopathy1DNA2 CL E G H1763352470ORPHA16012939601810
HP:0003198HP:0003756Skeletal myopathy1DNA2 CL E G H1763352470ORPHA16012939601810
HP:0003198HP:0009071Inflammatory myopathy1DPAGT1 CL E G H1798353327ORPHA13122995191350
HP:0003198HP:0008978Necrotizing myopathy1DPAGT1 CL E G H1798353327ORPHA13122995191350
HP:0003198HP:0003458EMG: myopathic abnormalities1DPAGT1 CL E G H1798353327ORPHA13122995191350
HP:0003198HP:0003715Myofibrillar myopathy1DPAGT1 CL E G H1798353327ORPHA13122995191350
HP:0003198HP:0003789Minicore myopathy1DPAGT1 CL E G H1798353327ORPHA13122995191350
HP:0003198HP:0003756Skeletal myopathy1DPAGT1 CL E G H1798353327ORPHA13122995191350
HP:0003198HP:0003789Minicore myopathy1DYSF CL E G H8291606768Myopathy, distal, with anterior tibial onset606768C1847532OMIM133553097603009
HP:0003198HP:0003756Skeletal myopathy1DYSF CL E G H8291606768Myopathy, distal, with anterior tibial onset606768C1847532OMIM133553097603009
HP:0003198HP:0009071Inflammatory myopathy1DYSF CL E G H8291606768Myopathy, distal, with anterior tibial onset606768C1847532OMIM133553097603009
HP:0003198HP:0008978Necrotizing myopathy1DYSF CL E G H8291606768Myopathy, distal, with anterior tibial onset606768C1847532OMIM133553097603009
HP:0003198HP:0003458EMG: myopathic abnormalities1DYSF CL E G H8291606768Myopathy, distal, with anterior tibial onset606768C1847532OMIM133553097603009
HP:0003198HP:0003715Myofibrillar myopathy1DYSF CL E G H8291606768Myopathy, distal, with anterior tibial onset606768C1847532OMIM133553097603009
HP:0003198HP:0003789Minicore myopathy1EMD CL E G H2010310300Emery-Dreifuss muscular dystrophy 1, X-linked310300C0751337OMIM16953331300384
HP:0003198HP:0003756Skeletal myopathy1EMD CL E G H2010310300Emery-Dreifuss muscular dystrophy 1, X-linked310300C0751337OMIM16953331300384
HP:0003198HP:0009071Inflammatory myopathy1EMD CL E G H2010310300Emery-Dreifuss muscular dystrophy 1, X-linked310300C0751337OMIM16953331300384
HP:0003198HP:0008978Necrotizing myopathy1EMD CL E G H2010310300Emery-Dreifuss muscular dystrophy 1, X-linked310300C0751337OMIM16953331300384
HP:0003198HP:0003458EMG: myopathic abnormalities1EMD CL E G H2010310300Emery-Dreifuss muscular dystrophy 1, X-linked310300C0751337OMIM16953331300384
HP:0003198HP:0003715Myofibrillar myopathy1EMD CL E G H2010310300Emery-Dreifuss muscular dystrophy 1, X-linked310300C0751337OMIM16953331300384
HP:0003198HP:0003789Minicore myopathy1EPG5 CL E G H57724242840Vici syndrome242840C1855772OMIM1164029331615068
HP:0003198HP:0003756Skeletal myopathy1EPG5 CL E G H57724242840Vici syndrome242840C1855772OMIM1164029331615068
HP:0003198HP:0009071Inflammatory myopathy1EPG5 CL E G H57724242840Vici syndrome242840C1855772OMIM1164029331615068
HP:0003198HP:0008978Necrotizing myopathy1EPG5 CL E G H57724242840Vici syndrome242840C1855772OMIM1164029331615068
HP:0003198HP:0003458EMG: myopathic abnormalities1EPG5 CL E G H57724242840Vici syndrome242840C1855772OMIM1164029331615068
HP:0003198HP:0003715Myofibrillar myopathy1EPG5 CL E G H57724242840Vici syndrome242840C1855772OMIM1164029331615068
HP:0003198HP:0003756Skeletal myopathy1ERGIC1 CL E G H57222208100Arthrogryposis multiplex congenita neurogenic type208100C1859721OMIM13929205617946
HP:0003198HP:0003789Minicore myopathy1ERGIC1 CL E G H57222208100Arthrogryposis multiplex congenita neurogenic type208100C1859721OMIM13929205617946
HP:0003198HP:0008978Necrotizing myopathy1ERGIC1 CL E G H57222208100Arthrogryposis multiplex congenita neurogenic type208100C1859721OMIM13929205617946
HP:0003198HP:0009071Inflammatory myopathy1ERGIC1 CL E G H57222208100Arthrogryposis multiplex congenita neurogenic type208100C1859721OMIM13929205617946
HP:0003198HP:0003458EMG: myopathic abnormalities1ERGIC1 CL E G H57222208100Arthrogryposis multiplex congenita neurogenic type208100C1859721OMIM13929205617946
HP:0003198HP:0003715Myofibrillar myopathy1ERGIC1 CL E G H57222208100Arthrogryposis multiplex congenita neurogenic type208100C1859721OMIM13929205617946
HP:0003198HP:0003789Minicore myopathy1FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003198HP:0003756Skeletal myopathy1FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003198HP:0009071Inflammatory myopathy1FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003198HP:0008978Necrotizing myopathy1FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003198HP:0003715Myofibrillar myopathy1FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003198HP:0003458EMG: myopathic abnormalities1FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003198HP:0009071Inflammatory myopathy1FKBP14 CL E G H55033300179ORPHA122018625614505
HP:0003198HP:0008978Necrotizing myopathy1FKBP14 CL E G H55033300179ORPHA122018625614505
HP:0003198HP:0003458EMG: myopathic abnormalities1FKBP14 CL E G H55033300179ORPHA122018625614505
HP:0003198HP:0003715Myofibrillar myopathy1FKBP14 CL E G H55033300179ORPHA122018625614505
HP:0003198HP:0003789Minicore myopathy1FKBP14 CL E G H55033300179ORPHA122018625614505
HP:0003198HP:0003756Skeletal myopathy1FKBP14 CL E G H55033300179ORPHA122018625614505
HP:0003198HP:0003789Minicore myopathy1FKBP14 CL E G H55033614557Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss614557C3281160OMIM122018625614505
HP:0003198HP:0003756Skeletal myopathy1FKBP14 CL E G H55033614557Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss614557C3281160OMIM122018625614505
HP:0003198HP:0009071Inflammatory myopathy1FKBP14 CL E G H55033614557Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss614557C3281160OMIM122018625614505
HP:0003198HP:0008978Necrotizing myopathy1FKBP14 CL E G H55033614557Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss614557C3281160OMIM122018625614505
HP:0003198HP:0003458EMG: myopathic abnormalities1FKBP14 CL E G H55033614557Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss614557C3281160OMIM122018625614505
HP:0003198HP:0003715Myofibrillar myopathy1FKBP14 CL E G H55033614557Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss614557C3281160OMIM122018625614505
HP:0003198HP:0003458EMG: myopathic abnormalities1FKRP CL E G H79147588ORPHA195017997606596
HP:0003198HP:0003715Myofibrillar myopathy1FKRP CL E G H79147588ORPHA195017997606596
HP:0003198HP:0003789Minicore myopathy1FKRP CL E G H79147588ORPHA195017997606596
HP:0003198HP:0003756Skeletal myopathy1FKRP CL E G H79147588ORPHA195017997606596
HP:0003198HP:0009071Inflammatory myopathy1FKRP CL E G H79147588ORPHA195017997606596
HP:0003198HP:0008978Necrotizing myopathy1FKRP CL E G H79147588ORPHA195017997606596
HP:0003198HP:0003458EMG: myopathic abnormalities1FKTN CL E G H2218588ORPHA19143622607440
HP:0003198HP:0003715Myofibrillar myopathy1FKTN CL E G H2218588ORPHA19143622607440
HP:0003198HP:0003789Minicore myopathy1FKTN CL E G H2218588ORPHA19143622607440
HP:0003198HP:0003756Skeletal myopathy1FKTN CL E G H2218588ORPHA19143622607440
HP:0003198HP:0009071Inflammatory myopathy1FKTN CL E G H2218588ORPHA19143622607440
HP:0003198HP:0008978Necrotizing myopathy1FKTN CL E G H2218588ORPHA19143622607440
HP:0003198HP:0003789Minicore myopathy1FKTN CL E G H2218272VACTERL hydrocephalyORPHA19143622607440
HP:0003198HP:0003756Skeletal myopathy1FKTN CL E G H2218272VACTERL hydrocephalyORPHA19143622607440
HP:0003198HP:0009071Inflammatory myopathy1FKTN CL E G H2218272VACTERL hydrocephalyORPHA19143622607440
HP:0003198HP:0008978Necrotizing myopathy1FKTN CL E G H2218272VACTERL hydrocephalyORPHA19143622607440
HP:0003198HP:0003458EMG: myopathic abnormalities1FKTN CL E G H2218272VACTERL hydrocephalyORPHA19143622607440
HP:0003198HP:0003715Myofibrillar myopathy1FKTN CL E G H2218272VACTERL hydrocephalyORPHA19143622607440
HP:0003198HP:0003789Minicore myopathy1FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003198HP:0003756Skeletal myopathy1FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003198HP:0008978Necrotizing myopathy1FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003198HP:0009071Inflammatory myopathy1FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003198HP:0003715Myofibrillar myopathy1FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003198HP:0003458EMG: myopathic abnormalities1FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003198HP:0003756Skeletal myopathy1FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003198HP:0003789Minicore myopathy1FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003198HP:0008978Necrotizing myopathy1FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003198HP:0009071Inflammatory myopathy1FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003198HP:0003458EMG: myopathic abnormalities1FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003198HP:0003715Myofibrillar myopathy1FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003198HP:0003458EMG: myopathic abnormalities1FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1403796164810
HP:0003198HP:0003715Myofibrillar myopathy1FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1403796164810
HP:0003198HP:0003789Minicore myopathy1FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1403796164810
HP:0003198HP:0003756Skeletal myopathy1FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1403796164810
HP:0003198HP:0009071Inflammatory myopathy1FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1403796164810
HP:0003198HP:0008978Necrotizing myopathy1FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1403796164810
HP:0003198HP:0003789Minicore myopathy1GCLC CL E G H2729230450Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to230450C1856603OMIM11284311606857
HP:0003198HP:0003756Skeletal myopathy1GCLC CL E G H2729230450Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to230450C1856603OMIM11284311606857
HP:0003198HP:0009071Inflammatory myopathy1GCLC CL E G H2729230450Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to230450C1856603OMIM11284311606857
HP:0003198HP:0008978Necrotizing myopathy1GCLC CL E G H2729230450Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to230450C1856603OMIM11284311606857
HP:0003198HP:0003458EMG: myopathic abnormalities1GCLC CL E G H2729230450Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to230450C1856603OMIM11284311606857
HP:0003198HP:0003715Myofibrillar myopathy1GCLC CL E G H2729230450Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to230450C1856603OMIM11284311606857
HP:0003198HP:0003789Minicore myopathy1GFER CL E G H2671613076Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay613076C2751320OMIM12004236600924
HP:0003198HP:0003756Skeletal myopathy1GFER CL E G H2671613076Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay613076C2751320OMIM12004236600924
HP:0003198HP:0009071Inflammatory myopathy1GFER CL E G H2671613076Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay613076C2751320OMIM12004236600924
HP:0003198HP:0008978Necrotizing myopathy1GFER CL E G H2671613076Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay613076C2751320OMIM12004236600924
HP:0003198HP:0003458EMG: myopathic abnormalities1GFER CL E G H2671613076Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay613076C2751320OMIM12004236600924
HP:0003198HP:0003715Myofibrillar myopathy1GFER CL E G H2671613076Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay613076C2751320OMIM12004236600924
HP:0003198HP:0008978Necrotizing myopathy1GFPT1 CL E G H2673353327ORPHA15244241138292
HP:0003198HP:0009071Inflammatory myopathy1GFPT1 CL E G H2673353327ORPHA15244241138292
HP:0003198HP:0003458EMG: myopathic abnormalities1GFPT1 CL E G H2673353327ORPHA15244241138292
HP:0003198HP:0003715Myofibrillar myopathy1GFPT1 CL E G H2673353327ORPHA15244241138292
HP:0003198HP:0003756Skeletal myopathy1GFPT1 CL E G H2673353327ORPHA15244241138292
HP:0003198HP:0003789Minicore myopathy1GFPT1 CL E G H2673353327ORPHA15244241138292
HP:0003198HP:0003789Minicore myopathy1GK CL E G H2710307030Deficiency of glycerol kinase307030C0268418OMIM12334289300474
HP:0003198HP:0003756Skeletal myopathy1GK CL E G H2710307030Deficiency of glycerol kinase307030C0268418OMIM12334289300474
HP:0003198HP:0009071Inflammatory myopathy1GK CL E G H2710307030Deficiency of glycerol kinase307030C0268418OMIM12334289300474
HP:0003198HP:0008978Necrotizing myopathy1GK CL E G H2710307030Deficiency of glycerol kinase307030C0268418OMIM12334289300474
HP:0003198HP:0003458EMG: myopathic abnormalities1GK CL E G H2710307030Deficiency of glycerol kinase307030C0268418OMIM12334289300474
HP:0003198HP:0003715Myofibrillar myopathy1GK CL E G H2710307030Deficiency of glycerol kinase307030C0268418OMIM12334289300474
HP:0003198HP:0009071Inflammatory myopathy1GMPPB CL E G H29925353327ORPHA136422932615320
HP:0003198HP:0008978Necrotizing myopathy1GMPPB CL E G H29925353327ORPHA136422932615320
HP:0003198HP:0003458EMG: myopathic abnormalities1GMPPB CL E G H29925588ORPHA136422932615320
HP:0003198HP:0003715Myofibrillar myopathy1GMPPB CL E G H29925588ORPHA136422932615320
HP:0003198HP:0003458EMG: myopathic abnormalities1GMPPB CL E G H29925353327ORPHA136422932615320
HP:0003198HP:0003715Myofibrillar myopathy1GMPPB CL E G H29925353327ORPHA136422932615320
HP:0003198HP:0003789Minicore myopathy1GMPPB CL E G H29925588ORPHA136422932615320
HP:0003198HP:0003756Skeletal myopathy1GMPPB CL E G H29925588ORPHA136422932615320
HP:0003198HP:0003789Minicore myopathy1GMPPB CL E G H29925353327ORPHA136422932615320
HP:0003198HP:0003756Skeletal myopathy1GMPPB CL E G H29925353327ORPHA136422932615320
HP:0003198HP:0009071Inflammatory myopathy1GMPPB CL E G H29925588ORPHA136422932615320
HP:0003198HP:0008978Necrotizing myopathy1GMPPB CL E G H29925588ORPHA136422932615320
HP:0003198HP:0003789Minicore myopathy1HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003198HP:0003756Skeletal myopathy1HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003198HP:0009071Inflammatory myopathy1HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003198HP:0008978Necrotizing myopathy1HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003198HP:0003458EMG: myopathic abnormalities1HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003198HP:0003715Myofibrillar myopathy1HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003198HP:0003756Skeletal myopathy1HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003198HP:0003789Minicore myopathy1HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003198HP:0009071Inflammatory myopathy1HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003198HP:0008978Necrotizing myopathy1HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003198HP:0003458EMG: myopathic abnormalities1HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003198HP:0003715Myofibrillar myopathy1HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003198HP:0003789Minicore myopathy1HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003198HP:0003756Skeletal myopathy1HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003198HP:0009071Inflammatory myopathy1HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003198HP:0008978Necrotizing myopathy1HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003198HP:0003458EMG: myopathic abnormalities1HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003198HP:0003715Myofibrillar myopathy1HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003198HP:0003789Minicore myopathy1HNRNPA2B1 CL E G H3181615422Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2615422C3809468OMIM12955033600124
HP:0003198HP:0003756Skeletal myopathy1HNRNPA2B1 CL E G H3181615422Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2615422C3809468OMIM12955033600124
HP:0003198HP:0009071Inflammatory myopathy1HNRNPA2B1 CL E G H3181615422Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2615422C3809468OMIM12955033600124
HP:0003198HP:0008978Necrotizing myopathy1HNRNPA2B1 CL E G H3181615422Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2615422C3809468OMIM12955033600124
HP:0003198HP:0003458EMG: myopathic abnormalities1HNRNPA2B1 CL E G H3181615422Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2615422C3809468OMIM12955033600124
HP:0003198HP:0003715Myofibrillar myopathy1HNRNPA2B1 CL E G H3181615422Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2615422C3809468OMIM12955033600124
HP:0003198HP:0003789Minicore myopathy1HNRNPDL CL E G H9987609115Limb-girdle muscular dystrophy, type 1G609115C1836765OMIM13545037607137
HP:0003198HP:0003756Skeletal myopathy1HNRNPDL CL E G H9987609115Limb-girdle muscular dystrophy, type 1G609115C1836765OMIM13545037607137
HP:0003198HP:0009071Inflammatory myopathy1HNRNPDL CL E G H9987609115Limb-girdle muscular dystrophy, type 1G609115C1836765OMIM13545037607137
HP:0003198HP:0008978Necrotizing myopathy1HNRNPDL CL E G H9987609115Limb-girdle muscular dystrophy, type 1G609115C1836765OMIM13545037607137
HP:0003198HP:0003458EMG: myopathic abnormalities1HNRNPDL CL E G H9987609115Limb-girdle muscular dystrophy, type 1G609115C1836765OMIM13545037607137
HP:0003198HP:0003715Myofibrillar myopathy1HNRNPDL CL E G H9987609115Limb-girdle muscular dystrophy, type 1G609115C1836765OMIM13545037607137
HP:0003198HP:0003715Myofibrillar myopathy1HSPG2 CL E G H3339800ORPHA124975273142461
HP:0003198HP:0003458EMG: myopathic abnormalities1HSPG2 CL E G H3339800ORPHA124975273142461
HP:0003198HP:0003789Minicore myopathy1HSPG2 CL E G H3339800ORPHA124975273142461
HP:0003198HP:0003756Skeletal myopathy1HSPG2 CL E G H3339800ORPHA124975273142461
HP:0003198HP:0009071Inflammatory myopathy1HSPG2 CL E G H3339800ORPHA124975273142461
HP:0003198HP:0008978Necrotizing myopathy1HSPG2 CL E G H3339800ORPHA124975273142461
HP:0003198HP:0003458EMG: myopathic abnormalities1INPP5K CL E G H51763559ORPHA118733882607875
HP:0003198HP:0003715Myofibrillar myopathy1INPP5K CL E G H51763559ORPHA118733882607875
HP:0003198HP:0003789Minicore myopathy1INPP5K CL E G H51763559ORPHA118733882607875
HP:0003198HP:0003756Skeletal myopathy1INPP5K CL E G H51763559ORPHA118733882607875
HP:0003198HP:0009071Inflammatory myopathy1INPP5K CL E G H51763559ORPHA118733882607875
HP:0003198HP:0008978Necrotizing myopathy1INPP5K CL E G H51763559ORPHA118733882607875
HP:0003198HP:0003789Minicore myopathy1ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM116029882611911
HP:0003198HP:0003756Skeletal myopathy1ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM116029882611911
HP:0003198HP:0009071Inflammatory myopathy1ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM116029882611911
HP:0003198HP:0008978Necrotizing myopathy1ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM116029882611911
HP:0003198HP:0003458EMG: myopathic abnormalities1ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM116029882611911
HP:0003198HP:0003715Myofibrillar myopathy1ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM116029882611911
HP:0003198HP:0003789Minicore myopathy1ITGA7 CL E G H3679613204Muscular dystrophy, congenital, due to integrin alpha-7 deficiency613204C2750786OMIM18986143600536
HP:0003198HP:0003756Skeletal myopathy1ITGA7 CL E G H3679613204Muscular dystrophy, congenital, due to integrin alpha-7 deficiency613204C2750786OMIM18986143600536
HP:0003198HP:0009071Inflammatory myopathy1ITGA7 CL E G H3679613204Muscular dystrophy, congenital, due to integrin alpha-7 deficiency613204C2750786OMIM18986143600536
HP:0003198HP:0008978Necrotizing myopathy1ITGA7 CL E G H3679613204Muscular dystrophy, congenital, due to integrin alpha-7 deficiency613204C2750786OMIM18986143600536
HP:0003198HP:0003458EMG: myopathic abnormalities1ITGA7 CL E G H3679613204Muscular dystrophy, congenital, due to integrin alpha-7 deficiency613204C2750786OMIM18986143600536
HP:0003198HP:0003715Myofibrillar myopathy1ITGA7 CL E G H3679613204Muscular dystrophy, congenital, due to integrin alpha-7 deficiency613204C2750786OMIM18986143600536
HP:0003198HP:0003789Minicore myopathy1KBTBD13 CL E G H390594609273Nemaline myopathy 6609273C1836472OMIM153037227613727
HP:0003198HP:0003756Skeletal myopathy1KBTBD13 CL E G H390594609273Nemaline myopathy 6609273C1836472OMIM153037227613727
HP:0003198HP:0009071Inflammatory myopathy1KBTBD13 CL E G H390594609273Nemaline myopathy 6609273C1836472OMIM153037227613727
HP:0003198HP:0008978Necrotizing myopathy1KBTBD13 CL E G H390594609273Nemaline myopathy 6609273C1836472OMIM153037227613727
HP:0003198HP:0003458EMG: myopathic abnormalities1KBTBD13 CL E G H390594609273Nemaline myopathy 6609273C1836472OMIM153037227613727
HP:0003198HP:0003715Myofibrillar myopathy1KBTBD13 CL E G H390594609273Nemaline myopathy 6609273C1836472OMIM153037227613727
HP:0003198HP:0008978Necrotizing myopathy1LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003198HP:0009071Inflammatory myopathy1LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003198HP:0003458EMG: myopathic abnormalities1LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003198HP:0003715Myofibrillar myopathy1LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003198HP:0003756Skeletal myopathy1LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003198HP:0003789Minicore myopathy1LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003198HP:0003715Myofibrillar myopathy1LARGE1 CL E G H9215588ORPHA17866511603590
HP:0003198HP:0003458EMG: myopathic abnormalities1LARGE1 CL E G H9215588ORPHA17866511603590
HP:0003198HP:0003789Minicore myopathy1LARGE1 CL E G H9215588ORPHA17866511603590
HP:0003198HP:0003756Skeletal myopathy1LARGE1 CL E G H9215588ORPHA17866511603590
HP:0003198HP:0009071Inflammatory myopathy1LARGE1 CL E G H9215588ORPHA17866511603590
HP:0003198HP:0008978Necrotizing myopathy1LARGE1 CL E G H9215588ORPHA17866511603590
HP:0003198HP:0009071Inflammatory myopathy1LMNA CL E G H4000157973ORPHA118146636150330
HP:0003198HP:0008978Necrotizing myopathy1LMNA CL E G H4000157973ORPHA118146636150330
HP:0003198HP:0003458EMG: myopathic abnormalities1LMNA CL E G H4000157973ORPHA118146636150330
HP:0003198HP:0003715Myofibrillar myopathy1LMNA CL E G H4000157973ORPHA118146636150330
HP:0003198HP:0003789Minicore myopathy1LMNA CL E G H4000157973ORPHA118146636150330
HP:0003198HP:0003756Skeletal myopathy1LMNA CL E G H4000157973ORPHA118146636150330
HP:0003198HP:0003458EMG: myopathic abnormalities1LMNB2 CL E G H8482379087ORPHA15486638150341
HP:0003198HP:0003715Myofibrillar myopathy1LMNB2 CL E G H8482379087ORPHA15486638150341
HP:0003198HP:0003789Minicore myopathy1LMNB2 CL E G H8482379087ORPHA15486638150341
HP:0003198HP:0003756Skeletal myopathy1LMNB2 CL E G H8482379087ORPHA15486638150341
HP:0003198HP:0009071Inflammatory myopathy1LMNB2 CL E G H8482379087ORPHA15486638150341
HP:0003198HP:0008978Necrotizing myopathy1LMNB2 CL E G H8482379087ORPHA15486638150341
HP:0003198HP:0009071Inflammatory myopathy1MGME1 CL E G H92667352447ORPHA115716205615076
HP:0003198HP:0008978Necrotizing myopathy1MGME1 CL E G H92667352447ORPHA115716205615076
HP:0003198HP:0003458EMG: myopathic abnormalities1MGME1 CL E G H92667352447ORPHA115716205615076
HP:0003198HP:0003715Myofibrillar myopathy1MGME1 CL E G H92667352447ORPHA115716205615076
HP:0003198HP:0003789Minicore myopathy1MGME1 CL E G H92667352447ORPHA115716205615076
HP:0003198HP:0003756Skeletal myopathy1MGME1 CL E G H92667352447ORPHA115716205615076
HP:0003198HP:0003789Minicore myopathy1MT-ATP6 CL E G H4508535000Leber's optic atrophy535000C0917796OMIM17414516060
HP:0003198HP:0003756Skeletal myopathy1MT-ATP6 CL E G H4508535000Leber's optic atrophy535000C0917796OMIM17414516060
HP:0003198HP:0009071Inflammatory myopathy1MT-ATP6 CL E G H4508535000Leber's optic atrophy535000C0917796OMIM17414516060
HP:0003198HP:0008978Necrotizing myopathy1MT-ATP6 CL E G H4508535000Leber's optic atrophy535000C0917796OMIM17414516060
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ATP6 CL E G H4508535000Leber's optic atrophy535000C0917796OMIM17414516060
HP:0003198HP:0003715Myofibrillar myopathy1MT-ATP6 CL E G H4508535000Leber's optic atrophy535000C0917796OMIM17414516060
HP:0003198HP:0003756Skeletal myopathy1MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003198HP:0003789Minicore myopathy1MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003198HP:0008978Necrotizing myopathy1MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003198HP:0009071Inflammatory myopathy1MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003198HP:0003715Myofibrillar myopathy1MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003198HP:0003789Minicore myopathy1MT-CO1 CL E G H4512540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17419516030
HP:0003198HP:0003756Skeletal myopathy1MT-CO1 CL E G H4512540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17419516030
HP:0003198HP:0009071Inflammatory myopathy1MT-CO1 CL E G H4512540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17419516030
HP:0003198HP:0008978Necrotizing myopathy1MT-CO1 CL E G H4512540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17419516030
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-CO1 CL E G H4512540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17419516030
HP:0003198HP:0003715Myofibrillar myopathy1MT-CO1 CL E G H4512540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17419516030
HP:0003198HP:0003756Skeletal myopathy1MT-CO2 CL E G H4513540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17421516040
HP:0003198HP:0003789Minicore myopathy1MT-CO2 CL E G H4513540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17421516040
HP:0003198HP:0008978Necrotizing myopathy1MT-CO2 CL E G H4513540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17421516040
HP:0003198HP:0009071Inflammatory myopathy1MT-CO2 CL E G H4513540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17421516040
HP:0003198HP:0003715Myofibrillar myopathy1MT-CO2 CL E G H4513540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17421516040
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-CO2 CL E G H4513540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17421516040
HP:0003198HP:0003789Minicore myopathy1MT-CO3 CL E G H4514540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17422516050
HP:0003198HP:0003756Skeletal myopathy1MT-CO3 CL E G H4514540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17422516050
HP:0003198HP:0009071Inflammatory myopathy1MT-CO3 CL E G H4514540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17422516050
HP:0003198HP:0008978Necrotizing myopathy1MT-CO3 CL E G H4514540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17422516050
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-CO3 CL E G H4514540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17422516050
HP:0003198HP:0003715Myofibrillar myopathy1MT-CO3 CL E G H4514540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17422516050
HP:0003198HP:0003789Minicore myopathy1MT-CO3 CL E G H4514535000Leber's optic atrophy535000C0917796OMIM17422516050
HP:0003198HP:0003756Skeletal myopathy1MT-CO3 CL E G H4514535000Leber's optic atrophy535000C0917796OMIM17422516050
HP:0003198HP:0009071Inflammatory myopathy1MT-CO3 CL E G H4514535000Leber's optic atrophy535000C0917796OMIM17422516050
HP:0003198HP:0008978Necrotizing myopathy1MT-CO3 CL E G H4514535000Leber's optic atrophy535000C0917796OMIM17422516050
HP:0003198HP:0003715Myofibrillar myopathy1MT-CO3 CL E G H4514535000Leber's optic atrophy535000C0917796OMIM17422516050
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-CO3 CL E G H4514535000Leber's optic atrophy535000C0917796OMIM17422516050
HP:0003198HP:0003756Skeletal myopathy1MT-CYB CL E G H4519540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17427516020
HP:0003198HP:0003789Minicore myopathy1MT-CYB CL E G H4519540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17427516020
HP:0003198HP:0009071Inflammatory myopathy1MT-CYB CL E G H4519540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17427516020
HP:0003198HP:0008978Necrotizing myopathy1MT-CYB CL E G H4519540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17427516020
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-CYB CL E G H4519540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17427516020
HP:0003198HP:0003715Myofibrillar myopathy1MT-CYB CL E G H4519540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17427516020
HP:0003198HP:0003789Minicore myopathy1MT-CYB CL E G H4519535000Leber's optic atrophy535000C0917796OMIM17427516020
HP:0003198HP:0003756Skeletal myopathy1MT-CYB CL E G H4519535000Leber's optic atrophy535000C0917796OMIM17427516020
HP:0003198HP:0009071Inflammatory myopathy1MT-CYB CL E G H4519535000Leber's optic atrophy535000C0917796OMIM17427516020
HP:0003198HP:0008978Necrotizing myopathy1MT-CYB CL E G H4519535000Leber's optic atrophy535000C0917796OMIM17427516020
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-CYB CL E G H4519535000Leber's optic atrophy535000C0917796OMIM17427516020
HP:0003198HP:0003715Myofibrillar myopathy1MT-CYB CL E G H4519535000Leber's optic atrophy535000C0917796OMIM17427516020
HP:0003198HP:0003789Minicore myopathy1MT-ND1 CL E G H4535540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17455516000
HP:0003198HP:0003756Skeletal myopathy1MT-ND1 CL E G H4535540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17455516000
HP:0003198HP:0009071Inflammatory myopathy1MT-ND1 CL E G H4535540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17455516000
HP:0003198HP:0008978Necrotizing myopathy1MT-ND1 CL E G H4535540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17455516000
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND1 CL E G H4535540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17455516000
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND1 CL E G H4535540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17455516000
HP:0003198HP:0003756Skeletal myopathy1MT-ND1 CL E G H4535535000Leber's optic atrophy535000C0917796OMIM17455516000
HP:0003198HP:0003789Minicore myopathy1MT-ND1 CL E G H4535535000Leber's optic atrophy535000C0917796OMIM17455516000
HP:0003198HP:0008978Necrotizing myopathy1MT-ND1 CL E G H4535535000Leber's optic atrophy535000C0917796OMIM17455516000
HP:0003198HP:0009071Inflammatory myopathy1MT-ND1 CL E G H4535535000Leber's optic atrophy535000C0917796OMIM17455516000
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND1 CL E G H4535535000Leber's optic atrophy535000C0917796OMIM17455516000
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND1 CL E G H4535535000Leber's optic atrophy535000C0917796OMIM17455516000
HP:0003198HP:0003789Minicore myopathy1MT-ND2 CL E G H4536535000Leber's optic atrophy535000C0917796OMIM17456516001
HP:0003198HP:0003756Skeletal myopathy1MT-ND2 CL E G H4536535000Leber's optic atrophy535000C0917796OMIM17456516001
HP:0003198HP:0009071Inflammatory myopathy1MT-ND2 CL E G H4536535000Leber's optic atrophy535000C0917796OMIM17456516001
HP:0003198HP:0008978Necrotizing myopathy1MT-ND2 CL E G H4536535000Leber's optic atrophy535000C0917796OMIM17456516001
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND2 CL E G H4536535000Leber's optic atrophy535000C0917796OMIM17456516001
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND2 CL E G H4536535000Leber's optic atrophy535000C0917796OMIM17456516001
HP:0003198HP:0003789Minicore myopathy1MT-ND4 CL E G H4538535000Leber's optic atrophy535000C0917796OMIM17459516003
HP:0003198HP:0003756Skeletal myopathy1MT-ND4 CL E G H4538535000Leber's optic atrophy535000C0917796OMIM17459516003
HP:0003198HP:0009071Inflammatory myopathy1MT-ND4 CL E G H4538535000Leber's optic atrophy535000C0917796OMIM17459516003
HP:0003198HP:0008978Necrotizing myopathy1MT-ND4 CL E G H4538535000Leber's optic atrophy535000C0917796OMIM17459516003
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND4 CL E G H4538535000Leber's optic atrophy535000C0917796OMIM17459516003
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND4 CL E G H4538535000Leber's optic atrophy535000C0917796OMIM17459516003
HP:0003198HP:0003789Minicore myopathy1MT-ND4L CL E G H4539535000Leber's optic atrophy535000C0917796OMIM17460516004
HP:0003198HP:0003756Skeletal myopathy1MT-ND4L CL E G H4539535000Leber's optic atrophy535000C0917796OMIM17460516004
HP:0003198HP:0009071Inflammatory myopathy1MT-ND4L CL E G H4539535000Leber's optic atrophy535000C0917796OMIM17460516004
HP:0003198HP:0008978Necrotizing myopathy1MT-ND4L CL E G H4539535000Leber's optic atrophy535000C0917796OMIM17460516004
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND4L CL E G H4539535000Leber's optic atrophy535000C0917796OMIM17460516004
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND4L CL E G H4539535000Leber's optic atrophy535000C0917796OMIM17460516004
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND5 CL E G H4540551ORPHA17461516005
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND5 CL E G H4540551ORPHA17461516005
HP:0003198HP:0003789Minicore myopathy1MT-ND5 CL E G H4540551ORPHA17461516005
HP:0003198HP:0003756Skeletal myopathy1MT-ND5 CL E G H4540551ORPHA17461516005
HP:0003198HP:0009071Inflammatory myopathy1MT-ND5 CL E G H4540551ORPHA17461516005
HP:0003198HP:0008978Necrotizing myopathy1MT-ND5 CL E G H4540551ORPHA17461516005
HP:0003198HP:0003789Minicore myopathy1MT-ND5 CL E G H4540540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17461516005
HP:0003198HP:0003756Skeletal myopathy1MT-ND5 CL E G H4540540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17461516005
HP:0003198HP:0009071Inflammatory myopathy1MT-ND5 CL E G H4540540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17461516005
HP:0003198HP:0008978Necrotizing myopathy1MT-ND5 CL E G H4540540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17461516005
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND5 CL E G H4540540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17461516005
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND5 CL E G H4540540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17461516005
HP:0003198HP:0003789Minicore myopathy1MT-ND5 CL E G H4540535000Leber's optic atrophy535000C0917796OMIM17461516005
HP:0003198HP:0003756Skeletal myopathy1MT-ND5 CL E G H4540535000Leber's optic atrophy535000C0917796OMIM17461516005
HP:0003198HP:0009071Inflammatory myopathy1MT-ND5 CL E G H4540535000Leber's optic atrophy535000C0917796OMIM17461516005
HP:0003198HP:0008978Necrotizing myopathy1MT-ND5 CL E G H4540535000Leber's optic atrophy535000C0917796OMIM17461516005
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND5 CL E G H4540535000Leber's optic atrophy535000C0917796OMIM17461516005
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND5 CL E G H4540535000Leber's optic atrophy535000C0917796OMIM17461516005
HP:0003198HP:0003789Minicore myopathy1MT-ND6 CL E G H4541540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17462516006
HP:0003198HP:0003756Skeletal myopathy1MT-ND6 CL E G H4541540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17462516006
HP:0003198HP:0009071Inflammatory myopathy1MT-ND6 CL E G H4541540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17462516006
HP:0003198HP:0008978Necrotizing myopathy1MT-ND6 CL E G H4541540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17462516006
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND6 CL E G H4541540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17462516006
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND6 CL E G H4541540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17462516006
HP:0003198HP:0003789Minicore myopathy1MT-ND6 CL E G H4541535000Leber's optic atrophy535000C0917796OMIM17462516006
HP:0003198HP:0003756Skeletal myopathy1MT-ND6 CL E G H4541535000Leber's optic atrophy535000C0917796OMIM17462516006
HP:0003198HP:0009071Inflammatory myopathy1MT-ND6 CL E G H4541535000Leber's optic atrophy535000C0917796OMIM17462516006
HP:0003198HP:0008978Necrotizing myopathy1MT-ND6 CL E G H4541535000Leber's optic atrophy535000C0917796OMIM17462516006
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND6 CL E G H4541535000Leber's optic atrophy535000C0917796OMIM17462516006
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND6 CL E G H4541535000Leber's optic atrophy535000C0917796OMIM17462516006
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-RNR1 CL E G H4549551ORPHA117470180450
HP:0003198HP:0003715Myofibrillar myopathy1MT-RNR1 CL E G H4549551ORPHA117470180450
HP:0003198HP:0003789Minicore myopathy1MT-RNR1 CL E G H4549551ORPHA117470180450
HP:0003198HP:0003756Skeletal myopathy1MT-RNR1 CL E G H4549551ORPHA117470180450
HP:0003198HP:0009071Inflammatory myopathy1MT-RNR1 CL E G H4549551ORPHA117470180450
HP:0003198HP:0008978Necrotizing myopathy1MT-RNR1 CL E G H4549551ORPHA117470180450
HP:0003198HP:0003789Minicore myopathy1MT-TC CL E G H4511540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17477590020
HP:0003198HP:0003756Skeletal myopathy1MT-TC CL E G H4511540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17477590020
HP:0003198HP:0009071Inflammatory myopathy1MT-TC CL E G H4511540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17477590020
HP:0003198HP:0008978Necrotizing myopathy1MT-TC CL E G H4511540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17477590020
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TC CL E G H4511540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17477590020
HP:0003198HP:0003715Myofibrillar myopathy1MT-TC CL E G H4511540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17477590020
HP:0003198HP:0009071Inflammatory myopathy1MT-TE CL E G H4556254864ORPHA17479590025
HP:0003198HP:0008978Necrotizing myopathy1MT-TE CL E G H4556254864ORPHA17479590025
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TE CL E G H4556254864ORPHA17479590025
HP:0003198HP:0003715Myofibrillar myopathy1MT-TE CL E G H4556254864ORPHA17479590025
HP:0003198HP:0003789Minicore myopathy1MT-TE CL E G H4556254864ORPHA17479590025
HP:0003198HP:0003756Skeletal myopathy1MT-TE CL E G H4556254864ORPHA17479590025
HP:0003198HP:0003715Myofibrillar myopathy1MT-TF CL E G H4558551ORPHA17481590070
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TF CL E G H4558551ORPHA17481590070
HP:0003198HP:0003789Minicore myopathy1MT-TF CL E G H4558551ORPHA17481590070
HP:0003198HP:0003756Skeletal myopathy1MT-TF CL E G H4558551ORPHA17481590070
HP:0003198HP:0008978Necrotizing myopathy1MT-TF CL E G H4558551ORPHA17481590070
HP:0003198HP:0009071Inflammatory myopathy1MT-TF CL E G H4558551ORPHA17481590070
HP:0003198HP:0003756Skeletal myopathy1MT-TF CL E G H4558540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17481590070
HP:0003198HP:0003789Minicore myopathy1MT-TF CL E G H4558540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17481590070
HP:0003198HP:0008978Necrotizing myopathy1MT-TF CL E G H4558540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17481590070
HP:0003198HP:0009071Inflammatory myopathy1MT-TF CL E G H4558540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17481590070
HP:0003198HP:0003715Myofibrillar myopathy1MT-TF CL E G H4558540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17481590070
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TF CL E G H4558540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17481590070
HP:0003198HP:0003789Minicore myopathy1MT-TF CL E G H4558545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17481590070
HP:0003198HP:0003756Skeletal myopathy1MT-TF CL E G H4558545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17481590070
HP:0003198HP:0009071Inflammatory myopathy1MT-TF CL E G H4558545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17481590070
HP:0003198HP:0008978Necrotizing myopathy1MT-TF CL E G H4558545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17481590070
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TF CL E G H4558545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17481590070
HP:0003198HP:0003715Myofibrillar myopathy1MT-TF CL E G H4558545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17481590070
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TH CL E G H4564551ORPHA17487590040
HP:0003198HP:0003715Myofibrillar myopathy1MT-TH CL E G H4564551ORPHA17487590040
HP:0003198HP:0003789Minicore myopathy1MT-TH CL E G H4564551ORPHA17487590040
HP:0003198HP:0003756Skeletal myopathy1MT-TH CL E G H4564551ORPHA17487590040
HP:0003198HP:0009071Inflammatory myopathy1MT-TH CL E G H4564551ORPHA17487590040
HP:0003198HP:0008978Necrotizing myopathy1MT-TH CL E G H4564551ORPHA17487590040
HP:0003198HP:0003756Skeletal myopathy1MT-TI CL E G H4565545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17488590045
HP:0003198HP:0003789Minicore myopathy1MT-TI CL E G H4565545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17488590045
HP:0003198HP:0009071Inflammatory myopathy1MT-TI CL E G H4565545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17488590045
HP:0003198HP:0008978Necrotizing myopathy1MT-TI CL E G H4565545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17488590045
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TI CL E G H4565545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17488590045
HP:0003198HP:0003715Myofibrillar myopathy1MT-TI CL E G H4565545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17488590045
HP:0003198HP:0003715Myofibrillar myopathy1MT-TK CL E G H4566551ORPHA17489590060
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TK CL E G H4566551ORPHA17489590060
HP:0003198HP:0003756Skeletal myopathy1MT-TK CL E G H4566551ORPHA17489590060
HP:0003198HP:0003789Minicore myopathy1MT-TK CL E G H4566551ORPHA17489590060
HP:0003198HP:0008978Necrotizing myopathy1MT-TK CL E G H4566551ORPHA17489590060
HP:0003198HP:0009071Inflammatory myopathy1MT-TK CL E G H4566551ORPHA17489590060
HP:0003198HP:0003789Minicore myopathy1MT-TK CL E G H4566540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17489590060
HP:0003198HP:0003756Skeletal myopathy1MT-TK CL E G H4566540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17489590060
HP:0003198HP:0009071Inflammatory myopathy1MT-TK CL E G H4566540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17489590060
HP:0003198HP:0008978Necrotizing myopathy1MT-TK CL E G H4566540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17489590060
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TK CL E G H4566540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17489590060
HP:0003198HP:0003715Myofibrillar myopathy1MT-TK CL E G H4566540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17489590060
HP:0003198HP:0003789Minicore myopathy1MT-TK CL E G H4566545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17489590060
HP:0003198HP:0003756Skeletal myopathy1MT-TK CL E G H4566545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17489590060
HP:0003198HP:0009071Inflammatory myopathy1MT-TK CL E G H4566545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17489590060
HP:0003198HP:0008978Necrotizing myopathy1MT-TK CL E G H4566545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17489590060
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TK CL E G H4566545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17489590060
HP:0003198HP:0003715Myofibrillar myopathy1MT-TK CL E G H4566545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17489590060
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TL1 CL E G H4567551ORPHA17490590050
HP:0003198HP:0003715Myofibrillar myopathy1MT-TL1 CL E G H4567551ORPHA17490590050
HP:0003198HP:0003789Minicore myopathy1MT-TL1 CL E G H4567551ORPHA17490590050
HP:0003198HP:0003756Skeletal myopathy1MT-TL1 CL E G H4567551ORPHA17490590050
HP:0003198HP:0009071Inflammatory myopathy1MT-TL1 CL E G H4567551ORPHA17490590050
HP:0003198HP:0008978Necrotizing myopathy1MT-TL1 CL E G H4567551ORPHA17490590050
HP:0003198HP:0003756Skeletal myopathy1MT-TL1 CL E G H4567540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17490590050
HP:0003198HP:0003789Minicore myopathy1MT-TL1 CL E G H4567540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17490590050
HP:0003198HP:0009071Inflammatory myopathy1MT-TL1 CL E G H4567540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17490590050
HP:0003198HP:0008978Necrotizing myopathy1MT-TL1 CL E G H4567540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17490590050
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TL1 CL E G H4567540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17490590050
HP:0003198HP:0003715Myofibrillar myopathy1MT-TL1 CL E G H4567540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17490590050
HP:0003198HP:0003789Minicore myopathy1MT-TL1 CL E G H4567545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17490590050
HP:0003198HP:0003756Skeletal myopathy1MT-TL1 CL E G H4567545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17490590050
HP:0003198HP:0009071Inflammatory myopathy1MT-TL1 CL E G H4567545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17490590050
HP:0003198HP:0008978Necrotizing myopathy1MT-TL1 CL E G H4567545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17490590050
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TL1 CL E G H4567545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17490590050
HP:0003198HP:0003715Myofibrillar myopathy1MT-TL1 CL E G H4567545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17490590050
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TP CL E G H4571551ORPHA17494590075
HP:0003198HP:0003715Myofibrillar myopathy1MT-TP CL E G H4571551ORPHA17494590075
HP:0003198HP:0003789Minicore myopathy1MT-TP CL E G H4571551ORPHA17494590075
HP:0003198HP:0003756Skeletal myopathy1MT-TP CL E G H4571551ORPHA17494590075
HP:0003198HP:0009071Inflammatory myopathy1MT-TP CL E G H4571551ORPHA17494590075
HP:0003198HP:0008978Necrotizing myopathy1MT-TP CL E G H4571551ORPHA17494590075
HP:0003198HP:0003789Minicore myopathy1MT-TP CL E G H4571545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17494590075
HP:0003198HP:0003756Skeletal myopathy1MT-TP CL E G H4571545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17494590075
HP:0003198HP:0009071Inflammatory myopathy1MT-TP CL E G H4571545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17494590075
HP:0003198HP:0008978Necrotizing myopathy1MT-TP CL E G H4571545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17494590075
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TP CL E G H4571545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17494590075
HP:0003198HP:0003715Myofibrillar myopathy1MT-TP CL E G H4571545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17494590075
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TQ CL E G H4572551ORPHA17495590030
HP:0003198HP:0003715Myofibrillar myopathy1MT-TQ CL E G H4572551ORPHA17495590030
HP:0003198HP:0003789Minicore myopathy1MT-TQ CL E G H4572551ORPHA17495590030
HP:0003198HP:0003756Skeletal myopathy1MT-TQ CL E G H4572551ORPHA17495590030
HP:0003198HP:0009071Inflammatory myopathy1MT-TQ CL E G H4572551ORPHA17495590030
HP:0003198HP:0008978Necrotizing myopathy1MT-TQ CL E G H4572551ORPHA17495590030
HP:0003198HP:0003789Minicore myopathy1MT-TQ CL E G H4572540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17495590030
HP:0003198HP:0003756Skeletal myopathy1MT-TQ CL E G H4572540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17495590030
HP:0003198HP:0009071Inflammatory myopathy1MT-TQ CL E G H4572540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17495590030
HP:0003198HP:0008978Necrotizing myopathy1MT-TQ CL E G H4572540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17495590030
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TQ CL E G H4572540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17495590030
HP:0003198HP:0003715Myofibrillar myopathy1MT-TQ CL E G H4572540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17495590030
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TS1 CL E G H4574551ORPHA17497590080
HP:0003198HP:0003715Myofibrillar myopathy1MT-TS1 CL E G H4574551ORPHA17497590080
HP:0003198HP:0003789Minicore myopathy1MT-TS1 CL E G H4574551ORPHA17497590080
HP:0003198HP:0003756Skeletal myopathy1MT-TS1 CL E G H4574551ORPHA17497590080
HP:0003198HP:0009071Inflammatory myopathy1MT-TS1 CL E G H4574551ORPHA17497590080
HP:0003198HP:0008978Necrotizing myopathy1MT-TS1 CL E G H4574551ORPHA17497590080
HP:0003198HP:0003789Minicore myopathy1MT-TS1 CL E G H4574540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17497590080
HP:0003198HP:0003756Skeletal myopathy1MT-TS1 CL E G H4574540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17497590080
HP:0003198HP:0009071Inflammatory myopathy1MT-TS1 CL E G H4574540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17497590080
HP:0003198HP:0008978Necrotizing myopathy1MT-TS1 CL E G H4574540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17497590080
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TS1 CL E G H4574540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17497590080
HP:0003198HP:0003715Myofibrillar myopathy1MT-TS1 CL E G H4574540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17497590080
HP:0003198HP:0003715Myofibrillar myopathy1MT-TS2 CL E G H4575551ORPHA17498590085
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TS2 CL E G H4575551ORPHA17498590085
HP:0003198HP:0003789Minicore myopathy1MT-TS2 CL E G H4575551ORPHA17498590085
HP:0003198HP:0003756Skeletal myopathy1MT-TS2 CL E G H4575551ORPHA17498590085
HP:0003198HP:0009071Inflammatory myopathy1MT-TS2 CL E G H4575551ORPHA17498590085
HP:0003198HP:0008978Necrotizing myopathy1MT-TS2 CL E G H4575551ORPHA17498590085
HP:0003198HP:0003789Minicore myopathy1MT-TS2 CL E G H4575540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17498590085
HP:0003198HP:0003756Skeletal myopathy1MT-TS2 CL E G H4575540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17498590085
HP:0003198HP:0009071Inflammatory myopathy1MT-TS2 CL E G H4575540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17498590085
HP:0003198HP:0008978Necrotizing myopathy1MT-TS2 CL E G H4575540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17498590085
HP:0003198HP:0003715Myofibrillar myopathy1MT-TS2 CL E G H4575540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17498590085
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TS2 CL E G H4575540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17498590085
HP:0003198HP:0003789Minicore myopathy1MT-TT CL E G H4576551000Lethal infantile mitochondrial myopathy551000C1838876OMIM17499590090
HP:0003198HP:0003756Skeletal myopathy1MT-TT CL E G H4576551000Lethal infantile mitochondrial myopathy551000C1838876OMIM17499590090
HP:0003198HP:0009071Inflammatory myopathy1MT-TT CL E G H4576551000Lethal infantile mitochondrial myopathy551000C1838876OMIM17499590090
HP:0003198HP:0008978Necrotizing myopathy1MT-TT CL E G H4576551000Lethal infantile mitochondrial myopathy551000C1838876OMIM17499590090
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TT CL E G H4576551000Lethal infantile mitochondrial myopathy551000C1838876OMIM17499590090
HP:0003198HP:0003715Myofibrillar myopathy1MT-TT CL E G H4576551000Lethal infantile mitochondrial myopathy551000C1838876OMIM17499590090
HP:0003198HP:0003789Minicore myopathy1MT-TV CL E G H4577540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17500590105
HP:0003198HP:0003756Skeletal myopathy1MT-TV CL E G H4577540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17500590105
HP:0003198HP:0009071Inflammatory myopathy1MT-TV CL E G H4577540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17500590105
HP:0003198HP:0008978Necrotizing myopathy1MT-TV CL E G H4577540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17500590105
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TV CL E G H4577540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17500590105
HP:0003198HP:0003715Myofibrillar myopathy1MT-TV CL E G H4577540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17500590105
HP:0003198HP:0003756Skeletal myopathy1MT-TW CL E G H4578540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17501590095
HP:0003198HP:0003789Minicore myopathy1MT-TW CL E G H4578540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17501590095
HP:0003198HP:0008978Necrotizing myopathy1MT-TW CL E G H4578540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17501590095
HP:0003198HP:0009071Inflammatory myopathy1MT-TW CL E G H4578540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17501590095
HP:0003198HP:0003715Myofibrillar myopathy1MT-TW CL E G H4578540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17501590095
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-TW CL E G H4578540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17501590095
HP:0003198HP:0003789Minicore myopathy1MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003198HP:0003756Skeletal myopathy1MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003198HP:0009071Inflammatory myopathy1MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003198HP:0008978Necrotizing myopathy1MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003198HP:0003458EMG: myopathic abnormalities1MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003198HP:0003715Myofibrillar myopathy1MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003198HP:0003789Minicore myopathy1MYMK CL E G H389827254940Congenital nonprogressive myopathy with Moebius and Robin sequences254940C1850746OMIM18633778615345
HP:0003198HP:0003756Skeletal myopathy1MYMK CL E G H389827254940Congenital nonprogressive myopathy with Moebius and Robin sequences254940C1850746OMIM18633778615345
HP:0003198HP:0009071Inflammatory myopathy1MYMK CL E G H389827254940Congenital nonprogressive myopathy with Moebius and Robin sequences254940C1850746OMIM18633778615345
HP:0003198HP:0008978Necrotizing myopathy1MYMK CL E G H389827254940Congenital nonprogressive myopathy with Moebius and Robin sequences254940C1850746OMIM18633778615345
HP:0003198HP:0003458EMG: myopathic abnormalities1MYMK CL E G H389827254940Congenital nonprogressive myopathy with Moebius and Robin sequences254940C1850746OMIM18633778615345
HP:0003198HP:0003715Myofibrillar myopathy1MYMK CL E G H389827254940Congenital nonprogressive myopathy with Moebius and Robin sequences254940C1850746OMIM18633778615345
HP:0003198HP:0003789Minicore myopathy1MYO18B CL E G H84700616549Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism616549C4225285OMIM1181018150607295
HP:0003198HP:0003756Skeletal myopathy1MYO18B CL E G H84700616549Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism616549C4225285OMIM1181018150607295
HP:0003198HP:0008978Necrotizing myopathy1MYO18B CL E G H84700616549Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism616549C4225285OMIM1181018150607295
HP:0003198HP:0009071Inflammatory myopathy1MYO18B CL E G H84700616549Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism616549C4225285OMIM1181018150607295
HP:0003198HP:0003715Myofibrillar myopathy1MYO18B CL E G H84700616549Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism616549C4225285OMIM1181018150607295
HP:0003198HP:0003458EMG: myopathic abnormalities1MYO18B CL E G H84700616549Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism616549C4225285OMIM1181018150607295
HP:0003198HP:0003789Minicore myopathy1MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003198HP:0003756Skeletal myopathy1MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003198HP:0009071Inflammatory myopathy1MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003198HP:0008978Necrotizing myopathy1MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003198HP:0003458EMG: myopathic abnormalities1MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003198HP:0003715Myofibrillar myopathy1MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003198HP:0003789Minicore myopathy1NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003198HP:0003756Skeletal myopathy1NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003198HP:0009071Inflammatory myopathy1NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003198HP:0008978Necrotizing myopathy1NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003198HP:0003458EMG: myopathic abnormalities1NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003198HP:0003715Myofibrillar myopathy1NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003198HP:0003789Minicore myopathy1NDUFA11 CL E G H126328618236MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14618236OMIM113120371612638
HP:0003198HP:0003756Skeletal myopathy1NDUFA11 CL E G H126328618236MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14618236OMIM113120371612638
HP:0003198HP:0008978Necrotizing myopathy1NDUFA11 CL E G H126328618236MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14618236OMIM113120371612638
HP:0003198HP:0009071Inflammatory myopathy1NDUFA11 CL E G H126328618236MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14618236OMIM113120371612638
HP:0003198HP:0003715Myofibrillar myopathy1NDUFA11 CL E G H126328618236MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14618236OMIM113120371612638
HP:0003198HP:0003458EMG: myopathic abnormalities1NDUFA11 CL E G H126328618236MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14618236OMIM113120371612638
HP:0003198HP:0003789Minicore myopathy1NDUFAF1 CL E G H51103618234MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11618234OMIM115418828606934
HP:0003198HP:0003756Skeletal myopathy1NDUFAF1 CL E G H51103618234MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11618234OMIM115418828606934
HP:0003198HP:0009071Inflammatory myopathy1NDUFAF1 CL E G H51103618234MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11618234OMIM115418828606934
HP:0003198HP:0008978Necrotizing myopathy1NDUFAF1 CL E G H51103618234MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11618234OMIM115418828606934
HP:0003198HP:0003458EMG: myopathic abnormalities1NDUFAF1 CL E G H51103618234MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11618234OMIM115418828606934
HP:0003198HP:0003715Myofibrillar myopathy1NDUFAF1 CL E G H51103618234MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11618234OMIM115418828606934
HP:0003198HP:0003789Minicore myopathy1NDUFAF4 CL E G H29078618237MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15618237OMIM113621034611776
HP:0003198HP:0003756Skeletal myopathy1NDUFAF4 CL E G H29078618237MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15618237OMIM113621034611776
HP:0003198HP:0009071Inflammatory myopathy1NDUFAF4 CL E G H29078618237MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15618237OMIM113621034611776
HP:0003198HP:0008978Necrotizing myopathy1NDUFAF4 CL E G H29078618237MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15618237OMIM113621034611776
HP:0003198HP:0003458EMG: myopathic abnormalities1NDUFAF4 CL E G H29078618237MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15618237OMIM113621034611776
HP:0003198HP:0003715Myofibrillar myopathy1NDUFAF4 CL E G H29078618237MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15618237OMIM113621034611776
HP:0003198HP:0003789Minicore myopathy1NDUFB3 CL E G H4709618246MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25618246OMIM1797698603839
HP:0003198HP:0003756Skeletal myopathy1NDUFB3 CL E G H4709618246MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25618246OMIM1797698603839
HP:0003198HP:0009071Inflammatory myopathy1NDUFB3 CL E G H4709618246MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25618246OMIM1797698603839
HP:0003198HP:0008978Necrotizing myopathy1NDUFB3 CL E G H4709618246MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25618246OMIM1797698603839
HP:0003198HP:0003458EMG: myopathic abnormalities1NDUFB3 CL E G H4709618246MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25618246OMIM1797698603839
HP:0003198HP:0003715Myofibrillar myopathy1NDUFB3 CL E G H4709618246MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25618246OMIM1797698603839
HP:0003198HP:0003756Skeletal myopathy1NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM17147737162230
HP:0003198HP:0003789Minicore myopathy1NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM17147737162230
HP:0003198HP:0008978Necrotizing myopathy1NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM17147737162230
HP:0003198HP:0009071Inflammatory myopathy1NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM17147737162230
HP:0003198HP:0003458EMG: myopathic abnormalities1NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM17147737162230
HP:0003198HP:0003715Myofibrillar myopathy1NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM17147737162230
HP:0003198HP:0003756Skeletal myopathy1NUBPL CL E G H80224618242MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21618242OMIM128420278613621
HP:0003198HP:0003789Minicore myopathy1NUBPL CL E G H80224618242MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21618242OMIM128420278613621
HP:0003198HP:0008978Necrotizing myopathy1NUBPL CL E G H80224618242MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21618242OMIM128420278613621
HP:0003198HP:0009071Inflammatory myopathy1NUBPL CL E G H80224618242MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21618242OMIM128420278613621
HP:0003198HP:0003458EMG: myopathic abnormalities1NUBPL CL E G H80224618242MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21618242OMIM128420278613621
HP:0003198HP:0003715Myofibrillar myopathy1NUBPL CL E G H80224618242MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21618242OMIM128420278613621
HP:0003198HP:0003789Minicore myopathy1OPA1 CL E G H4976125250Autosomal dominant optic atrophy plus syndrome125250C1852267OMIM112248140605290
HP:0003198HP:0003756Skeletal myopathy1OPA1 CL E G H4976125250Autosomal dominant optic atrophy plus syndrome125250C1852267OMIM112248140605290
HP:0003198HP:0009071Inflammatory myopathy1OPA1 CL E G H4976125250Autosomal dominant optic atrophy plus syndrome125250C1852267OMIM112248140605290
HP:0003198HP:0008978Necrotizing myopathy1OPA1 CL E G H4976125250Autosomal dominant optic atrophy plus syndrome125250C1852267OMIM112248140605290
HP:0003198HP:0003458EMG: myopathic abnormalities1OPA1 CL E G H4976125250Autosomal dominant optic atrophy plus syndrome125250C1852267OMIM112248140605290
HP:0003198HP:0003715Myofibrillar myopathy1OPA1 CL E G H4976125250Autosomal dominant optic atrophy plus syndrome125250C1852267OMIM112248140605290
HP:0003198HP:0003756Skeletal myopathy1ORAI1 CL E G H84876612782Immune dysfunction with T-cell inactivation due to calcium entry defect 1612782C2748568OMIM132625896610277
HP:0003198HP:0003789Minicore myopathy1ORAI1 CL E G H84876612782Immune dysfunction with T-cell inactivation due to calcium entry defect 1612782C2748568OMIM132625896610277
HP:0003198HP:0008978Necrotizing myopathy1ORAI1 CL E G H84876612782Immune dysfunction with T-cell inactivation due to calcium entry defect 1612782C2748568OMIM132625896610277
HP:0003198HP:0009071Inflammatory myopathy1ORAI1 CL E G H84876612782Immune dysfunction with T-cell inactivation due to calcium entry defect 1612782C2748568OMIM132625896610277
HP:0003198HP:0003458EMG: myopathic abnormalities1ORAI1 CL E G H84876612782Immune dysfunction with T-cell inactivation due to calcium entry defect 1612782C2748568OMIM132625896610277
HP:0003198HP:0003715Myofibrillar myopathy1ORAI1 CL E G H84876612782Immune dysfunction with T-cell inactivation due to calcium entry defect 1612782C2748568OMIM132625896610277
HP:0003198HP:0003756Skeletal myopathy1PABPN1 CL E G H8106270ORPHA1858565602279
HP:0003198HP:0003789Minicore myopathy1PABPN1 CL E G H8106270ORPHA1858565602279
HP:0003198HP:0008978Necrotizing myopathy1PABPN1 CL E G H8106270ORPHA1858565602279
HP:0003198HP:0009071Inflammatory myopathy1PABPN1 CL E G H8106270ORPHA1858565602279
HP:0003198HP:0003458EMG: myopathic abnormalities1PABPN1 CL E G H8106270ORPHA1858565602279
HP:0003198HP:0003715Myofibrillar myopathy1PABPN1 CL E G H8106270ORPHA1858565602279
HP:0003198HP:0003789Minicore myopathy1PANK2 CL E G H80025234200Pigmentary pallidal degeneration234200C0018523OMIM149915894606157
HP:0003198HP:0003756Skeletal myopathy1PANK2 CL E G H80025234200Pigmentary pallidal degeneration234200C0018523OMIM149915894606157
HP:0003198HP:0009071Inflammatory myopathy1PANK2 CL E G H80025234200Pigmentary pallidal degeneration234200C0018523OMIM149915894606157
HP:0003198HP:0008978Necrotizing myopathy1PANK2 CL E G H80025234200Pigmentary pallidal degeneration234200C0018523OMIM149915894606157
HP:0003198HP:0003458EMG: myopathic abnormalities1PANK2 CL E G H80025234200Pigmentary pallidal degeneration234200C0018523OMIM149915894606157
HP:0003198HP:0003715Myofibrillar myopathy1PANK2 CL E G H80025234200Pigmentary pallidal degeneration234200C0018523OMIM149915894606157
HP:0003198HP:0003756Skeletal myopathy1PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003198HP:0003789Minicore myopathy1PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003198HP:0008978Necrotizing myopathy1PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003198HP:0009071Inflammatory myopathy1PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003198HP:0003715Myofibrillar myopathy1PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003198HP:0003458EMG: myopathic abnormalities1PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003198HP:0003789Minicore myopathy1PLEC CL E G H5339257ORPHA150689069601282
HP:0003198HP:0003756Skeletal myopathy1PLEC CL E G H5339257ORPHA150689069601282
HP:0003198HP:0009071Inflammatory myopathy1PLEC CL E G H5339257ORPHA150689069601282
HP:0003198HP:0008978Necrotizing myopathy1PLEC CL E G H5339257ORPHA150689069601282
HP:0003198HP:0003458EMG: myopathic abnormalities1PLEC CL E G H5339257ORPHA150689069601282
HP:0003198HP:0003715Myofibrillar myopathy1PLEC CL E G H5339257ORPHA150689069601282
HP:0003198HP:0008978Necrotizing myopathy1PNPLA2 CL E G H5710498908ORPHA156630802609059
HP:0003198HP:0009071Inflammatory myopathy1PNPLA2 CL E G H5710498908ORPHA156630802609059
HP:0003198HP:0003715Myofibrillar myopathy1PNPLA2 CL E G H5710498908ORPHA156630802609059
HP:0003198HP:0003458EMG: myopathic abnormalities1PNPLA2 CL E G H5710498908ORPHA156630802609059
HP:0003198HP:0003756Skeletal myopathy1PNPLA2 CL E G H5710498908ORPHA156630802609059
HP:0003198HP:0003789Minicore myopathy1PNPLA2 CL E G H5710498908ORPHA156630802609059
HP:0003198HP:0003789Minicore myopathy1PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003198HP:0003756Skeletal myopathy1PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003198HP:0009071Inflammatory myopathy1PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003198HP:0008978Necrotizing myopathy1PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003198HP:0003458EMG: myopathic abnormalities1PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003198HP:0003715Myofibrillar myopathy1PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003198HP:0008978Necrotizing myopathy1POLG CL E G H5428254886ORPHA123249179174763
HP:0003198HP:0009071Inflammatory myopathy1POLG CL E G H5428254886ORPHA123249179174763
HP:0003198HP:0003715Myofibrillar myopathy1POLG CL E G H5428254886ORPHA123249179174763
HP:0003198HP:0003458EMG: myopathic abnormalities1POLG CL E G H5428254886ORPHA123249179174763
HP:0003198HP:0003789Minicore myopathy1POLG CL E G H5428254886ORPHA123249179174763
HP:0003198HP:0003756Skeletal myopathy1POLG CL E G H5428254886ORPHA123249179174763
HP:0003198HP:0003458EMG: myopathic abnormalities1POMGNT1 CL E G H55624588ORPHA1117419139606822
HP:0003198HP:0003715Myofibrillar myopathy1POMGNT1 CL E G H55624588ORPHA1117419139606822
HP:0003198HP:0003789Minicore myopathy1POMGNT1 CL E G H55624588ORPHA1117419139606822
HP:0003198HP:0003756Skeletal myopathy1POMGNT1 CL E G H55624588ORPHA1117419139606822
HP:0003198HP:0009071Inflammatory myopathy1POMGNT1 CL E G H55624588ORPHA1117419139606822
HP:0003198HP:0008978Necrotizing myopathy1POMGNT1 CL E G H55624588ORPHA1117419139606822
HP:0003198HP:0003715Myofibrillar myopathy1POMT1 CL E G H10585588ORPHA19069202607423
HP:0003198HP:0003458EMG: myopathic abnormalities1POMT1 CL E G H10585588ORPHA19069202607423
HP:0003198HP:0003756Skeletal myopathy1POMT1 CL E G H10585588ORPHA19069202607423
HP:0003198HP:0003789Minicore myopathy1POMT1 CL E G H10585588ORPHA19069202607423
HP:0003198HP:0008978Necrotizing myopathy1POMT1 CL E G H10585588ORPHA19069202607423
HP:0003198HP:0009071Inflammatory myopathy1POMT1 CL E G H10585588ORPHA19069202607423
HP:0003198HP:0003458EMG: myopathic abnormalities1POMT2 CL E G H29954588ORPHA193619743607439
HP:0003198HP:0003715Myofibrillar myopathy1POMT2 CL E G H29954588ORPHA193619743607439
HP:0003198HP:0003789Minicore myopathy1POMT2 CL E G H29954588ORPHA193619743607439
HP:0003198HP:0003756Skeletal myopathy1POMT2 CL E G H29954588ORPHA193619743607439
HP:0003198HP:0009071Inflammatory myopathy1POMT2 CL E G H29954588ORPHA193619743607439
HP:0003198HP:0008978Necrotizing myopathy1POMT2 CL E G H29954588ORPHA193619743607439
HP:0003198HP:0003458EMG: myopathic abnormalities1PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11669236601487
HP:0003198HP:0003715Myofibrillar myopathy1PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11669236601487
HP:0003198HP:0003789Minicore myopathy1PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11669236601487
HP:0003198HP:0003756Skeletal myopathy1PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11669236601487
HP:0003198HP:0009071Inflammatory myopathy1PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11669236601487
HP:0003198HP:0008978Necrotizing myopathy1PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11669236601487
HP:0003198HP:0003789Minicore myopathy1PRKAG2 CL E G H51422261740Glycogen storage disease of heart, lethal congenital261740C1849813OMIM110799386602743
HP:0003198HP:0003756Skeletal myopathy1PRKAG2 CL E G H51422261740Glycogen storage disease of heart, lethal congenital261740C1849813OMIM110799386602743
HP:0003198HP:0009071Inflammatory myopathy1PRKAG2 CL E G H51422261740Glycogen storage disease of heart, lethal congenital261740C1849813OMIM110799386602743
HP:0003198HP:0008978Necrotizing myopathy1PRKAG2 CL E G H51422261740Glycogen storage disease of heart, lethal congenital261740C1849813OMIM110799386602743
HP:0003198HP:0003458EMG: myopathic abnormalities1PRKAG2 CL E G H51422261740Glycogen storage disease of heart, lethal congenital261740C1849813OMIM110799386602743
HP:0003198HP:0003715Myofibrillar myopathy1PRKAG2 CL E G H51422261740Glycogen storage disease of heart, lethal congenital261740C1849813OMIM110799386602743
HP:0003198HP:0003715Myofibrillar myopathy1PUS1 CL E G H803242598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA147815508608109
HP:0003198HP:0003458EMG: myopathic abnormalities1PUS1 CL E G H803242598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA147815508608109
HP:0003198HP:0003789Minicore myopathy1PUS1 CL E G H803242598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA147815508608109
HP:0003198HP:0003756Skeletal myopathy1PUS1 CL E G H803242598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA147815508608109
HP:0003198HP:0009071Inflammatory myopathy1PUS1 CL E G H803242598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA147815508608109
HP:0003198HP:0008978Necrotizing myopathy1PUS1 CL E G H803242598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA147815508608109
HP:0003198HP:0003789Minicore myopathy1PYGM CL E G H5837368ORPHA110559726608455
HP:0003198HP:0003756Skeletal myopathy1PYGM CL E G H5837368ORPHA110559726608455
HP:0003198HP:0009071Inflammatory myopathy1PYGM CL E G H5837368ORPHA110559726608455
HP:0003198HP:0008978Necrotizing myopathy1PYGM CL E G H5837368ORPHA110559726608455
HP:0003198HP:0003458EMG: myopathic abnormalities1PYGM CL E G H5837368ORPHA110559726608455
HP:0003198HP:0003715Myofibrillar myopathy1PYGM CL E G H5837368ORPHA110559726608455
HP:0003198HP:0003756Skeletal myopathy1RET CL E G H5979162300Multiple endocrine neoplasia, type 2b162300C0025269OMIM131659967164761
HP:0003198HP:0003789Minicore myopathy1RET CL E G H5979162300Multiple endocrine neoplasia, type 2b162300C0025269OMIM131659967164761
HP:0003198HP:0008978Necrotizing myopathy1RET CL E G H5979162300Multiple endocrine neoplasia, type 2b162300C0025269OMIM131659967164761
HP:0003198HP:0009071Inflammatory myopathy1RET CL E G H5979162300Multiple endocrine neoplasia, type 2b162300C0025269OMIM131659967164761
HP:0003198HP:0003458EMG: myopathic abnormalities1RET CL E G H5979162300Multiple endocrine neoplasia, type 2b162300C0025269OMIM131659967164761
HP:0003198HP:0003715Myofibrillar myopathy1RET CL E G H5979162300Multiple endocrine neoplasia, type 2b162300C0025269OMIM131659967164761
HP:0003198HP:0003789Minicore myopathy1RMND1 CL E G H55005614922Combined oxidative phosphorylation deficiency 11614922C3554067OMIM126221176614917
HP:0003198HP:0003756Skeletal myopathy1RMND1 CL E G H55005614922Combined oxidative phosphorylation deficiency 11614922C3554067OMIM126221176614917
HP:0003198HP:0009071Inflammatory myopathy1RMND1 CL E G H55005614922Combined oxidative phosphorylation deficiency 11614922C3554067OMIM126221176614917
HP:0003198HP:0008978Necrotizing myopathy1RMND1 CL E G H55005614922Combined oxidative phosphorylation deficiency 11614922C3554067OMIM126221176614917
HP:0003198HP:0003458EMG: myopathic abnormalities1RMND1 CL E G H55005614922Combined oxidative phosphorylation deficiency 11614922C3554067OMIM126221176614917
HP:0003198HP:0003715Myofibrillar myopathy1RMND1 CL E G H55005614922Combined oxidative phosphorylation deficiency 11614922C3554067OMIM126221176614917
HP:0003198HP:0003789Minicore myopathy1RRM2B CL E G H50484613077Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5613077C2751319OMIM135417296604712
HP:0003198HP:0003756Skeletal myopathy1RRM2B CL E G H50484613077Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5613077C2751319OMIM135417296604712
HP:0003198HP:0009071Inflammatory myopathy1RRM2B CL E G H50484613077Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5613077C2751319OMIM135417296604712
HP:0003198HP:0008978Necrotizing myopathy1RRM2B CL E G H50484613077Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5613077C2751319OMIM135417296604712
HP:0003198HP:0003458EMG: myopathic abnormalities1RRM2B CL E G H50484613077Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5613077C2751319OMIM135417296604712
HP:0003198HP:0003715Myofibrillar myopathy1RRM2B CL E G H50484613077Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5613077C2751319OMIM135417296604712
HP:0003198HP:0003458EMG: myopathic abnormalities1RYR1 CL E G H6261597ORPHA1616410483180901
HP:0003198HP:0003715Myofibrillar myopathy1RYR1 CL E G H6261597ORPHA1616410483180901
HP:0003198HP:0003756Skeletal myopathy1RYR1 CL E G H6261597ORPHA1616410483180901
HP:0003198HP:0003789Minicore myopathy1RYR1 CL E G H6261597ORPHA1616410483180901
HP:0003198HP:0009071Inflammatory myopathy1RYR1 CL E G H6261597ORPHA1616410483180901
HP:0003198HP:0008978Necrotizing myopathy1RYR1 CL E G H6261597ORPHA1616410483180901
HP:0003198HP:0003756Skeletal myopathy1SCN4A CL E G H6329613345Hypokalemic periodic paralysis, type 2613345C2750061OMIM1176510591603967
HP:0003198HP:0003789Minicore myopathy1SCN4A CL E G H6329613345Hypokalemic periodic paralysis, type 2613345C2750061OMIM1176510591603967
HP:0003198HP:0008978Necrotizing myopathy1SCN4A CL E G H6329613345Hypokalemic periodic paralysis, type 2613345C2750061OMIM1176510591603967
HP:0003198HP:0009071Inflammatory myopathy1SCN4A CL E G H6329613345Hypokalemic periodic paralysis, type 2613345C2750061OMIM1176510591603967
HP:0003198HP:0003715Myofibrillar myopathy1SCN4A CL E G H6329613345Hypokalemic periodic paralysis, type 2613345C2750061OMIM1176510591603967
HP:0003198HP:0003458EMG: myopathic abnormalities1SCN4A CL E G H6329613345Hypokalemic periodic paralysis, type 2613345C2750061OMIM1176510591603967
HP:0003198HP:0009071Inflammatory myopathy1SELENON CL E G H5719097244ORPHA165115999606210
HP:0003198HP:0008978Necrotizing myopathy1SELENON CL E G H5719097244ORPHA165115999606210
HP:0003198HP:0003458EMG: myopathic abnormalities1SELENON CL E G H5719097244ORPHA165115999606210
HP:0003198HP:0003715Myofibrillar myopathy1SELENON CL E G H5719097244ORPHA165115999606210
HP:0003198HP:0003789Minicore myopathy1SELENON CL E G H5719097244ORPHA165115999606210
HP:0003198HP:0003756Skeletal myopathy1SELENON CL E G H5719097244ORPHA165115999606210
HP:0003198HP:0003789Minicore myopathy1SGCB CL E G H6443119ORPHA150010806600900
HP:0003198HP:0003756Skeletal myopathy1SGCB CL E G H6443119ORPHA150010806600900
HP:0003198HP:0009071Inflammatory myopathy1SGCB CL E G H6443119ORPHA150010806600900
HP:0003198HP:0008978Necrotizing myopathy1SGCB CL E G H6443119ORPHA150010806600900
HP:0003198HP:0003458EMG: myopathic abnormalities1SGCB CL E G H6443119ORPHA150010806600900
HP:0003198HP:0003715Myofibrillar myopathy1SGCB CL E G H6443119ORPHA150010806600900
HP:0003198HP:0003715Myofibrillar myopathy1SIL1 CL E G H64374559ORPHA135224624608005
HP:0003198HP:0003458EMG: myopathic abnormalities1SIL1 CL E G H64374559ORPHA135224624608005
HP:0003198HP:0003756Skeletal myopathy1SIL1 CL E G H64374559ORPHA135224624608005
HP:0003198HP:0003789Minicore myopathy1SIL1 CL E G H64374559ORPHA135224624608005
HP:0003198HP:0008978Necrotizing myopathy1SIL1 CL E G H64374559ORPHA135224624608005
HP:0003198HP:0009071Inflammatory myopathy1SIL1 CL E G H64374559ORPHA135224624608005
HP:0003198HP:0003789Minicore myopathy1SIL1 CL E G H64374248800Marinesco-Sjögren syndrome248800C0024814OMIM135224624608005
HP:0003198HP:0003756Skeletal myopathy1SIL1 CL E G H64374248800Marinesco-Sjögren syndrome248800C0024814OMIM135224624608005
HP:0003198HP:0009071Inflammatory myopathy1SIL1 CL E G H64374248800Marinesco-Sjögren syndrome248800C0024814OMIM135224624608005
HP:0003198HP:0008978Necrotizing myopathy1SIL1 CL E G H64374248800Marinesco-Sjögren syndrome248800C0024814OMIM135224624608005
HP:0003198HP:0003458EMG: myopathic abnormalities1SIL1 CL E G H64374248800Marinesco-Sjögren syndrome248800C0024814OMIM135224624608005
HP:0003198HP:0003715Myofibrillar myopathy1SIL1 CL E G H64374248800Marinesco-Sjögren syndrome248800C0024814OMIM135224624608005
HP:0003198HP:0003789Minicore myopathy1SLC22A5 CL E G H6584212140Renal carnitine transport defect212140C0342788OMIM1102710969603377
HP:0003198HP:0003756Skeletal myopathy1SLC22A5 CL E G H6584212140Renal carnitine transport defect212140C0342788OMIM1102710969603377
HP:0003198HP:0009071Inflammatory myopathy1SLC22A5 CL E G H6584212140Renal carnitine transport defect212140C0342788OMIM1102710969603377
HP:0003198HP:0008978Necrotizing myopathy1SLC22A5 CL E G H6584212140Renal carnitine transport defect212140C0342788OMIM1102710969603377
HP:0003198HP:0003458EMG: myopathic abnormalities1SLC22A5 CL E G H6584212140Renal carnitine transport defect212140C0342788OMIM1102710969603377
HP:0003198HP:0003715Myofibrillar myopathy1SLC22A5 CL E G H6584212140Renal carnitine transport defect212140C0342788OMIM1102710969603377
HP:0003198HP:0008978Necrotizing myopathy1SLC25A3 CL E G H525091130ORPHA117610989600370
HP:0003198HP:0009071Inflammatory myopathy1SLC25A3 CL E G H525091130ORPHA117610989600370
HP:0003198HP:0003458EMG: myopathic abnormalities1SLC25A3 CL E G H525091130ORPHA117610989600370
HP:0003198HP:0003715Myofibrillar myopathy1SLC25A3 CL E G H525091130ORPHA117610989600370
HP:0003198HP:0003756Skeletal myopathy1SLC25A3 CL E G H525091130ORPHA117610989600370
HP:0003198HP:0003789Minicore myopathy1SLC25A3 CL E G H525091130ORPHA117610989600370
HP:0003198HP:0003458EMG: myopathic abnormalities1SLC25A4 CL E G H2911369ORPHA133310990103220
HP:0003198HP:0003715Myofibrillar myopathy1SLC25A4 CL E G H2911369ORPHA133310990103220
HP:0003198HP:0003756Skeletal myopathy1SLC25A4 CL E G H2911369ORPHA133310990103220
HP:0003198HP:0003789Minicore myopathy1SLC25A4 CL E G H2911369ORPHA133310990103220
HP:0003198HP:0009071Inflammatory myopathy1SLC25A4 CL E G H2911369ORPHA133310990103220
HP:0003198HP:0008978Necrotizing myopathy1SLC25A4 CL E G H2911369ORPHA133310990103220
HP:0003198HP:0003789Minicore myopathy1STIM1 CL E G H6786612783Immune dysfunction with T-cell inactivation due to calcium entry defect 2612783C2748557OMIM163511386605921
HP:0003198HP:0003756Skeletal myopathy1STIM1 CL E G H6786612783Immune dysfunction with T-cell inactivation due to calcium entry defect 2612783C2748557OMIM163511386605921
HP:0003198HP:0009071Inflammatory myopathy1STIM1 CL E G H6786612783Immune dysfunction with T-cell inactivation due to calcium entry defect 2612783C2748557OMIM163511386605921
HP:0003198HP:0008978Necrotizing myopathy1STIM1 CL E G H6786612783Immune dysfunction with T-cell inactivation due to calcium entry defect 2612783C2748557OMIM163511386605921
HP:0003198HP:0003458EMG: myopathic abnormalities1STIM1 CL E G H6786612783Immune dysfunction with T-cell inactivation due to calcium entry defect 2612783C2748557OMIM163511386605921
HP:0003198HP:0003715Myofibrillar myopathy1STIM1 CL E G H6786612783Immune dysfunction with T-cell inactivation due to calcium entry defect 2612783C2748557OMIM163511386605921
HP:0003198HP:0003789Minicore myopathy1STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003198HP:0003756Skeletal myopathy1STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003198HP:0009071Inflammatory myopathy1STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003198HP:0008978Necrotizing myopathy1STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003198HP:0003458EMG: myopathic abnormalities1STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003198HP:0003715Myofibrillar myopathy1STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003198HP:0003789Minicore myopathy1STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003198HP:0003756Skeletal myopathy1STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003198HP:0008978Necrotizing myopathy1STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003198HP:0009071Inflammatory myopathy1STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003198HP:0003715Myofibrillar myopathy1STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003198HP:0003458EMG: myopathic abnormalities1STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003198HP:0003458EMG: myopathic abnormalities1TIA1 CL E G H7072603ORPHA125011802603518
HP:0003198HP:0003715Myofibrillar myopathy1TIA1 CL E G H7072603ORPHA125011802603518
HP:0003198HP:0003789Minicore myopathy1TIA1 CL E G H7072603ORPHA125011802603518
HP:0003198HP:0003756Skeletal myopathy1TIA1 CL E G H7072603ORPHA125011802603518
HP:0003198HP:0009071Inflammatory myopathy1TIA1 CL E G H7072603ORPHA125011802603518
HP:0003198HP:0008978Necrotizing myopathy1TIA1 CL E G H7072603ORPHA125011802603518
HP:0003198HP:0009071Inflammatory myopathy1TK2 CL E G H7084254886ORPHA144211831188250
HP:0003198HP:0009071Inflammatory myopathy1TK2 CL E G H7084254875ORPHA144211831188250
HP:0003198HP:0008978Necrotizing myopathy1TK2 CL E G H7084254886ORPHA144211831188250
HP:0003198HP:0008978Necrotizing myopathy1TK2 CL E G H7084254875ORPHA144211831188250
HP:0003198HP:0003458EMG: myopathic abnormalities1TK2 CL E G H7084254886ORPHA144211831188250
HP:0003198HP:0003458EMG: myopathic abnormalities1TK2 CL E G H7084254875ORPHA144211831188250
HP:0003198HP:0003715Myofibrillar myopathy1TK2 CL E G H7084254886ORPHA144211831188250
HP:0003198HP:0003715Myofibrillar myopathy1TK2 CL E G H7084254875ORPHA144211831188250
HP:0003198HP:0003789Minicore myopathy1TK2 CL E G H7084254886ORPHA144211831188250
HP:0003198HP:0003789Minicore myopathy1TK2 CL E G H7084254875ORPHA144211831188250
HP:0003198HP:0003756Skeletal myopathy1TK2 CL E G H7084254886ORPHA144211831188250
HP:0003198HP:0003756Skeletal myopathy1TK2 CL E G H7084254875ORPHA144211831188250
HP:0003198HP:0003789Minicore myopathy1TNNT1 CL E G H7138605355Nemaline myopathy 5605355C1854380OMIM137211948191041
HP:0003198HP:0003756Skeletal myopathy1TNNT1 CL E G H7138605355Nemaline myopathy 5605355C1854380OMIM137211948191041
HP:0003198HP:0009071Inflammatory myopathy1TNNT1 CL E G H7138605355Nemaline myopathy 5605355C1854380OMIM137211948191041
HP:0003198HP:0008978Necrotizing myopathy1TNNT1 CL E G H7138605355Nemaline myopathy 5605355C1854380OMIM137211948191041
HP:0003198HP:0003458EMG: myopathic abnormalities1TNNT1 CL E G H7138605355Nemaline myopathy 5605355C1854380OMIM137211948191041
HP:0003198HP:0003715Myofibrillar myopathy1TNNT1 CL E G H7138605355Nemaline myopathy 5605355C1854380OMIM137211948191041
HP:0003198HP:0003789Minicore myopathy1TPI1 CL E G H7167615512Triosephosphate isomerase deficiency615512C1860808OMIM118112009190450
HP:0003198HP:0003756Skeletal myopathy1TPI1 CL E G H7167615512Triosephosphate isomerase deficiency615512C1860808OMIM118112009190450
HP:0003198HP:0008978Necrotizing myopathy1TPI1 CL E G H7167615512Triosephosphate isomerase deficiency615512C1860808OMIM118112009190450
HP:0003198HP:0009071Inflammatory myopathy1TPI1 CL E G H7167615512Triosephosphate isomerase deficiency615512C1860808OMIM118112009190450
HP:0003198HP:0003715Myofibrillar myopathy1TPI1 CL E G H7167615512Triosephosphate isomerase deficiency615512C1860808OMIM118112009190450
HP:0003198HP:0003458EMG: myopathic abnormalities1TPI1 CL E G H7167615512Triosephosphate isomerase deficiency615512C1860808OMIM118112009190450
HP:0003198HP:0009071Inflammatory myopathy1TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003198HP:0008978Necrotizing myopathy1TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003198HP:0009071Inflammatory myopathy1TRAPPC11 CL E G H60684369847ORPHA198325751614138
HP:0003198HP:0008978Necrotizing myopathy1TRAPPC11 CL E G H60684369847ORPHA198325751614138
HP:0003198HP:0003458EMG: myopathic abnormalities1TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003198HP:0003715Myofibrillar myopathy1TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003198HP:0003458EMG: myopathic abnormalities1TRAPPC11 CL E G H60684369847ORPHA198325751614138
HP:0003198HP:0003715Myofibrillar myopathy1TRAPPC11 CL E G H60684369847ORPHA198325751614138
HP:0003198HP:0003789Minicore myopathy1TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003198HP:0003756Skeletal myopathy1TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003198HP:0003789Minicore myopathy1TRAPPC11 CL E G H60684369847ORPHA198325751614138
HP:0003198HP:0003756Skeletal myopathy1TRAPPC11 CL E G H60684369847ORPHA198325751614138
HP:0003198HP:0003458EMG: myopathic abnormalities1TRIM32 CL E G H229541878Chromosome 1, uniparental disomy 1q12 q21CN035970ORPHA162716380602290
HP:0003198HP:0003715Myofibrillar myopathy1TRIM32 CL E G H229541878Chromosome 1, uniparental disomy 1q12 q21CN035970ORPHA162716380602290
HP:0003198HP:0003789Minicore myopathy1TRIM32 CL E G H229541878Chromosome 1, uniparental disomy 1q12 q21CN035970ORPHA162716380602290
HP:0003198HP:0003756Skeletal myopathy1TRIM32 CL E G H229541878Chromosome 1, uniparental disomy 1q12 q21CN035970ORPHA162716380602290
HP:0003198HP:0009071Inflammatory myopathy1TRIM32 CL E G H229541878Chromosome 1, uniparental disomy 1q12 q21CN035970ORPHA162716380602290
HP:0003198HP:0008978Necrotizing myopathy1TRIM32 CL E G H229541878Chromosome 1, uniparental disomy 1q12 q21CN035970ORPHA162716380602290
HP:0003198HP:0009071Inflammatory myopathy1TRMU CL E G H55687254864ORPHA162325481610230
HP:0003198HP:0008978Necrotizing myopathy1TRMU CL E G H55687254864ORPHA162325481610230
HP:0003198HP:0003458EMG: myopathic abnormalities1TRMU CL E G H55687254864ORPHA162325481610230
HP:0003198HP:0003715Myofibrillar myopathy1TRMU CL E G H55687254864ORPHA162325481610230
HP:0003198HP:0003789Minicore myopathy1TRMU CL E G H55687254864ORPHA162325481610230
HP:0003198HP:0003756Skeletal myopathy1TRMU CL E G H55687254864ORPHA162325481610230
HP:0003198HP:0003756Skeletal myopathy1TTN CL E G H7273611705Myopathy, early-onset, with fatal cardiomyopathy611705C2673677OMIM12750312403188840
HP:0003198HP:0003789Minicore myopathy1TTN CL E G H7273611705Myopathy, early-onset, with fatal cardiomyopathy611705C2673677OMIM12750312403188840
HP:0003198HP:0008978Necrotizing myopathy1TTN CL E G H7273611705Myopathy, early-onset, with fatal cardiomyopathy611705C2673677OMIM12750312403188840
HP:0003198HP:0009071Inflammatory myopathy1TTN CL E G H7273611705Myopathy, early-onset, with fatal cardiomyopathy611705C2673677OMIM12750312403188840
HP:0003198HP:0003715Myofibrillar myopathy1TTN CL E G H7273611705Myopathy, early-onset, with fatal cardiomyopathy611705C2673677OMIM12750312403188840
HP:0003198HP:0003458EMG: myopathic abnormalities1TTN CL E G H7273611705Myopathy, early-onset, with fatal cardiomyopathy611705C2673677OMIM12750312403188840
HP:0003198HP:0003756Skeletal myopathy1UBA1 CL E G H7317301830Spinal muscular atrophy, X-linked 2301830C1844934OMIM163112469314370
HP:0003198HP:0003789Minicore myopathy1UBA1 CL E G H7317301830Spinal muscular atrophy, X-linked 2301830C1844934OMIM163112469314370
HP:0003198HP:0008978Necrotizing myopathy1UBA1 CL E G H7317301830Spinal muscular atrophy, X-linked 2301830C1844934OMIM163112469314370
HP:0003198HP:0009071Inflammatory myopathy1UBA1 CL E G H7317301830Spinal muscular atrophy, X-linked 2301830C1844934OMIM163112469314370
HP:0003198HP:0003715Myofibrillar myopathy1UBA1 CL E G H7317301830Spinal muscular atrophy, X-linked 2301830C1844934OMIM163112469314370
HP:0003198HP:0003458EMG: myopathic abnormalities1UBA1 CL E G H7317301830Spinal muscular atrophy, X-linked 2301830C1844934OMIM163112469314370
HP:0003198HP:0003789Minicore myopathy1VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003198HP:0003756Skeletal myopathy1VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003198HP:0009071Inflammatory myopathy1VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003198HP:0008978Necrotizing myopathy1VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003198HP:0003458EMG: myopathic abnormalities1VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003198HP:0003715Myofibrillar myopathy1VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003198HP:0003789Minicore myopathy1VMA21 CL E G H203547310440Myopathy, X-linked, with excessive autophagy310440C1839615OMIM125422082300913
HP:0003198HP:0003756Skeletal myopathy1VMA21 CL E G H203547310440Myopathy, X-linked, with excessive autophagy310440C1839615OMIM125422082300913
HP:0003198HP:0009071Inflammatory myopathy1VMA21 CL E G H203547310440Myopathy, X-linked, with excessive autophagy310440C1839615OMIM125422082300913
HP:0003198HP:0008978Necrotizing myopathy1VMA21 CL E G H203547310440Myopathy, X-linked, with excessive autophagy310440C1839615OMIM125422082300913
HP:0003198HP:0003458EMG: myopathic abnormalities1VMA21 CL E G H203547310440Myopathy, X-linked, with excessive autophagy310440C1839615OMIM125422082300913
HP:0003198HP:0003715Myofibrillar myopathy1VMA21 CL E G H203547310440Myopathy, X-linked, with excessive autophagy310440C1839615OMIM125422082300913
HP:0003198HP:0003458EMG: myopathic abnormalities1VPS13A CL E G H232302388ORPHA123621908605978
HP:0003198HP:0003715Myofibrillar myopathy1VPS13A CL E G H232302388ORPHA123621908605978
HP:0003198HP:0003789Minicore myopathy1VPS13A CL E G H232302388ORPHA123621908605978
HP:0003198HP:0003756Skeletal myopathy1VPS13A CL E G H232302388ORPHA123621908605978
HP:0003198HP:0009071Inflammatory myopathy1VPS13A CL E G H232302388ORPHA123621908605978
HP:0003198HP:0008978Necrotizing myopathy1VPS13A CL E G H232302388ORPHA123621908605978
HP:0003198HP:0003789Minicore myopathy1XDH CL E G H7498278300Deficiency of xanthine oxidase278300C0268118OMIM169112805607633
HP:0003198HP:0003756Skeletal myopathy1XDH CL E G H7498278300Deficiency of xanthine oxidase278300C0268118OMIM169112805607633
HP:0003198HP:0009071Inflammatory myopathy1XDH CL E G H7498278300Deficiency of xanthine oxidase278300C0268118OMIM169112805607633
HP:0003198HP:0008978Necrotizing myopathy1XDH CL E G H7498278300Deficiency of xanthine oxidase278300C0268118OMIM169112805607633
HP:0003198HP:0003458EMG: myopathic abnormalities1XDH CL E G H7498278300Deficiency of xanthine oxidase278300C0268118OMIM169112805607633
HP:0003198HP:0003715Myofibrillar myopathy1XDH CL E G H7498278300Deficiency of xanthine oxidase278300C0268118OMIM169112805607633
HP:0003198HP:0003789Minicore myopathy1XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM121812811314850
HP:0003198HP:0003756Skeletal myopathy1XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM121812811314850
HP:0003198HP:0009071Inflammatory myopathy1XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM121812811314850
HP:0003198HP:0008978Necrotizing myopathy1XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM121812811314850
HP:0003198HP:0003458EMG: myopathic abnormalities1XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM121812811314850
HP:0003198HP:0003715Myofibrillar myopathy1XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM121812811314850
HP:0003198HP:0003458EMG: myopathic abnormalities1YARS2 CL E G H510672598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA127424249610957
HP:0003198HP:0003715Myofibrillar myopathy1YARS2 CL E G H510672598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA127424249610957
HP:0003198HP:0003789Minicore myopathy1YARS2 CL E G H510672598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA127424249610957
HP:0003198HP:0003756Skeletal myopathy1YARS2 CL E G H510672598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA127424249610957
HP:0003198HP:0009071Inflammatory myopathy1YARS2 CL E G H510672598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA127424249610957
HP:0003198HP:0008978Necrotizing myopathy1YARS2 CL E G H510672598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA127424249610957
HP:0003198HP:0003715Myofibrillar myopathy1ZBTB20 CL E G H261373042ORPHA125213503606025
HP:0003198HP:0003458EMG: myopathic abnormalities1ZBTB20 CL E G H261373042ORPHA125213503606025
HP:0003198HP:0003756Skeletal myopathy1ZBTB20 CL E G H261373042ORPHA125213503606025
HP:0003198HP:0003789Minicore myopathy1ZBTB20 CL E G H261373042ORPHA125213503606025
HP:0003198HP:0008978Necrotizing myopathy1ZBTB20 CL E G H261373042ORPHA125213503606025
HP:0003198HP:0009071Inflammatory myopathy1ZBTB20 CL E G H261373042ORPHA125213503606025
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ABHD5 CL E G H51099275630Triglyceride storage disease with ichthyosis275630C0268238OMIM129121396604780
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ACACA CL E G H31613933Acetyl-CoA: carboxylase deficiency613933C0268603OMIM130784200350
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ACADS CL E G H35201470Deficiency of butyryl-CoA dehydrogenase201470C0342783OMIM140690606885
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ACTA1 CL E G H5897244ORPHA1506129102610
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ADGRG6 CL E G H57211616503Lethal congenital contracture syndrome 9616503C4225303OMIM115313841612243
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ADSSL1 CL E G H122622617030Myopathy, distal, 5617030C4310754OMIM120093612498
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2AGK CL E G H557501369ORPHA134721869610345
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2AGK CL E G H55750212350Cataract and cardiomyopathy212350C1859317OMIM134721869610345
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2AGL CL E G H178366Arnold Stickler Bourne syndromeORPHA12263321610860
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2AGL CL E G H178232400Glycogen storage disease type III232400C0017922OMIM12263321610860
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1242325603100
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ALG14 CL E G H199857353327ORPHA114428287612866
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ALG2 CL E G H85365353327ORPHA133523159607905
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ALPL CL E G H249241510Childhood hypophosphatasia241510C0220743OMIM1934438171760
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2AP1S2 CL E G H890585329ORPHA1241560300629
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2B3GALNT2 CL E G H148789588ORPHA158728596610194
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2B4GALT1 CL E G H268379332ORPHA1184924137060
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2B4GALT1 CL E G H2683607091Congenital disorder of glycosylation type 2D607091C1846816OMIM1184924137060
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA151015832606158
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2C1QBP CL E G H708617713COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33617713C4540209OMIM11371243601269
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CASQ1 CL E G H84488635ORPHA12491512114250
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA11351527601047
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11289688603198
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CCDC174 CL E G H51244616816Hypotonia, infantile, with psychomotor retardation616816C4225196OMIM18728033616735
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CENPF CL E G H1063243605Stromme syndrome243605C1855705OMIM15541857600236
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CHKB CL E G H1120602541Muscular dystrophy, congenital, megaconial type602541C1865233OMIM15021938612395
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CHRNB1 CL E G H1140616313Myasthenic syndrome, congenital, 2a, slow-channel616313C4225374OMIM14541961100710
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CHRNB1 CL E G H1140616314Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency616314C4225373OMIM14541961100710
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CHRND CL E G H1144616321Myasthenic syndrome, congenital, 3a, slow-channel616321C4225372OMIM15051965100720
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CHRNE CL E G H1145605809Myasthenic syndrome, congenital, 4a, slow-channel605809C1853949OMIM110111966100725
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2COL12A1 CL E G H1303616471Bethlem myopathy 2616471C4225313OMIM125482188120320
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2COLQ CL E G H829298915ORPHA15422226603033
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2COLQ CL E G H8292603034Endplate acetylcholinesterase deficiency603034C1864233OMIM15422226603033
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CPT2 CL E G H1376228305ORPHA18762330600650
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CPT2 CL E G H1376228302ORPHA18762330600650
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2DNA2 CL E G H1763352470ORPHA16012939601810
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2DPAGT1 CL E G H1798353327ORPHA13122995191350
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2DYSF CL E G H8291606768Myopathy, distal, with anterior tibial onset606768C1847532OMIM133553097603009
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2EMD CL E G H2010310300Emery-Dreifuss muscular dystrophy 1, X-linked310300C0751337OMIM16953331300384
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2EPG5 CL E G H57724242840Vici syndrome242840C1855772OMIM1164029331615068
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ERGIC1 CL E G H57222208100Arthrogryposis multiplex congenita neurogenic type208100C1859721OMIM13929205617946
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2FKBP14 CL E G H55033300179ORPHA122018625614505
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2FKBP14 CL E G H55033614557Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss614557C3281160OMIM122018625614505
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2FKRP CL E G H79147588ORPHA195017997606596
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2FKTN CL E G H2218588ORPHA19143622607440
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2FKTN CL E G H2218272VACTERL hydrocephalyORPHA19143622607440
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1403796164810
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2GCLC CL E G H2729230450Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to230450C1856603OMIM11284311606857
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2GFER CL E G H2671613076Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay613076C2751320OMIM12004236600924
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2GFPT1 CL E G H2673353327ORPHA15244241138292
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2GK CL E G H2710307030Deficiency of glycerol kinase307030C0268418OMIM12334289300474
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2GMPPB CL E G H29925588ORPHA136422932615320
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2GMPPB CL E G H29925353327ORPHA136422932615320
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2HNRNPA2B1 CL E G H3181615422Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2615422C3809468OMIM12955033600124
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2HNRNPDL CL E G H9987609115Limb-girdle muscular dystrophy, type 1G609115C1836765OMIM13545037607137
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2HSPG2 CL E G H3339800ORPHA124975273142461
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2INPP5K CL E G H51763559ORPHA118733882607875
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM116029882611911
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ITGA7 CL E G H3679613204Muscular dystrophy, congenital, due to integrin alpha-7 deficiency613204C2750786OMIM18986143600536
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2KBTBD13 CL E G H390594609273Nemaline myopathy 6609273C1836472OMIM153037227613727
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2LARGE1 CL E G H9215588ORPHA17866511603590
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2LMNA CL E G H4000157973ORPHA118146636150330
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2LMNB2 CL E G H8482379087ORPHA15486638150341
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MGME1 CL E G H92667352447ORPHA115716205615076
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ATP6 CL E G H4508535000Leber's optic atrophy535000C0917796OMIM17414516060
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-CO1 CL E G H4512540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17419516030
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-CO2 CL E G H4513540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17421516040
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-CO3 CL E G H4514540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17422516050
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-CO3 CL E G H4514535000Leber's optic atrophy535000C0917796OMIM17422516050
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-CYB CL E G H4519540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17427516020
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-CYB CL E G H4519535000Leber's optic atrophy535000C0917796OMIM17427516020
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND1 CL E G H4535540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17455516000
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND1 CL E G H4535535000Leber's optic atrophy535000C0917796OMIM17455516000
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND2 CL E G H4536535000Leber's optic atrophy535000C0917796OMIM17456516001
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND4 CL E G H4538535000Leber's optic atrophy535000C0917796OMIM17459516003
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND4L CL E G H4539535000Leber's optic atrophy535000C0917796OMIM17460516004
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND5 CL E G H4540551ORPHA17461516005
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND5 CL E G H4540540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17461516005
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND5 CL E G H4540535000Leber's optic atrophy535000C0917796OMIM17461516005
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND6 CL E G H4541540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17462516006
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND6 CL E G H4541535000Leber's optic atrophy535000C0917796OMIM17462516006
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-RNR1 CL E G H4549551ORPHA117470180450
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TC CL E G H4511540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17477590020
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TE CL E G H4556254864ORPHA17479590025
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TF CL E G H4558551ORPHA17481590070
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TF CL E G H4558540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17481590070
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TF CL E G H4558545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17481590070
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TH CL E G H4564551ORPHA17487590040
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TI CL E G H4565545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17488590045
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TK CL E G H4566551ORPHA17489590060
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TK CL E G H4566540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17489590060
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TK CL E G H4566545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17489590060
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TL1 CL E G H4567551ORPHA17490590050
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TL1 CL E G H4567540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17490590050
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TL1 CL E G H4567545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17490590050
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TP CL E G H4571551ORPHA17494590075
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TP CL E G H4571545000Myoclonus with epilepsy with ragged red fibers545000C0162672OMIM17494590075
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TQ CL E G H4572551ORPHA17495590030
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TQ CL E G H4572540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17495590030
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TS1 CL E G H4574551ORPHA17497590080
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TS1 CL E G H4574540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17497590080
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TS2 CL E G H4575551ORPHA17498590085
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TS2 CL E G H4575540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17498590085
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TT CL E G H4576551000Lethal infantile mitochondrial myopathy551000C1838876OMIM17499590090
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TV CL E G H4577540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17500590105
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-TW CL E G H4578540000Juvenile myopathy, encephalopathy, lactic acidosis AND stroke540000C0162671OMIM17501590095
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MYMK CL E G H389827254940Congenital nonprogressive myopathy with Moebius and Robin sequences254940C1850746OMIM18633778615345
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MYO18B CL E G H84700616549Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism616549C4225285OMIM1181018150607295
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2NDUFA11 CL E G H126328618236MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14618236OMIM113120371612638
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2NDUFAF1 CL E G H51103618234MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11618234OMIM115418828606934
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2NDUFAF4 CL E G H29078618237MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15618237OMIM113621034611776
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2NDUFB3 CL E G H4709618246MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25618246OMIM1797698603839
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM17147737162230
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2NUBPL CL E G H80224618242MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21618242OMIM128420278613621
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2OPA1 CL E G H4976125250Autosomal dominant optic atrophy plus syndrome125250C1852267OMIM112248140605290
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ORAI1 CL E G H84876612782Immune dysfunction with T-cell inactivation due to calcium entry defect 1612782C2748568OMIM132625896610277
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PABPN1 CL E G H8106270ORPHA1858565602279
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PANK2 CL E G H80025234200Pigmentary pallidal degeneration234200C0018523OMIM149915894606157
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PLEC CL E G H5339257ORPHA150689069601282
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PNPLA2 CL E G H5710498908ORPHA156630802609059
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2POLG CL E G H5428254886ORPHA123249179174763
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2POMGNT1 CL E G H55624588ORPHA1117419139606822
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2POMT1 CL E G H10585588ORPHA19069202607423
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2POMT2 CL E G H29954588ORPHA193619743607439
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11669236601487
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PRKAG2 CL E G H51422261740Glycogen storage disease of heart, lethal congenital261740C1849813OMIM110799386602743
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PUS1 CL E G H803242598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA147815508608109
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PYGM CL E G H5837368ORPHA110559726608455
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2RET CL E G H5979162300Multiple endocrine neoplasia, type 2b162300C0025269OMIM131659967164761
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2RMND1 CL E G H55005614922Combined oxidative phosphorylation deficiency 11614922C3554067OMIM126221176614917
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2RRM2B CL E G H50484613077Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5613077C2751319OMIM135417296604712
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2RYR1 CL E G H6261597ORPHA1616410483180901
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SCN4A CL E G H6329613345Hypokalemic periodic paralysis, type 2613345C2750061OMIM1176510591603967
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SELENON CL E G H5719097244ORPHA165115999606210
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SGCB CL E G H6443119ORPHA150010806600900
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SIL1 CL E G H64374559ORPHA135224624608005
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SIL1 CL E G H64374248800Marinesco-Sjögren syndrome248800C0024814OMIM135224624608005
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SLC22A5 CL E G H6584212140Renal carnitine transport defect212140C0342788OMIM1102710969603377
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SLC25A3 CL E G H525091130ORPHA117610989600370
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SLC25A4 CL E G H2911369ORPHA133310990103220
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2STIM1 CL E G H6786612783Immune dysfunction with T-cell inactivation due to calcium entry defect 2612783C2748557OMIM163511386605921
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TIA1 CL E G H7072603ORPHA125011802603518
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TK2 CL E G H7084254886ORPHA144211831188250
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TK2 CL E G H7084254875ORPHA144211831188250
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TNNT1 CL E G H7138605355Nemaline myopathy 5605355C1854380OMIM137211948191041
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TPI1 CL E G H7167615512Triosephosphate isomerase deficiency615512C1860808OMIM118112009190450
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TRAPPC11 CL E G H60684369847ORPHA198325751614138
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TRIM32 CL E G H229541878Chromosome 1, uniparental disomy 1q12 q21CN035970ORPHA162716380602290
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TRMU CL E G H55687254864ORPHA162325481610230
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TTN CL E G H7273611705Myopathy, early-onset, with fatal cardiomyopathy611705C2673677OMIM12750312403188840
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2UBA1 CL E G H7317301830Spinal muscular atrophy, X-linked 2301830C1844934OMIM163112469314370
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2VMA21 CL E G H203547310440Myopathy, X-linked, with excessive autophagy310440C1839615OMIM125422082300913
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2VPS13A CL E G H232302388ORPHA123621908605978
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2XDH CL E G H7498278300Deficiency of xanthine oxidase278300C0268118OMIM169112805607633
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM121812811314850
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2YARS2 CL E G H510672598Mitochondrial myopathy and sideroblastic anemiaCN220387ORPHA127424249610957
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ZBTB20 CL E G H261373042ORPHA125213503606025
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003198HP:0003198Myopathy0ABCC9 CL E G H10060154Sandhaus Ben-Ami syndromeORPHA0150760601439
HP:0003198HP:0003198Myopathy0ACTA1 CL E G H58171436ORPHA0506129102610
HP:0003198HP:0003198Myopathy0ACTC1 CL E G H70154Sandhaus Ben-Ami syndromeORPHA0672143102540
HP:0003198HP:0003198Myopathy0ACTN2 CL E G H88154Sandhaus Ben-Ami syndromeORPHA01361164102573
HP:0003198HP:0003198Myopathy0ALDOA CL E G H226611881HNSHA due to aldolase A deficiency611881C0272066OMIM0504414103850
HP:0003198HP:0003198Myopathy0ANKRD1 CL E G H27063154Sandhaus Ben-Ami syndromeORPHA044215819609599
HP:0003198HP:0003198Myopathy0BAG3 CL E G H9531154Sandhaus Ben-Ami syndromeORPHA0986939603883
HP:0003198HP:0003198Myopathy0BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA0249961605681
HP:0003198HP:0003198Myopathy0BSCL2 CL E G H26580363400ORPHA051015832606158
HP:0003198HP:0003198Myopathy0CACNA1S CL E G H779170400Hypokalemic periodic paralysis 1170400C3714580OMIM018861397114208
HP:0003198HP:0003198Myopathy0CDH23 CL E G H6407296253ORPHA0452213733605516
HP:0003198HP:0003198Myopathy0CFL2 CL E G H1073171436ORPHA01671875601443
HP:0003198HP:0003198Myopathy0CISD2 CL E G H4938563463ORPHA07124212611507
HP:0003198HP:0003198Myopathy0CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA02292586603432
HP:0003198HP:0003198Myopathy0CRYAB CL E G H1410154Sandhaus Ben-Ami syndromeORPHA02732389123590
HP:0003198HP:0003198Myopathy0CSRP3 CL E G H8048154Sandhaus Ben-Ami syndromeORPHA04072472600824
HP:0003198HP:0003198Myopathy0CTNS CL E G H1497219800Nephropathic cystinosis219800C0010690OMIM07782518606272
HP:0003198HP:0003198Myopathy0DES CL E G H1674154Sandhaus Ben-Ami syndromeORPHA09762770125660
HP:0003198HP:0003198Myopathy0DMD CL E G H1756154Sandhaus Ben-Ami syndromeORPHA081842928300377
HP:0003198HP:0003198Myopathy0DOLK CL E G H22845154Sandhaus Ben-Ami syndromeORPHA052123406610746
HP:0003198HP:0003198Myopathy0DSG2 CL E G H1829154Sandhaus Ben-Ami syndromeORPHA015703049125671
HP:0003198HP:0003198Myopathy0ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA09663327130160
HP:0003198HP:0003198Myopathy0FHL2 CL E G H2274154Sandhaus Ben-Ami syndromeORPHA02003703602633
HP:0003198HP:0003198Myopathy0FKTN CL E G H2218154Sandhaus Ben-Ami syndromeORPHA09143622607440
HP:0003198HP:0003198Myopathy0GABRD CL E G H25631606ORPHA04744084137163
HP:0003198HP:0003198Myopathy0GATAD1 CL E G H57798154Sandhaus Ben-Ami syndromeORPHA061829941614518
HP:0003198HP:0003198Myopathy0GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA01784659601679
HP:0003198HP:0003198Myopathy0GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA02664661604318
HP:0003198HP:0003198Myopathy0KCNAB2 CL E G H85141606ORPHA01146229601142
HP:0003198HP:0003198Myopathy0KLHL41 CL E G H10324171436ORPHA029416905607701
HP:0003198HP:0003198Myopathy0LAMA4 CL E G H3910154Sandhaus Ben-Ami syndromeORPHA016136484600133
HP:0003198HP:0003198Myopathy0LDB3 CL E G H11155154Sandhaus Ben-Ami syndromeORPHA0122615710605906
HP:0003198HP:0003198Myopathy0LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA02326613601329
HP:0003198HP:0003198Myopathy0LMNA CL E G H40002348ORPHA018146636150330
HP:0003198HP:0003198Myopathy0LMNA CL E G H4000280365ORPHA018146636150330
HP:0003198HP:0003198Myopathy0LMNA CL E G H4000610140Heart-hand syndrome, Slovenian type610140C1857829OMIM018146636150330
HP:0003198HP:0003198Myopathy0LMOD3 CL E G H56203171436ORPHA03926649616112
HP:0003198HP:0003198Myopathy0MT-ATP6 CL E G H4508104ORPHA07414516060
HP:0003198HP:0003198Myopathy0MT-CO1 CL E G H4512104ORPHA07419516030
HP:0003198HP:0003198Myopathy0MT-CO3 CL E G H4514104ORPHA07422516050
HP:0003198HP:0003198Myopathy0MT-CYB CL E G H4519104ORPHA07427516020
HP:0003198HP:0003198Myopathy0MT-ND1 CL E G H4535104ORPHA07455516000
HP:0003198HP:0003198Myopathy0MT-ND2 CL E G H4536104ORPHA07456516001
HP:0003198HP:0003198Myopathy0MT-ND4 CL E G H4538104ORPHA07459516003
HP:0003198HP:0003198Myopathy0MT-ND4L CL E G H4539104ORPHA07460516004
HP:0003198HP:0003198Myopathy0MT-ND5 CL E G H4540104ORPHA07461516005
HP:0003198HP:0003198Myopathy0MT-ND6 CL E G H4541104ORPHA07462516006
HP:0003198HP:0003198Myopathy0MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM02517413156540
HP:0003198HP:0003198Myopathy0MYBPC3 CL E G H4607154Sandhaus Ben-Ami syndromeORPHA033177551600958
HP:0003198HP:0003198Myopathy0MYH6 CL E G H4624154Sandhaus Ben-Ami syndromeORPHA021167576160710
HP:0003198HP:0003198Myopathy0MYH7 CL E G H4625154Sandhaus Ben-Ami syndromeORPHA041067577160760
HP:0003198HP:0003198Myopathy0MYMK CL E G H3898271358ORPHA08633778615345
HP:0003198HP:0003198Myopathy0MYPN CL E G H84665154Sandhaus Ben-Ami syndromeORPHA0148523246608517
HP:0003198HP:0003198Myopathy0NDUFS2 CL E G H4720104ORPHA02477708602985
HP:0003198HP:0003198Myopathy0NEB CL E G H4703171436ORPHA085307720161650
HP:0003198HP:0003198Myopathy0NEBL CL E G H10529154Sandhaus Ben-Ami syndromeORPHA0101616932605491
HP:0003198HP:0003198Myopathy0NEXN CL E G H91624154Sandhaus Ben-Ami syndromeORPHA066929557613121
HP:0003198HP:0003198Myopathy0PDE11A CL E G H50940189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02038773604961
HP:0003198HP:0003198Myopathy0PDE8B CL E G H8622189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02438794603390
HP:0003198HP:0003198Myopathy0PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM03468896311800
HP:0003198HP:0003198Myopathy0PLN CL E G H5350154Sandhaus Ben-Ami syndromeORPHA01789080172405
HP:0003198HP:0003198Myopathy0POMT1 CL E G H1058586812ORPHA09069202607423
HP:0003198HP:0003198Myopathy0PPARG CL E G H546879083ORPHA01669236601487
HP:0003198HP:0003198Myopathy0PPCS CL E G H79717154Sandhaus Ben-Ami syndromeORPHA020425686609853
HP:0003198HP:0003198Myopathy0PRDM16 CL E G H639761606ORPHA0127214000605557
HP:0003198HP:0003198Myopathy0PRDM16 CL E G H63976154Sandhaus Ben-Ami syndromeORPHA0127214000605557
HP:0003198HP:0003198Myopathy0PRKACA CL E G H5566189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA0439380601639
HP:0003198HP:0003198Myopathy0PRKAR1A CL E G H5573189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA011319388188830
HP:0003198HP:0003198Myopathy0PSEN1 CL E G H5663154Sandhaus Ben-Ami syndromeORPHA05019508104311
HP:0003198HP:0003198Myopathy0PSEN2 CL E G H5664154Sandhaus Ben-Ami syndromeORPHA02799509600759
HP:0003198HP:0003198Myopathy0PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA030129588601728
HP:0003198HP:0003198Myopathy0RAF1 CL E G H5894154Sandhaus Ben-Ami syndromeORPHA09909829164760
HP:0003198HP:0003198Myopathy0RBM20 CL E G H282996154Sandhaus Ben-Ami syndromeORPHA0162327424613171
HP:0003198HP:0003198Myopathy0RERE CL E G H4731606ORPHA06599965605226
HP:0003198HP:0003198Myopathy0RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA02009970600404
HP:0003198HP:0003198Myopathy0SCN4A CL E G H6329682ORPHA0176510591603967
HP:0003198HP:0003198Myopathy0SCN4A CL E G H632999734ORPHA0176510591603967
HP:0003198HP:0003198Myopathy0SCN4A CL E G H6329170400Hypokalemic periodic paralysis 1170400C3714580OMIM0176510591603967
HP:0003198HP:0003198Myopathy0SCN5A CL E G H6331154Sandhaus Ben-Ami syndromeORPHA0353110593600163
HP:0003198HP:0003198Myopathy0SDHA CL E G H6389154Sandhaus Ben-Ami syndromeORPHA0250310680600857
HP:0003198HP:0003198Myopathy0SDHD CL E G H6392100093ORPHA068610683602690
HP:0003198HP:0003198Myopathy0SGCD CL E G H6444154Sandhaus Ben-Ami syndromeORPHA067310807601411
HP:0003198HP:0003198Myopathy0SKI CL E G H64971606ORPHA0106210896164780
HP:0003198HP:0003198Myopathy0TAF1A CL E G H9015154Sandhaus Ben-Ami syndromeORPHA04911532604903
HP:0003198HP:0003198Myopathy0TAZ CL E G H6901154Sandhaus Ben-Ami syndromeORPHA011577300394
HP:0003198HP:0003198Myopathy0TBCE CL E G H69052323Triple-Negative Breast Cancer FindingC2348819ORPHA045611582604934
HP:0003198HP:0003198Myopathy0TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA019411586605842
HP:0003198HP:0003198Myopathy0TCAP CL E G H8557154Sandhaus Ben-Ami syndromeORPHA029811610604488
HP:0003198HP:0003198Myopathy0TMPO CL E G H7112154Sandhaus Ben-Ami syndromeORPHA059711875188380
HP:0003198HP:0003198Myopathy0TNNC1 CL E G H7134154Sandhaus Ben-Ami syndromeORPHA030011943191040
HP:0003198HP:0003198Myopathy0TNNI3 CL E G H7137154Sandhaus Ben-Ami syndromeORPHA065511947191044
HP:0003198HP:0003198Myopathy0TNNT2 CL E G H7139154Sandhaus Ben-Ami syndromeORPHA081711949191045
HP:0003198HP:0003198Myopathy0TPM1 CL E G H7168154Sandhaus Ben-Ami syndromeORPHA076712010191010
HP:0003198HP:0003198Myopathy0TPM2 CL E G H7169171436ORPHA034112011190990
HP:0003198HP:0003198Myopathy0TTN CL E G H7273154Sandhaus Ben-Ami syndromeORPHA02750312403188840
HP:0003198HP:0003198Myopathy0TXNRD2 CL E G H10587154Sandhaus Ben-Ami syndromeORPHA0106818155606448
HP:0003198HP:0003198Myopathy0USP8 CL E G H910196253ORPHA015812631603158
HP:0003198HP:0003198Myopathy0VCL CL E G H7414154Sandhaus Ben-Ami syndromeORPHA0117512665193065
HP:0003198HP:0003198Myopathy0WFS1 CL E G H74663463ORPHA0163412762606201
HP:0003198HP:0003756Skeletal myopathy1ABCC9 CL E G H10060154Sandhaus Ben-Ami syndromeORPHA0150760601439
HP:0003198HP:0003789Minicore myopathy1ABCC9 CL E G H10060154Sandhaus Ben-Ami syndromeORPHA0150760601439
HP:0003198HP:0008978Necrotizing myopathy1ABCC9 CL E G H10060154Sandhaus Ben-Ami syndromeORPHA0150760601439
HP:0003198HP:0009071Inflammatory myopathy1ABCC9 CL E G H10060154Sandhaus Ben-Ami syndromeORPHA0150760601439
HP:0003198HP:0003715Myofibrillar myopathy1ABCC9 CL E G H10060154Sandhaus Ben-Ami syndromeORPHA0150760601439
HP:0003198HP:0003458EMG: myopathic abnormalities1ABCC9 CL E G H10060154Sandhaus Ben-Ami syndromeORPHA0150760601439
HP:0003198HP:0009071Inflammatory myopathy1ACTA1 CL E G H58171436ORPHA0506129102610
HP:0003198HP:0008978Necrotizing myopathy1ACTA1 CL E G H58171436ORPHA0506129102610
HP:0003198HP:0003458EMG: myopathic abnormalities1ACTA1 CL E G H58171436ORPHA0506129102610
HP:0003198HP:0003715Myofibrillar myopathy1ACTA1 CL E G H58171436ORPHA0506129102610
HP:0003198HP:0003789Minicore myopathy1ACTA1 CL E G H58171436ORPHA0506129102610
HP:0003198HP:0003756Skeletal myopathy1ACTA1 CL E G H58171436ORPHA0506129102610
HP:0003198HP:0003789Minicore myopathy1ACTC1 CL E G H70154Sandhaus Ben-Ami syndromeORPHA0672143102540
HP:0003198HP:0003756Skeletal myopathy1ACTC1 CL E G H70154Sandhaus Ben-Ami syndromeORPHA0672143102540
HP:0003198HP:0009071Inflammatory myopathy1ACTC1 CL E G H70154Sandhaus Ben-Ami syndromeORPHA0672143102540
HP:0003198HP:0008978Necrotizing myopathy1ACTC1 CL E G H70154Sandhaus Ben-Ami syndromeORPHA0672143102540
HP:0003198HP:0003458EMG: myopathic abnormalities1ACTC1 CL E G H70154Sandhaus Ben-Ami syndromeORPHA0672143102540
HP:0003198HP:0003715Myofibrillar myopathy1ACTC1 CL E G H70154Sandhaus Ben-Ami syndromeORPHA0672143102540
HP:0003198HP:0003756Skeletal myopathy1ACTN2 CL E G H88154Sandhaus Ben-Ami syndromeORPHA01361164102573
HP:0003198HP:0003789Minicore myopathy1ACTN2 CL E G H88154Sandhaus Ben-Ami syndromeORPHA01361164102573
HP:0003198HP:0009071Inflammatory myopathy1ACTN2 CL E G H88154Sandhaus Ben-Ami syndromeORPHA01361164102573
HP:0003198HP:0008978Necrotizing myopathy1ACTN2 CL E G H88154Sandhaus Ben-Ami syndromeORPHA01361164102573
HP:0003198HP:0003458EMG: myopathic abnormalities1ACTN2 CL E G H88154Sandhaus Ben-Ami syndromeORPHA01361164102573
HP:0003198HP:0003715Myofibrillar myopathy1ACTN2 CL E G H88154Sandhaus Ben-Ami syndromeORPHA01361164102573
HP:0003198HP:0003789Minicore myopathy1ALDOA CL E G H226611881HNSHA due to aldolase A deficiency611881C0272066OMIM0504414103850
HP:0003198HP:0003756Skeletal myopathy1ALDOA CL E G H226611881HNSHA due to aldolase A deficiency611881C0272066OMIM0504414103850
HP:0003198HP:0009071Inflammatory myopathy1ALDOA CL E G H226611881HNSHA due to aldolase A deficiency611881C0272066OMIM0504414103850
HP:0003198HP:0008978Necrotizing myopathy1ALDOA CL E G H226611881HNSHA due to aldolase A deficiency611881C0272066OMIM0504414103850
HP:0003198HP:0003458EMG: myopathic abnormalities1ALDOA CL E G H226611881HNSHA due to aldolase A deficiency611881C0272066OMIM0504414103850
HP:0003198HP:0003715Myofibrillar myopathy1ALDOA CL E G H226611881HNSHA due to aldolase A deficiency611881C0272066OMIM0504414103850
HP:0003198HP:0003789Minicore myopathy1ANKRD1 CL E G H27063154Sandhaus Ben-Ami syndromeORPHA044215819609599
HP:0003198HP:0003756Skeletal myopathy1ANKRD1 CL E G H27063154Sandhaus Ben-Ami syndromeORPHA044215819609599
HP:0003198HP:0009071Inflammatory myopathy1ANKRD1 CL E G H27063154Sandhaus Ben-Ami syndromeORPHA044215819609599
HP:0003198HP:0008978Necrotizing myopathy1ANKRD1 CL E G H27063154Sandhaus Ben-Ami syndromeORPHA044215819609599
HP:0003198HP:0003458EMG: myopathic abnormalities1ANKRD1 CL E G H27063154Sandhaus Ben-Ami syndromeORPHA044215819609599
HP:0003198HP:0003715Myofibrillar myopathy1ANKRD1 CL E G H27063154Sandhaus Ben-Ami syndromeORPHA044215819609599
HP:0003198HP:0003789Minicore myopathy1BAG3 CL E G H9531154Sandhaus Ben-Ami syndromeORPHA0986939603883
HP:0003198HP:0003756Skeletal myopathy1BAG3 CL E G H9531154Sandhaus Ben-Ami syndromeORPHA0986939603883
HP:0003198HP:0009071Inflammatory myopathy1BAG3 CL E G H9531154Sandhaus Ben-Ami syndromeORPHA0986939603883
HP:0003198HP:0008978Necrotizing myopathy1BAG3 CL E G H9531154Sandhaus Ben-Ami syndromeORPHA0986939603883
HP:0003198HP:0003458EMG: myopathic abnormalities1BAG3 CL E G H9531154Sandhaus Ben-Ami syndromeORPHA0986939603883
HP:0003198HP:0003715Myofibrillar myopathy1BAG3 CL E G H9531154Sandhaus Ben-Ami syndromeORPHA0986939603883
HP:0003198HP:0003458EMG: myopathic abnormalities1BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA0249961605681
HP:0003198HP:0003715Myofibrillar myopathy1BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA0249961605681
HP:0003198HP:0003789Minicore myopathy1BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA0249961605681
HP:0003198HP:0003756Skeletal myopathy1BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA0249961605681
HP:0003198HP:0009071Inflammatory myopathy1BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA0249961605681
HP:0003198HP:0008978Necrotizing myopathy1BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA0249961605681
HP:0003198HP:0009071Inflammatory myopathy1BSCL2 CL E G H26580363400ORPHA051015832606158
HP:0003198HP:0008978Necrotizing myopathy1BSCL2 CL E G H26580363400ORPHA051015832606158
HP:0003198HP:0003458EMG: myopathic abnormalities1BSCL2 CL E G H26580363400ORPHA051015832606158
HP:0003198HP:0003715Myofibrillar myopathy1BSCL2 CL E G H26580363400ORPHA051015832606158
HP:0003198HP:0003789Minicore myopathy1BSCL2 CL E G H26580363400ORPHA051015832606158
HP:0003198HP:0003756Skeletal myopathy1BSCL2 CL E G H26580363400ORPHA051015832606158
HP:0003198HP:0003789Minicore myopathy1CACNA1S CL E G H779170400Hypokalemic periodic paralysis 1170400C3714580OMIM018861397114208
HP:0003198HP:0003756Skeletal myopathy1CACNA1S CL E G H779170400Hypokalemic periodic paralysis 1170400C3714580OMIM018861397114208
HP:0003198HP:0009071Inflammatory myopathy1CACNA1S CL E G H779170400Hypokalemic periodic paralysis 1170400C3714580OMIM018861397114208
HP:0003198HP:0008978Necrotizing myopathy1CACNA1S CL E G H779170400Hypokalemic periodic paralysis 1170400C3714580OMIM018861397114208
HP:0003198HP:0003458EMG: myopathic abnormalities1CACNA1S CL E G H779170400Hypokalemic periodic paralysis 1170400C3714580OMIM018861397114208
HP:0003198HP:0003715Myofibrillar myopathy1CACNA1S CL E G H779170400Hypokalemic periodic paralysis 1170400C3714580OMIM018861397114208
HP:0003198HP:0009071Inflammatory myopathy1CDH23 CL E G H6407296253ORPHA0452213733605516
HP:0003198HP:0008978Necrotizing myopathy1CDH23 CL E G H6407296253ORPHA0452213733605516
HP:0003198HP:0003458EMG: myopathic abnormalities1CDH23 CL E G H6407296253ORPHA0452213733605516
HP:0003198HP:0003715Myofibrillar myopathy1CDH23 CL E G H6407296253ORPHA0452213733605516
HP:0003198HP:0003789Minicore myopathy1CDH23 CL E G H6407296253ORPHA0452213733605516
HP:0003198HP:0003756Skeletal myopathy1CDH23 CL E G H6407296253ORPHA0452213733605516
HP:0003198HP:0008978Necrotizing myopathy1CFL2 CL E G H1073171436ORPHA01671875601443
HP:0003198HP:0009071Inflammatory myopathy1CFL2 CL E G H1073171436ORPHA01671875601443
HP:0003198HP:0003715Myofibrillar myopathy1CFL2 CL E G H1073171436ORPHA01671875601443
HP:0003198HP:0003458EMG: myopathic abnormalities1CFL2 CL E G H1073171436ORPHA01671875601443
HP:0003198HP:0003756Skeletal myopathy1CFL2 CL E G H1073171436ORPHA01671875601443
HP:0003198HP:0003789Minicore myopathy1CFL2 CL E G H1073171436ORPHA01671875601443
HP:0003198HP:0003458EMG: myopathic abnormalities1CISD2 CL E G H4938563463ORPHA07124212611507
HP:0003198HP:0003715Myofibrillar myopathy1CISD2 CL E G H4938563463ORPHA07124212611507
HP:0003198HP:0003789Minicore myopathy1CISD2 CL E G H4938563463ORPHA07124212611507
HP:0003198HP:0003756Skeletal myopathy1CISD2 CL E G H4938563463ORPHA07124212611507
HP:0003198HP:0009071Inflammatory myopathy1CISD2 CL E G H4938563463ORPHA07124212611507
HP:0003198HP:0008978Necrotizing myopathy1CISD2 CL E G H4938563463ORPHA07124212611507
HP:0003198HP:0003715Myofibrillar myopathy1CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA02292586603432
HP:0003198HP:0003458EMG: myopathic abnormalities1CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA02292586603432
HP:0003198HP:0003756Skeletal myopathy1CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA02292586603432
HP:0003198HP:0003789Minicore myopathy1CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA02292586603432
HP:0003198HP:0008978Necrotizing myopathy1CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA02292586603432
HP:0003198HP:0009071Inflammatory myopathy1CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA02292586603432
HP:0003198HP:0003789Minicore myopathy1CRYAB CL E G H1410154Sandhaus Ben-Ami syndromeORPHA02732389123590
HP:0003198HP:0003756Skeletal myopathy1CRYAB CL E G H1410154Sandhaus Ben-Ami syndromeORPHA02732389123590
HP:0003198HP:0009071Inflammatory myopathy1CRYAB CL E G H1410154Sandhaus Ben-Ami syndromeORPHA02732389123590
HP:0003198HP:0008978Necrotizing myopathy1CRYAB CL E G H1410154Sandhaus Ben-Ami syndromeORPHA02732389123590
HP:0003198HP:0003458EMG: myopathic abnormalities1CRYAB CL E G H1410154Sandhaus Ben-Ami syndromeORPHA02732389123590
HP:0003198HP:0003715Myofibrillar myopathy1CRYAB CL E G H1410154Sandhaus Ben-Ami syndromeORPHA02732389123590
HP:0003198HP:0003789Minicore myopathy1CSRP3 CL E G H8048154Sandhaus Ben-Ami syndromeORPHA04072472600824
HP:0003198HP:0003756Skeletal myopathy1CSRP3 CL E G H8048154Sandhaus Ben-Ami syndromeORPHA04072472600824
HP:0003198HP:0009071Inflammatory myopathy1CSRP3 CL E G H8048154Sandhaus Ben-Ami syndromeORPHA04072472600824
HP:0003198HP:0008978Necrotizing myopathy1CSRP3 CL E G H8048154Sandhaus Ben-Ami syndromeORPHA04072472600824
HP:0003198HP:0003458EMG: myopathic abnormalities1CSRP3 CL E G H8048154Sandhaus Ben-Ami syndromeORPHA04072472600824
HP:0003198HP:0003715Myofibrillar myopathy1CSRP3 CL E G H8048154Sandhaus Ben-Ami syndromeORPHA04072472600824
HP:0003198HP:0003789Minicore myopathy1CTNS CL E G H1497219800Nephropathic cystinosis219800C0010690OMIM07782518606272
HP:0003198HP:0003756Skeletal myopathy1CTNS CL E G H1497219800Nephropathic cystinosis219800C0010690OMIM07782518606272
HP:0003198HP:0009071Inflammatory myopathy1CTNS CL E G H1497219800Nephropathic cystinosis219800C0010690OMIM07782518606272
HP:0003198HP:0008978Necrotizing myopathy1CTNS CL E G H1497219800Nephropathic cystinosis219800C0010690OMIM07782518606272
HP:0003198HP:0003458EMG: myopathic abnormalities1CTNS CL E G H1497219800Nephropathic cystinosis219800C0010690OMIM07782518606272
HP:0003198HP:0003715Myofibrillar myopathy1CTNS CL E G H1497219800Nephropathic cystinosis219800C0010690OMIM07782518606272
HP:0003198HP:0003756Skeletal myopathy1DES CL E G H1674154Sandhaus Ben-Ami syndromeORPHA09762770125660
HP:0003198HP:0003789Minicore myopathy1DES CL E G H1674154Sandhaus Ben-Ami syndromeORPHA09762770125660
HP:0003198HP:0008978Necrotizing myopathy1DES CL E G H1674154Sandhaus Ben-Ami syndromeORPHA09762770125660
HP:0003198HP:0009071Inflammatory myopathy1DES CL E G H1674154Sandhaus Ben-Ami syndromeORPHA09762770125660
HP:0003198HP:0003715Myofibrillar myopathy1DES CL E G H1674154Sandhaus Ben-Ami syndromeORPHA09762770125660
HP:0003198HP:0003458EMG: myopathic abnormalities1DES CL E G H1674154Sandhaus Ben-Ami syndromeORPHA09762770125660
HP:0003198HP:0003789Minicore myopathy1DMD CL E G H1756154Sandhaus Ben-Ami syndromeORPHA081842928300377
HP:0003198HP:0003756Skeletal myopathy1DMD CL E G H1756154Sandhaus Ben-Ami syndromeORPHA081842928300377
HP:0003198HP:0009071Inflammatory myopathy1DMD CL E G H1756154Sandhaus Ben-Ami syndromeORPHA081842928300377
HP:0003198HP:0008978Necrotizing myopathy1DMD CL E G H1756154Sandhaus Ben-Ami syndromeORPHA081842928300377
HP:0003198HP:0003458EMG: myopathic abnormalities1DMD CL E G H1756154Sandhaus Ben-Ami syndromeORPHA081842928300377
HP:0003198HP:0003715Myofibrillar myopathy1DMD CL E G H1756154Sandhaus Ben-Ami syndromeORPHA081842928300377
HP:0003198HP:0003756Skeletal myopathy1DOLK CL E G H22845154Sandhaus Ben-Ami syndromeORPHA052123406610746
HP:0003198HP:0003789Minicore myopathy1DOLK CL E G H22845154Sandhaus Ben-Ami syndromeORPHA052123406610746
HP:0003198HP:0008978Necrotizing myopathy1DOLK CL E G H22845154Sandhaus Ben-Ami syndromeORPHA052123406610746
HP:0003198HP:0009071Inflammatory myopathy1DOLK CL E G H22845154Sandhaus Ben-Ami syndromeORPHA052123406610746
HP:0003198HP:0003458EMG: myopathic abnormalities1DOLK CL E G H22845154Sandhaus Ben-Ami syndromeORPHA052123406610746
HP:0003198HP:0003715Myofibrillar myopathy1DOLK CL E G H22845154Sandhaus Ben-Ami syndromeORPHA052123406610746
HP:0003198HP:0003789Minicore myopathy1DSG2 CL E G H1829154Sandhaus Ben-Ami syndromeORPHA015703049125671
HP:0003198HP:0003756Skeletal myopathy1DSG2 CL E G H1829154Sandhaus Ben-Ami syndromeORPHA015703049125671
HP:0003198HP:0009071Inflammatory myopathy1DSG2 CL E G H1829154Sandhaus Ben-Ami syndromeORPHA015703049125671
HP:0003198HP:0008978Necrotizing myopathy1DSG2 CL E G H1829154Sandhaus Ben-Ami syndromeORPHA015703049125671
HP:0003198HP:0003458EMG: myopathic abnormalities1DSG2 CL E G H1829154Sandhaus Ben-Ami syndromeORPHA015703049125671
HP:0003198HP:0003715Myofibrillar myopathy1DSG2 CL E G H1829154Sandhaus Ben-Ami syndromeORPHA015703049125671
HP:0003198HP:0003458EMG: myopathic abnormalities1ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA09663327130160
HP:0003198HP:0003715Myofibrillar myopathy1ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA09663327130160
HP:0003198HP:0003789Minicore myopathy1ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA09663327130160
HP:0003198HP:0003756Skeletal myopathy1ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA09663327130160
HP:0003198HP:0009071Inflammatory myopathy1ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA09663327130160
HP:0003198HP:0008978Necrotizing myopathy1ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA09663327130160
HP:0003198HP:0003789Minicore myopathy1FHL2 CL E G H2274154Sandhaus Ben-Ami syndromeORPHA02003703602633
HP:0003198HP:0003756Skeletal myopathy1FHL2 CL E G H2274154Sandhaus Ben-Ami syndromeORPHA02003703602633
HP:0003198HP:0009071Inflammatory myopathy1FHL2 CL E G H2274154Sandhaus Ben-Ami syndromeORPHA02003703602633
HP:0003198HP:0008978Necrotizing myopathy1FHL2 CL E G H2274154Sandhaus Ben-Ami syndromeORPHA02003703602633
HP:0003198HP:0003458EMG: myopathic abnormalities1FHL2 CL E G H2274154Sandhaus Ben-Ami syndromeORPHA02003703602633
HP:0003198HP:0003715Myofibrillar myopathy1FHL2 CL E G H2274154Sandhaus Ben-Ami syndromeORPHA02003703602633
HP:0003198HP:0003789Minicore myopathy1FKTN CL E G H2218154Sandhaus Ben-Ami syndromeORPHA09143622607440
HP:0003198HP:0003756Skeletal myopathy1FKTN CL E G H2218154Sandhaus Ben-Ami syndromeORPHA09143622607440
HP:0003198HP:0009071Inflammatory myopathy1FKTN CL E G H2218154Sandhaus Ben-Ami syndromeORPHA09143622607440
HP:0003198HP:0008978Necrotizing myopathy1FKTN CL E G H2218154Sandhaus Ben-Ami syndromeORPHA09143622607440
HP:0003198HP:0003458EMG: myopathic abnormalities1FKTN CL E G H2218154Sandhaus Ben-Ami syndromeORPHA09143622607440
HP:0003198HP:0003715Myofibrillar myopathy1FKTN CL E G H2218154Sandhaus Ben-Ami syndromeORPHA09143622607440
HP:0003198HP:0003458EMG: myopathic abnormalities1GABRD CL E G H25631606ORPHA04744084137163
HP:0003198HP:0003715Myofibrillar myopathy1GABRD CL E G H25631606ORPHA04744084137163
HP:0003198HP:0003789Minicore myopathy1GABRD CL E G H25631606ORPHA04744084137163
HP:0003198HP:0003756Skeletal myopathy1GABRD CL E G H25631606ORPHA04744084137163
HP:0003198HP:0009071Inflammatory myopathy1GABRD CL E G H25631606ORPHA04744084137163
HP:0003198HP:0008978Necrotizing myopathy1GABRD CL E G H25631606ORPHA04744084137163
HP:0003198HP:0003789Minicore myopathy1GATAD1 CL E G H57798154Sandhaus Ben-Ami syndromeORPHA061829941614518
HP:0003198HP:0003756Skeletal myopathy1GATAD1 CL E G H57798154Sandhaus Ben-Ami syndromeORPHA061829941614518
HP:0003198HP:0009071Inflammatory myopathy1GATAD1 CL E G H57798154Sandhaus Ben-Ami syndromeORPHA061829941614518
HP:0003198HP:0008978Necrotizing myopathy1GATAD1 CL E G H57798154Sandhaus Ben-Ami syndromeORPHA061829941614518
HP:0003198HP:0003458EMG: myopathic abnormalities1GATAD1 CL E G H57798154Sandhaus Ben-Ami syndromeORPHA061829941614518
HP:0003198HP:0003715Myofibrillar myopathy1GATAD1 CL E G H57798154Sandhaus Ben-Ami syndromeORPHA061829941614518
HP:0003198HP:0003458EMG: myopathic abnormalities1GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA01784659601679
HP:0003198HP:0003715Myofibrillar myopathy1GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA01784659601679
HP:0003198HP:0003756Skeletal myopathy1GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA01784659601679
HP:0003198HP:0003789Minicore myopathy1GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA01784659601679
HP:0003198HP:0009071Inflammatory myopathy1GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA01784659601679
HP:0003198HP:0008978Necrotizing myopathy1GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA01784659601679
HP:0003198HP:0003458EMG: myopathic abnormalities1GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA02664661604318
HP:0003198HP:0003715Myofibrillar myopathy1GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA02664661604318
HP:0003198HP:0003789Minicore myopathy1GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA02664661604318
HP:0003198HP:0003756Skeletal myopathy1GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA02664661604318
HP:0003198HP:0009071Inflammatory myopathy1GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA02664661604318
HP:0003198HP:0008978Necrotizing myopathy1GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA02664661604318
HP:0003198HP:0003458EMG: myopathic abnormalities1KCNAB2 CL E G H85141606ORPHA01146229601142
HP:0003198HP:0003715Myofibrillar myopathy1KCNAB2 CL E G H85141606ORPHA01146229601142
HP:0003198HP:0003789Minicore myopathy1KCNAB2 CL E G H85141606ORPHA01146229601142
HP:0003198HP:0003756Skeletal myopathy1KCNAB2 CL E G H85141606ORPHA01146229601142
HP:0003198HP:0009071Inflammatory myopathy1KCNAB2 CL E G H85141606ORPHA01146229601142
HP:0003198HP:0008978Necrotizing myopathy1KCNAB2 CL E G H85141606ORPHA01146229601142
HP:0003198HP:0009071Inflammatory myopathy1KLHL41 CL E G H10324171436ORPHA029416905607701
HP:0003198HP:0008978Necrotizing myopathy1KLHL41 CL E G H10324171436ORPHA029416905607701
HP:0003198HP:0003458EMG: myopathic abnormalities1KLHL41 CL E G H10324171436ORPHA029416905607701
HP:0003198HP:0003715Myofibrillar myopathy1KLHL41 CL E G H10324171436ORPHA029416905607701
HP:0003198HP:0003789Minicore myopathy1KLHL41 CL E G H10324171436ORPHA029416905607701
HP:0003198HP:0003756Skeletal myopathy1KLHL41 CL E G H10324171436ORPHA029416905607701
HP:0003198HP:0003756Skeletal myopathy1LAMA4 CL E G H3910154Sandhaus Ben-Ami syndromeORPHA016136484600133
HP:0003198HP:0003789Minicore myopathy1LAMA4 CL E G H3910154Sandhaus Ben-Ami syndromeORPHA016136484600133
HP:0003198HP:0008978Necrotizing myopathy1LAMA4 CL E G H3910154Sandhaus Ben-Ami syndromeORPHA016136484600133
HP:0003198HP:0009071Inflammatory myopathy1LAMA4 CL E G H3910154Sandhaus Ben-Ami syndromeORPHA016136484600133
HP:0003198HP:0003715Myofibrillar myopathy1LAMA4 CL E G H3910154Sandhaus Ben-Ami syndromeORPHA016136484600133
HP:0003198HP:0003458EMG: myopathic abnormalities1LAMA4 CL E G H3910154Sandhaus Ben-Ami syndromeORPHA016136484600133
HP:0003198HP:0003789Minicore myopathy1LDB3 CL E G H11155154Sandhaus Ben-Ami syndromeORPHA0122615710605906
HP:0003198HP:0003756Skeletal myopathy1LDB3 CL E G H11155154Sandhaus Ben-Ami syndromeORPHA0122615710605906
HP:0003198HP:0009071Inflammatory myopathy1LDB3 CL E G H11155154Sandhaus Ben-Ami syndromeORPHA0122615710605906
HP:0003198HP:0008978Necrotizing myopathy1LDB3 CL E G H11155154Sandhaus Ben-Ami syndromeORPHA0122615710605906
HP:0003198HP:0003458EMG: myopathic abnormalities1LDB3 CL E G H11155154Sandhaus Ben-Ami syndromeORPHA0122615710605906
HP:0003198HP:0003715Myofibrillar myopathy1LDB3 CL E G H11155154Sandhaus Ben-Ami syndromeORPHA0122615710605906
HP:0003198HP:0003458EMG: myopathic abnormalities1LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA02326613601329
HP:0003198HP:0003715Myofibrillar myopathy1LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA02326613601329
HP:0003198HP:0003789Minicore myopathy1LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA02326613601329
HP:0003198HP:0003756Skeletal myopathy1LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA02326613601329
HP:0003198HP:0009071Inflammatory myopathy1LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA02326613601329
HP:0003198HP:0008978Necrotizing myopathy1LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA02326613601329
HP:0003198HP:0008978Necrotizing myopathy1LMNA CL E G H4000280365ORPHA018146636150330
HP:0003198HP:0009071Inflammatory myopathy1LMNA CL E G H4000280365ORPHA018146636150330
HP:0003198HP:0003458EMG: myopathic abnormalities1LMNA CL E G H40002348ORPHA018146636150330
HP:0003198HP:0003715Myofibrillar myopathy1LMNA CL E G H40002348ORPHA018146636150330
HP:0003198HP:0003458EMG: myopathic abnormalities1LMNA CL E G H4000280365ORPHA018146636150330
HP:0003198HP:0003715Myofibrillar myopathy1LMNA CL E G H4000280365ORPHA018146636150330
HP:0003198HP:0003789Minicore myopathy1LMNA CL E G H40002348ORPHA018146636150330
HP:0003198HP:0003756Skeletal myopathy1LMNA CL E G H40002348ORPHA018146636150330
HP:0003198HP:0003756Skeletal myopathy1LMNA CL E G H4000280365ORPHA018146636150330
HP:0003198HP:0003789Minicore myopathy1LMNA CL E G H4000280365ORPHA018146636150330
HP:0003198HP:0009071Inflammatory myopathy1LMNA CL E G H40002348ORPHA018146636150330
HP:0003198HP:0008978Necrotizing myopathy1LMNA CL E G H40002348ORPHA018146636150330
HP:0003198HP:0003789Minicore myopathy1LMNA CL E G H4000610140Heart-hand syndrome, Slovenian type610140C1857829OMIM018146636150330
HP:0003198HP:0003756Skeletal myopathy1LMNA CL E G H4000610140Heart-hand syndrome, Slovenian type610140C1857829OMIM018146636150330
HP:0003198HP:0009071Inflammatory myopathy1LMNA CL E G H4000610140Heart-hand syndrome, Slovenian type610140C1857829OMIM018146636150330
HP:0003198HP:0008978Necrotizing myopathy1LMNA CL E G H4000610140Heart-hand syndrome, Slovenian type610140C1857829OMIM018146636150330
HP:0003198HP:0003458EMG: myopathic abnormalities1LMNA CL E G H4000610140Heart-hand syndrome, Slovenian type610140C1857829OMIM018146636150330
HP:0003198HP:0003715Myofibrillar myopathy1LMNA CL E G H4000610140Heart-hand syndrome, Slovenian type610140C1857829OMIM018146636150330
HP:0003198HP:0008978Necrotizing myopathy1LMOD3 CL E G H56203171436ORPHA03926649616112
HP:0003198HP:0009071Inflammatory myopathy1LMOD3 CL E G H56203171436ORPHA03926649616112
HP:0003198HP:0003458EMG: myopathic abnormalities1LMOD3 CL E G H56203171436ORPHA03926649616112
HP:0003198HP:0003715Myofibrillar myopathy1LMOD3 CL E G H56203171436ORPHA03926649616112
HP:0003198HP:0003756Skeletal myopathy1LMOD3 CL E G H56203171436ORPHA03926649616112
HP:0003198HP:0003789Minicore myopathy1LMOD3 CL E G H56203171436ORPHA03926649616112
HP:0003198HP:0003789Minicore myopathy1MT-ATP6 CL E G H4508104ORPHA07414516060
HP:0003198HP:0003756Skeletal myopathy1MT-ATP6 CL E G H4508104ORPHA07414516060
HP:0003198HP:0009071Inflammatory myopathy1MT-ATP6 CL E G H4508104ORPHA07414516060
HP:0003198HP:0008978Necrotizing myopathy1MT-ATP6 CL E G H4508104ORPHA07414516060
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ATP6 CL E G H4508104ORPHA07414516060
HP:0003198HP:0003715Myofibrillar myopathy1MT-ATP6 CL E G H4508104ORPHA07414516060
HP:0003198HP:0003789Minicore myopathy1MT-CO1 CL E G H4512104ORPHA07419516030
HP:0003198HP:0003756Skeletal myopathy1MT-CO1 CL E G H4512104ORPHA07419516030
HP:0003198HP:0009071Inflammatory myopathy1MT-CO1 CL E G H4512104ORPHA07419516030
HP:0003198HP:0008978Necrotizing myopathy1MT-CO1 CL E G H4512104ORPHA07419516030
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-CO1 CL E G H4512104ORPHA07419516030
HP:0003198HP:0003715Myofibrillar myopathy1MT-CO1 CL E G H4512104ORPHA07419516030
HP:0003198HP:0003789Minicore myopathy1MT-CO3 CL E G H4514104ORPHA07422516050
HP:0003198HP:0003756Skeletal myopathy1MT-CO3 CL E G H4514104ORPHA07422516050
HP:0003198HP:0009071Inflammatory myopathy1MT-CO3 CL E G H4514104ORPHA07422516050
HP:0003198HP:0008978Necrotizing myopathy1MT-CO3 CL E G H4514104ORPHA07422516050
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-CO3 CL E G H4514104ORPHA07422516050
HP:0003198HP:0003715Myofibrillar myopathy1MT-CO3 CL E G H4514104ORPHA07422516050
HP:0003198HP:0003789Minicore myopathy1MT-CYB CL E G H4519104ORPHA07427516020
HP:0003198HP:0003756Skeletal myopathy1MT-CYB CL E G H4519104ORPHA07427516020
HP:0003198HP:0009071Inflammatory myopathy1MT-CYB CL E G H4519104ORPHA07427516020
HP:0003198HP:0008978Necrotizing myopathy1MT-CYB CL E G H4519104ORPHA07427516020
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-CYB CL E G H4519104ORPHA07427516020
HP:0003198HP:0003715Myofibrillar myopathy1MT-CYB CL E G H4519104ORPHA07427516020
HP:0003198HP:0003789Minicore myopathy1MT-ND1 CL E G H4535104ORPHA07455516000
HP:0003198HP:0003756Skeletal myopathy1MT-ND1 CL E G H4535104ORPHA07455516000
HP:0003198HP:0009071Inflammatory myopathy1MT-ND1 CL E G H4535104ORPHA07455516000
HP:0003198HP:0008978Necrotizing myopathy1MT-ND1 CL E G H4535104ORPHA07455516000
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND1 CL E G H4535104ORPHA07455516000
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND1 CL E G H4535104ORPHA07455516000
HP:0003198HP:0003789Minicore myopathy1MT-ND2 CL E G H4536104ORPHA07456516001
HP:0003198HP:0003756Skeletal myopathy1MT-ND2 CL E G H4536104ORPHA07456516001
HP:0003198HP:0009071Inflammatory myopathy1MT-ND2 CL E G H4536104ORPHA07456516001
HP:0003198HP:0008978Necrotizing myopathy1MT-ND2 CL E G H4536104ORPHA07456516001
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND2 CL E G H4536104ORPHA07456516001
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND2 CL E G H4536104ORPHA07456516001
HP:0003198HP:0003756Skeletal myopathy1MT-ND4 CL E G H4538104ORPHA07459516003
HP:0003198HP:0003789Minicore myopathy1MT-ND4 CL E G H4538104ORPHA07459516003
HP:0003198HP:0008978Necrotizing myopathy1MT-ND4 CL E G H4538104ORPHA07459516003
HP:0003198HP:0009071Inflammatory myopathy1MT-ND4 CL E G H4538104ORPHA07459516003
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND4 CL E G H4538104ORPHA07459516003
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND4 CL E G H4538104ORPHA07459516003
HP:0003198HP:0003789Minicore myopathy1MT-ND4L CL E G H4539104ORPHA07460516004
HP:0003198HP:0003756Skeletal myopathy1MT-ND4L CL E G H4539104ORPHA07460516004
HP:0003198HP:0009071Inflammatory myopathy1MT-ND4L CL E G H4539104ORPHA07460516004
HP:0003198HP:0008978Necrotizing myopathy1MT-ND4L CL E G H4539104ORPHA07460516004
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND4L CL E G H4539104ORPHA07460516004
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND4L CL E G H4539104ORPHA07460516004
HP:0003198HP:0003756Skeletal myopathy1MT-ND5 CL E G H4540104ORPHA07461516005
HP:0003198HP:0003789Minicore myopathy1MT-ND5 CL E G H4540104ORPHA07461516005
HP:0003198HP:0009071Inflammatory myopathy1MT-ND5 CL E G H4540104ORPHA07461516005
HP:0003198HP:0008978Necrotizing myopathy1MT-ND5 CL E G H4540104ORPHA07461516005
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND5 CL E G H4540104ORPHA07461516005
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND5 CL E G H4540104ORPHA07461516005
HP:0003198HP:0003789Minicore myopathy1MT-ND6 CL E G H4541104ORPHA07462516006
HP:0003198HP:0003756Skeletal myopathy1MT-ND6 CL E G H4541104ORPHA07462516006
HP:0003198HP:0009071Inflammatory myopathy1MT-ND6 CL E G H4541104ORPHA07462516006
HP:0003198HP:0008978Necrotizing myopathy1MT-ND6 CL E G H4541104ORPHA07462516006
HP:0003198HP:0003458EMG: myopathic abnormalities1MT-ND6 CL E G H4541104ORPHA07462516006
HP:0003198HP:0003715Myofibrillar myopathy1MT-ND6 CL E G H4541104ORPHA07462516006
HP:0003198HP:0003789Minicore myopathy1MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM02517413156540
HP:0003198HP:0003756Skeletal myopathy1MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM02517413156540
HP:0003198HP:0009071Inflammatory myopathy1MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM02517413156540
HP:0003198HP:0008978Necrotizing myopathy1MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM02517413156540
HP:0003198HP:0003458EMG: myopathic abnormalities1MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM02517413156540
HP:0003198HP:0003715Myofibrillar myopathy1MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM02517413156540
HP:0003198HP:0003756Skeletal myopathy1MYBPC3 CL E G H4607154Sandhaus Ben-Ami syndromeORPHA033177551600958
HP:0003198HP:0003789Minicore myopathy1MYBPC3 CL E G H4607154Sandhaus Ben-Ami syndromeORPHA033177551600958
HP:0003198HP:0008978Necrotizing myopathy1MYBPC3 CL E G H4607154Sandhaus Ben-Ami syndromeORPHA033177551600958
HP:0003198HP:0009071Inflammatory myopathy1MYBPC3 CL E G H4607154Sandhaus Ben-Ami syndromeORPHA033177551600958
HP:0003198HP:0003458EMG: myopathic abnormalities1MYBPC3 CL E G H4607154Sandhaus Ben-Ami syndromeORPHA033177551600958
HP:0003198HP:0003715Myofibrillar myopathy1MYBPC3 CL E G H4607154Sandhaus Ben-Ami syndromeORPHA033177551600958
HP:0003198HP:0003789Minicore myopathy1MYH6 CL E G H4624154Sandhaus Ben-Ami syndromeORPHA021167576160710
HP:0003198HP:0003756Skeletal myopathy1MYH6 CL E G H4624154Sandhaus Ben-Ami syndromeORPHA021167576160710
HP:0003198HP:0009071Inflammatory myopathy1MYH6 CL E G H4624154Sandhaus Ben-Ami syndromeORPHA021167576160710
HP:0003198HP:0008978Necrotizing myopathy1MYH6 CL E G H4624154Sandhaus Ben-Ami syndromeORPHA021167576160710
HP:0003198HP:0003458EMG: myopathic abnormalities1MYH6 CL E G H4624154Sandhaus Ben-Ami syndromeORPHA021167576160710
HP:0003198HP:0003715Myofibrillar myopathy1MYH6 CL E G H4624154Sandhaus Ben-Ami syndromeORPHA021167576160710
HP:0003198HP:0003789Minicore myopathy1MYH7 CL E G H4625154Sandhaus Ben-Ami syndromeORPHA041067577160760
HP:0003198HP:0003756Skeletal myopathy1MYH7 CL E G H4625154Sandhaus Ben-Ami syndromeORPHA041067577160760
HP:0003198HP:0009071Inflammatory myopathy1MYH7 CL E G H4625154Sandhaus Ben-Ami syndromeORPHA041067577160760
HP:0003198HP:0008978Necrotizing myopathy1MYH7 CL E G H4625154Sandhaus Ben-Ami syndromeORPHA041067577160760
HP:0003198HP:0003458EMG: myopathic abnormalities1MYH7 CL E G H4625154Sandhaus Ben-Ami syndromeORPHA041067577160760
HP:0003198HP:0003715Myofibrillar myopathy1MYH7 CL E G H4625154Sandhaus Ben-Ami syndromeORPHA041067577160760
HP:0003198HP:0003715Myofibrillar myopathy1MYMK CL E G H3898271358ORPHA08633778615345
HP:0003198HP:0003458EMG: myopathic abnormalities1MYMK CL E G H3898271358ORPHA08633778615345
HP:0003198HP:0003756Skeletal myopathy1MYMK CL E G H3898271358ORPHA08633778615345
HP:0003198HP:0003789Minicore myopathy1MYMK CL E G H3898271358ORPHA08633778615345
HP:0003198HP:0008978Necrotizing myopathy1MYMK CL E G H3898271358ORPHA08633778615345
HP:0003198HP:0009071Inflammatory myopathy1MYMK CL E G H3898271358ORPHA08633778615345
HP:0003198HP:0003789Minicore myopathy1MYPN CL E G H84665154Sandhaus Ben-Ami syndromeORPHA0148523246608517
HP:0003198HP:0003756Skeletal myopathy1MYPN CL E G H84665154Sandhaus Ben-Ami syndromeORPHA0148523246608517
HP:0003198HP:0009071Inflammatory myopathy1MYPN CL E G H84665154Sandhaus Ben-Ami syndromeORPHA0148523246608517
HP:0003198HP:0008978Necrotizing myopathy1MYPN CL E G H84665154Sandhaus Ben-Ami syndromeORPHA0148523246608517
HP:0003198HP:0003458EMG: myopathic abnormalities1MYPN CL E G H84665154Sandhaus Ben-Ami syndromeORPHA0148523246608517
HP:0003198HP:0003715Myofibrillar myopathy1MYPN CL E G H84665154Sandhaus Ben-Ami syndromeORPHA0148523246608517
HP:0003198HP:0003789Minicore myopathy1NDUFS2 CL E G H4720104ORPHA02477708602985
HP:0003198HP:0003756Skeletal myopathy1NDUFS2 CL E G H4720104ORPHA02477708602985
HP:0003198HP:0009071Inflammatory myopathy1NDUFS2 CL E G H4720104ORPHA02477708602985
HP:0003198HP:0008978Necrotizing myopathy1NDUFS2 CL E G H4720104ORPHA02477708602985
HP:0003198HP:0003458EMG: myopathic abnormalities1NDUFS2 CL E G H4720104ORPHA02477708602985
HP:0003198HP:0003715Myofibrillar myopathy1NDUFS2 CL E G H4720104ORPHA02477708602985
HP:0003198HP:0009071Inflammatory myopathy1NEB CL E G H4703171436ORPHA085307720161650
HP:0003198HP:0008978Necrotizing myopathy1NEB CL E G H4703171436ORPHA085307720161650
HP:0003198HP:0003458EMG: myopathic abnormalities1NEB CL E G H4703171436ORPHA085307720161650
HP:0003198HP:0003715Myofibrillar myopathy1NEB CL E G H4703171436ORPHA085307720161650
HP:0003198HP:0003789Minicore myopathy1NEB CL E G H4703171436ORPHA085307720161650
HP:0003198HP:0003756Skeletal myopathy1NEB CL E G H4703171436ORPHA085307720161650
HP:0003198HP:0003789Minicore myopathy1NEBL CL E G H10529154Sandhaus Ben-Ami syndromeORPHA0101616932605491
HP:0003198HP:0003756Skeletal myopathy1NEBL CL E G H10529154Sandhaus Ben-Ami syndromeORPHA0101616932605491
HP:0003198HP:0009071Inflammatory myopathy1NEBL CL E G H10529154Sandhaus Ben-Ami syndromeORPHA0101616932605491
HP:0003198HP:0008978Necrotizing myopathy1NEBL CL E G H10529154Sandhaus Ben-Ami syndromeORPHA0101616932605491
HP:0003198HP:0003458EMG: myopathic abnormalities1NEBL CL E G H10529154Sandhaus Ben-Ami syndromeORPHA0101616932605491
HP:0003198HP:0003715Myofibrillar myopathy1NEBL CL E G H10529154Sandhaus Ben-Ami syndromeORPHA0101616932605491
HP:0003198HP:0003756Skeletal myopathy1NEXN CL E G H91624154Sandhaus Ben-Ami syndromeORPHA066929557613121
HP:0003198HP:0003789Minicore myopathy1NEXN CL E G H91624154Sandhaus Ben-Ami syndromeORPHA066929557613121
HP:0003198HP:0008978Necrotizing myopathy1NEXN CL E G H91624154Sandhaus Ben-Ami syndromeORPHA066929557613121
HP:0003198HP:0009071Inflammatory myopathy1NEXN CL E G H91624154Sandhaus Ben-Ami syndromeORPHA066929557613121
HP:0003198HP:0003715Myofibrillar myopathy1NEXN CL E G H91624154Sandhaus Ben-Ami syndromeORPHA066929557613121
HP:0003198HP:0003458EMG: myopathic abnormalities1NEXN CL E G H91624154Sandhaus Ben-Ami syndromeORPHA066929557613121
HP:0003198HP:0009071Inflammatory myopathy1PDE11A CL E G H50940189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02038773604961
HP:0003198HP:0008978Necrotizing myopathy1PDE11A CL E G H50940189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02038773604961
HP:0003198HP:0003458EMG: myopathic abnormalities1PDE11A CL E G H50940189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02038773604961
HP:0003198HP:0003715Myofibrillar myopathy1PDE11A CL E G H50940189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02038773604961
HP:0003198HP:0003789Minicore myopathy1PDE11A CL E G H50940189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02038773604961
HP:0003198HP:0003756Skeletal myopathy1PDE11A CL E G H50940189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02038773604961
HP:0003198HP:0009071Inflammatory myopathy1PDE8B CL E G H8622189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02438794603390
HP:0003198HP:0008978Necrotizing myopathy1PDE8B CL E G H8622189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02438794603390
HP:0003198HP:0003458EMG: myopathic abnormalities1PDE8B CL E G H8622189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02438794603390
HP:0003198HP:0003715Myofibrillar myopathy1PDE8B CL E G H8622189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02438794603390
HP:0003198HP:0003789Minicore myopathy1PDE8B CL E G H8622189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02438794603390
HP:0003198HP:0003756Skeletal myopathy1PDE8B CL E G H8622189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02438794603390
HP:0003198HP:0003789Minicore myopathy1PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM03468896311800
HP:0003198HP:0003756Skeletal myopathy1PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM03468896311800
HP:0003198HP:0009071Inflammatory myopathy1PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM03468896311800
HP:0003198HP:0008978Necrotizing myopathy1PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM03468896311800
HP:0003198HP:0003458EMG: myopathic abnormalities1PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM03468896311800
HP:0003198HP:0003715Myofibrillar myopathy1PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM03468896311800
HP:0003198HP:0003789Minicore myopathy1PLN CL E G H5350154Sandhaus Ben-Ami syndromeORPHA01789080172405
HP:0003198HP:0003756Skeletal myopathy1PLN CL E G H5350154Sandhaus Ben-Ami syndromeORPHA01789080172405
HP:0003198HP:0009071Inflammatory myopathy1PLN CL E G H5350154Sandhaus Ben-Ami syndromeORPHA01789080172405
HP:0003198HP:0008978Necrotizing myopathy1PLN CL E G H5350154Sandhaus Ben-Ami syndromeORPHA01789080172405
HP:0003198HP:0003458EMG: myopathic abnormalities1PLN CL E G H5350154Sandhaus Ben-Ami syndromeORPHA01789080172405
HP:0003198HP:0003715Myofibrillar myopathy1PLN CL E G H5350154Sandhaus Ben-Ami syndromeORPHA01789080172405
HP:0003198HP:0003715Myofibrillar myopathy1POMT1 CL E G H1058586812ORPHA09069202607423
HP:0003198HP:0003458EMG: myopathic abnormalities1POMT1 CL E G H1058586812ORPHA09069202607423
HP:0003198HP:0003756Skeletal myopathy1POMT1 CL E G H1058586812ORPHA09069202607423
HP:0003198HP:0003789Minicore myopathy1POMT1 CL E G H1058586812ORPHA09069202607423
HP:0003198HP:0008978Necrotizing myopathy1POMT1 CL E G H1058586812ORPHA09069202607423
HP:0003198HP:0009071Inflammatory myopathy1POMT1 CL E G H1058586812ORPHA09069202607423
HP:0003198HP:0003458EMG: myopathic abnormalities1PPARG CL E G H546879083ORPHA01669236601487
HP:0003198HP:0003715Myofibrillar myopathy1PPARG CL E G H546879083ORPHA01669236601487
HP:0003198HP:0003789Minicore myopathy1PPARG CL E G H546879083ORPHA01669236601487
HP:0003198HP:0003756Skeletal myopathy1PPARG CL E G H546879083ORPHA01669236601487
HP:0003198HP:0009071Inflammatory myopathy1PPARG CL E G H546879083ORPHA01669236601487
HP:0003198HP:0008978Necrotizing myopathy1PPARG CL E G H546879083ORPHA01669236601487
HP:0003198HP:0003756Skeletal myopathy1PPCS CL E G H79717154Sandhaus Ben-Ami syndromeORPHA020425686609853
HP:0003198HP:0003789Minicore myopathy1PPCS CL E G H79717154Sandhaus Ben-Ami syndromeORPHA020425686609853
HP:0003198HP:0008978Necrotizing myopathy1PPCS CL E G H79717154Sandhaus Ben-Ami syndromeORPHA020425686609853
HP:0003198HP:0009071Inflammatory myopathy1PPCS CL E G H79717154Sandhaus Ben-Ami syndromeORPHA020425686609853
HP:0003198HP:0003458EMG: myopathic abnormalities1PPCS CL E G H79717154Sandhaus Ben-Ami syndromeORPHA020425686609853
HP:0003198HP:0003715Myofibrillar myopathy1PPCS CL E G H79717154Sandhaus Ben-Ami syndromeORPHA020425686609853
HP:0003198HP:0003715Myofibrillar myopathy1PRDM16 CL E G H639761606ORPHA0127214000605557
HP:0003198HP:0003458EMG: myopathic abnormalities1PRDM16 CL E G H639761606ORPHA0127214000605557
HP:0003198HP:0003789Minicore myopathy1PRDM16 CL E G H639761606ORPHA0127214000605557
HP:0003198HP:0003756Skeletal myopathy1PRDM16 CL E G H639761606ORPHA0127214000605557
HP:0003198HP:0009071Inflammatory myopathy1PRDM16 CL E G H639761606ORPHA0127214000605557
HP:0003198HP:0008978Necrotizing myopathy1PRDM16 CL E G H639761606ORPHA0127214000605557
HP:0003198HP:0003789Minicore myopathy1PRDM16 CL E G H63976154Sandhaus Ben-Ami syndromeORPHA0127214000605557
HP:0003198HP:0003756Skeletal myopathy1PRDM16 CL E G H63976154Sandhaus Ben-Ami syndromeORPHA0127214000605557
HP:0003198HP:0009071Inflammatory myopathy1PRDM16 CL E G H63976154Sandhaus Ben-Ami syndromeORPHA0127214000605557
HP:0003198HP:0008978Necrotizing myopathy1PRDM16 CL E G H63976154Sandhaus Ben-Ami syndromeORPHA0127214000605557
HP:0003198HP:0003458EMG: myopathic abnormalities1PRDM16 CL E G H63976154Sandhaus Ben-Ami syndromeORPHA0127214000605557
HP:0003198HP:0003715Myofibrillar myopathy1PRDM16 CL E G H63976154Sandhaus Ben-Ami syndromeORPHA0127214000605557
HP:0003198HP:0008978Necrotizing myopathy1PRKACA CL E G H5566189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA0439380601639
HP:0003198HP:0009071Inflammatory myopathy1PRKACA CL E G H5566189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA0439380601639
HP:0003198HP:0003715Myofibrillar myopathy1PRKACA CL E G H5566189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA0439380601639
HP:0003198HP:0003458EMG: myopathic abnormalities1PRKACA CL E G H5566189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA0439380601639
HP:0003198HP:0003789Minicore myopathy1PRKACA CL E G H5566189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA0439380601639
HP:0003198HP:0003756Skeletal myopathy1PRKACA CL E G H5566189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA0439380601639
HP:0003198HP:0009071Inflammatory myopathy1PRKAR1A CL E G H5573189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA011319388188830
HP:0003198HP:0008978Necrotizing myopathy1PRKAR1A CL E G H5573189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA011319388188830
HP:0003198HP:0003458EMG: myopathic abnormalities1PRKAR1A CL E G H5573189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA011319388188830
HP:0003198HP:0003715Myofibrillar myopathy1PRKAR1A CL E G H5573189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA011319388188830
HP:0003198HP:0003789Minicore myopathy1PRKAR1A CL E G H5573189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA011319388188830
HP:0003198HP:0003756Skeletal myopathy1PRKAR1A CL E G H5573189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA011319388188830
HP:0003198HP:0003789Minicore myopathy1PSEN1 CL E G H5663154Sandhaus Ben-Ami syndromeORPHA05019508104311
HP:0003198HP:0003756Skeletal myopathy1PSEN1 CL E G H5663154Sandhaus Ben-Ami syndromeORPHA05019508104311
HP:0003198HP:0009071Inflammatory myopathy1PSEN1 CL E G H5663154Sandhaus Ben-Ami syndromeORPHA05019508104311
HP:0003198HP:0008978Necrotizing myopathy1PSEN1 CL E G H5663154Sandhaus Ben-Ami syndromeORPHA05019508104311
HP:0003198HP:0003458EMG: myopathic abnormalities1PSEN1 CL E G H5663154Sandhaus Ben-Ami syndromeORPHA05019508104311
HP:0003198HP:0003715Myofibrillar myopathy1PSEN1 CL E G H5663154Sandhaus Ben-Ami syndromeORPHA05019508104311
HP:0003198HP:0003789Minicore myopathy1PSEN2 CL E G H5664154Sandhaus Ben-Ami syndromeORPHA02799509600759
HP:0003198HP:0003756Skeletal myopathy1PSEN2 CL E G H5664154Sandhaus Ben-Ami syndromeORPHA02799509600759
HP:0003198HP:0009071Inflammatory myopathy1PSEN2 CL E G H5664154Sandhaus Ben-Ami syndromeORPHA02799509600759
HP:0003198HP:0008978Necrotizing myopathy1PSEN2 CL E G H5664154Sandhaus Ben-Ami syndromeORPHA02799509600759
HP:0003198HP:0003458EMG: myopathic abnormalities1PSEN2 CL E G H5664154Sandhaus Ben-Ami syndromeORPHA02799509600759
HP:0003198HP:0003715Myofibrillar myopathy1PSEN2 CL E G H5664154Sandhaus Ben-Ami syndromeORPHA02799509600759
HP:0003198HP:0003789Minicore myopathy1PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA030129588601728
HP:0003198HP:0003756Skeletal myopathy1PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA030129588601728
HP:0003198HP:0009071Inflammatory myopathy1PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA030129588601728
HP:0003198HP:0008978Necrotizing myopathy1PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA030129588601728
HP:0003198HP:0003458EMG: myopathic abnormalities1PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA030129588601728
HP:0003198HP:0003715Myofibrillar myopathy1PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA030129588601728
HP:0003198HP:0003789Minicore myopathy1RAF1 CL E G H5894154Sandhaus Ben-Ami syndromeORPHA09909829164760
HP:0003198HP:0003756Skeletal myopathy1RAF1 CL E G H5894154Sandhaus Ben-Ami syndromeORPHA09909829164760
HP:0003198HP:0009071Inflammatory myopathy1RAF1 CL E G H5894154Sandhaus Ben-Ami syndromeORPHA09909829164760
HP:0003198HP:0008978Necrotizing myopathy1RAF1 CL E G H5894154Sandhaus Ben-Ami syndromeORPHA09909829164760
HP:0003198HP:0003458EMG: myopathic abnormalities1RAF1 CL E G H5894154Sandhaus Ben-Ami syndromeORPHA09909829164760
HP:0003198HP:0003715Myofibrillar myopathy1RAF1 CL E G H5894154Sandhaus Ben-Ami syndromeORPHA09909829164760
HP:0003198HP:0003789Minicore myopathy1RBM20 CL E G H282996154Sandhaus Ben-Ami syndromeORPHA0162327424613171
HP:0003198HP:0003756Skeletal myopathy1RBM20 CL E G H282996154Sandhaus Ben-Ami syndromeORPHA0162327424613171
HP:0003198HP:0008978Necrotizing myopathy1RBM20 CL E G H282996154Sandhaus Ben-Ami syndromeORPHA0162327424613171
HP:0003198HP:0009071Inflammatory myopathy1RBM20 CL E G H282996154Sandhaus Ben-Ami syndromeORPHA0162327424613171
HP:0003198HP:0003715Myofibrillar myopathy1RBM20 CL E G H282996154Sandhaus Ben-Ami syndromeORPHA0162327424613171
HP:0003198HP:0003458EMG: myopathic abnormalities1RBM20 CL E G H282996154Sandhaus Ben-Ami syndromeORPHA0162327424613171
HP:0003198HP:0003458EMG: myopathic abnormalities1RERE CL E G H4731606ORPHA06599965605226
HP:0003198HP:0003715Myofibrillar myopathy1RERE CL E G H4731606ORPHA06599965605226
HP:0003198HP:0003789Minicore myopathy1RERE CL E G H4731606ORPHA06599965605226
HP:0003198HP:0003756Skeletal myopathy1RERE CL E G H4731606ORPHA06599965605226
HP:0003198HP:0009071Inflammatory myopathy1RERE CL E G H4731606ORPHA06599965605226
HP:0003198HP:0008978Necrotizing myopathy1RERE CL E G H4731606ORPHA06599965605226
HP:0003198HP:0003715Myofibrillar myopathy1RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA02009970600404
HP:0003198HP:0003458EMG: myopathic abnormalities1RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA02009970600404
HP:0003198HP:0003789Minicore myopathy1RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA02009970600404
HP:0003198HP:0003756Skeletal myopathy1RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA02009970600404
HP:0003198HP:0009071Inflammatory myopathy1RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA02009970600404
HP:0003198HP:0008978Necrotizing myopathy1RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA02009970600404
HP:0003198HP:0009071Inflammatory myopathy1SCN4A CL E G H632999734ORPHA0176510591603967
HP:0003198HP:0008978Necrotizing myopathy1SCN4A CL E G H632999734ORPHA0176510591603967
HP:0003198HP:0003458EMG: myopathic abnormalities1SCN4A CL E G H6329682ORPHA0176510591603967
HP:0003198HP:0003715Myofibrillar myopathy1SCN4A CL E G H6329682ORPHA0176510591603967
HP:0003198HP:0003458EMG: myopathic abnormalities1SCN4A CL E G H632999734ORPHA0176510591603967
HP:0003198HP:0003715Myofibrillar myopathy1SCN4A CL E G H632999734ORPHA0176510591603967
HP:0003198HP:0003789Minicore myopathy1SCN4A CL E G H6329682ORPHA0176510591603967
HP:0003198HP:0003756Skeletal myopathy1SCN4A CL E G H6329682ORPHA0176510591603967
HP:0003198HP:0003789Minicore myopathy1SCN4A CL E G H632999734ORPHA0176510591603967
HP:0003198HP:0003756Skeletal myopathy1SCN4A CL E G H632999734ORPHA0176510591603967
HP:0003198HP:0009071Inflammatory myopathy1SCN4A CL E G H6329682ORPHA0176510591603967
HP:0003198HP:0008978Necrotizing myopathy1SCN4A CL E G H6329682ORPHA0176510591603967
HP:0003198HP:0003789Minicore myopathy1SCN4A CL E G H6329170400Hypokalemic periodic paralysis 1170400C3714580OMIM0176510591603967
HP:0003198HP:0003756Skeletal myopathy1SCN4A CL E G H6329170400Hypokalemic periodic paralysis 1170400C3714580OMIM0176510591603967
HP:0003198HP:0009071Inflammatory myopathy1SCN4A CL E G H6329170400Hypokalemic periodic paralysis 1170400C3714580OMIM0176510591603967
HP:0003198HP:0008978Necrotizing myopathy1SCN4A CL E G H6329170400Hypokalemic periodic paralysis 1170400C3714580OMIM0176510591603967
HP:0003198HP:0003458EMG: myopathic abnormalities1SCN4A CL E G H6329170400Hypokalemic periodic paralysis 1170400C3714580OMIM0176510591603967
HP:0003198HP:0003715Myofibrillar myopathy1SCN4A CL E G H6329170400Hypokalemic periodic paralysis 1170400C3714580OMIM0176510591603967
HP:0003198HP:0003789Minicore myopathy1SCN5A CL E G H6331154Sandhaus Ben-Ami syndromeORPHA0353110593600163
HP:0003198HP:0003756Skeletal myopathy1SCN5A CL E G H6331154Sandhaus Ben-Ami syndromeORPHA0353110593600163
HP:0003198HP:0009071Inflammatory myopathy1SCN5A CL E G H6331154Sandhaus Ben-Ami syndromeORPHA0353110593600163
HP:0003198HP:0008978Necrotizing myopathy1SCN5A CL E G H6331154Sandhaus Ben-Ami syndromeORPHA0353110593600163
HP:0003198HP:0003458EMG: myopathic abnormalities1SCN5A CL E G H6331154Sandhaus Ben-Ami syndromeORPHA0353110593600163
HP:0003198HP:0003715Myofibrillar myopathy1SCN5A CL E G H6331154Sandhaus Ben-Ami syndromeORPHA0353110593600163
HP:0003198HP:0003756Skeletal myopathy1SDHA CL E G H6389154Sandhaus Ben-Ami syndromeORPHA0250310680600857
HP:0003198HP:0003789Minicore myopathy1SDHA CL E G H6389154Sandhaus Ben-Ami syndromeORPHA0250310680600857
HP:0003198HP:0008978Necrotizing myopathy1SDHA CL E G H6389154Sandhaus Ben-Ami syndromeORPHA0250310680600857
HP:0003198HP:0009071Inflammatory myopathy1SDHA CL E G H6389154Sandhaus Ben-Ami syndromeORPHA0250310680600857
HP:0003198HP:0003458EMG: myopathic abnormalities1SDHA CL E G H6389154Sandhaus Ben-Ami syndromeORPHA0250310680600857
HP:0003198HP:0003715Myofibrillar myopathy1SDHA CL E G H6389154Sandhaus Ben-Ami syndromeORPHA0250310680600857
HP:0003198HP:0009071Inflammatory myopathy1SDHD CL E G H6392100093ORPHA068610683602690
HP:0003198HP:0008978Necrotizing myopathy1SDHD CL E G H6392100093ORPHA068610683602690
HP:0003198HP:0003458EMG: myopathic abnormalities1SDHD CL E G H6392100093ORPHA068610683602690
HP:0003198HP:0003715Myofibrillar myopathy1SDHD CL E G H6392100093ORPHA068610683602690
HP:0003198HP:0003789Minicore myopathy1SDHD CL E G H6392100093ORPHA068610683602690
HP:0003198HP:0003756Skeletal myopathy1SDHD CL E G H6392100093ORPHA068610683602690
HP:0003198HP:0003789Minicore myopathy1SGCD CL E G H6444154Sandhaus Ben-Ami syndromeORPHA067310807601411
HP:0003198HP:0003756Skeletal myopathy1SGCD CL E G H6444154Sandhaus Ben-Ami syndromeORPHA067310807601411
HP:0003198HP:0009071Inflammatory myopathy1SGCD CL E G H6444154Sandhaus Ben-Ami syndromeORPHA067310807601411
HP:0003198HP:0008978Necrotizing myopathy1SGCD CL E G H6444154Sandhaus Ben-Ami syndromeORPHA067310807601411
HP:0003198HP:0003458EMG: myopathic abnormalities1SGCD CL E G H6444154Sandhaus Ben-Ami syndromeORPHA067310807601411
HP:0003198HP:0003715Myofibrillar myopathy1SGCD CL E G H6444154Sandhaus Ben-Ami syndromeORPHA067310807601411
HP:0003198HP:0003715Myofibrillar myopathy1SKI CL E G H64971606ORPHA0106210896164780
HP:0003198HP:0003458EMG: myopathic abnormalities1SKI CL E G H64971606ORPHA0106210896164780
HP:0003198HP:0003756Skeletal myopathy1SKI CL E G H64971606ORPHA0106210896164780
HP:0003198HP:0003789Minicore myopathy1SKI CL E G H64971606ORPHA0106210896164780
HP:0003198HP:0008978Necrotizing myopathy1SKI CL E G H64971606ORPHA0106210896164780
HP:0003198HP:0009071Inflammatory myopathy1SKI CL E G H64971606ORPHA0106210896164780
HP:0003198HP:0003789Minicore myopathy1TAF1A CL E G H9015154Sandhaus Ben-Ami syndromeORPHA04911532604903
HP:0003198HP:0003756Skeletal myopathy1TAF1A CL E G H9015154Sandhaus Ben-Ami syndromeORPHA04911532604903
HP:0003198HP:0009071Inflammatory myopathy1TAF1A CL E G H9015154Sandhaus Ben-Ami syndromeORPHA04911532604903
HP:0003198HP:0008978Necrotizing myopathy1TAF1A CL E G H9015154Sandhaus Ben-Ami syndromeORPHA04911532604903
HP:0003198HP:0003458EMG: myopathic abnormalities1TAF1A CL E G H9015154Sandhaus Ben-Ami syndromeORPHA04911532604903
HP:0003198HP:0003715Myofibrillar myopathy1TAF1A CL E G H9015154Sandhaus Ben-Ami syndromeORPHA04911532604903
HP:0003198HP:0003789Minicore myopathy1TAZ CL E G H6901154Sandhaus Ben-Ami syndromeORPHA011577300394
HP:0003198HP:0003756Skeletal myopathy1TAZ CL E G H6901154Sandhaus Ben-Ami syndromeORPHA011577300394
HP:0003198HP:0009071Inflammatory myopathy1TAZ CL E G H6901154Sandhaus Ben-Ami syndromeORPHA011577300394
HP:0003198HP:0008978Necrotizing myopathy1TAZ CL E G H6901154Sandhaus Ben-Ami syndromeORPHA011577300394
HP:0003198HP:0003458EMG: myopathic abnormalities1TAZ CL E G H6901154Sandhaus Ben-Ami syndromeORPHA011577300394
HP:0003198HP:0003715Myofibrillar myopathy1TAZ CL E G H6901154Sandhaus Ben-Ami syndromeORPHA011577300394
HP:0003198HP:0003458EMG: myopathic abnormalities1TBCE CL E G H69052323Triple-Negative Breast Cancer FindingC2348819ORPHA045611582604934
HP:0003198HP:0003715Myofibrillar myopathy1TBCE CL E G H69052323Triple-Negative Breast Cancer FindingC2348819ORPHA045611582604934
HP:0003198HP:0003756Skeletal myopathy1TBCE CL E G H69052323Triple-Negative Breast Cancer FindingC2348819ORPHA045611582604934
HP:0003198HP:0003789Minicore myopathy1TBCE CL E G H69052323Triple-Negative Breast Cancer FindingC2348819ORPHA045611582604934
HP:0003198HP:0009071Inflammatory myopathy1TBCE CL E G H69052323Triple-Negative Breast Cancer FindingC2348819ORPHA045611582604934
HP:0003198HP:0008978Necrotizing myopathy1TBCE CL E G H69052323Triple-Negative Breast Cancer FindingC2348819ORPHA045611582604934
HP:0003198HP:0003458EMG: myopathic abnormalities1TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA019411586605842
HP:0003198HP:0003715Myofibrillar myopathy1TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA019411586605842
HP:0003198HP:0003789Minicore myopathy1TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA019411586605842
HP:0003198HP:0003756Skeletal myopathy1TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA019411586605842
HP:0003198HP:0009071Inflammatory myopathy1TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA019411586605842
HP:0003198HP:0008978Necrotizing myopathy1TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA019411586605842
HP:0003198HP:0003789Minicore myopathy1TCAP CL E G H8557154Sandhaus Ben-Ami syndromeORPHA029811610604488
HP:0003198HP:0003756Skeletal myopathy1TCAP CL E G H8557154Sandhaus Ben-Ami syndromeORPHA029811610604488
HP:0003198HP:0009071Inflammatory myopathy1TCAP CL E G H8557154Sandhaus Ben-Ami syndromeORPHA029811610604488
HP:0003198HP:0008978Necrotizing myopathy1TCAP CL E G H8557154Sandhaus Ben-Ami syndromeORPHA029811610604488
HP:0003198HP:0003458EMG: myopathic abnormalities1TCAP CL E G H8557154Sandhaus Ben-Ami syndromeORPHA029811610604488
HP:0003198HP:0003715Myofibrillar myopathy1TCAP CL E G H8557154Sandhaus Ben-Ami syndromeORPHA029811610604488
HP:0003198HP:0003789Minicore myopathy1TMPO CL E G H7112154Sandhaus Ben-Ami syndromeORPHA059711875188380
HP:0003198HP:0003756Skeletal myopathy1TMPO CL E G H7112154Sandhaus Ben-Ami syndromeORPHA059711875188380
HP:0003198HP:0008978Necrotizing myopathy1TMPO CL E G H7112154Sandhaus Ben-Ami syndromeORPHA059711875188380
HP:0003198HP:0009071Inflammatory myopathy1TMPO CL E G H7112154Sandhaus Ben-Ami syndromeORPHA059711875188380
HP:0003198HP:0003715Myofibrillar myopathy1TMPO CL E G H7112154Sandhaus Ben-Ami syndromeORPHA059711875188380
HP:0003198HP:0003458EMG: myopathic abnormalities1TMPO CL E G H7112154Sandhaus Ben-Ami syndromeORPHA059711875188380
HP:0003198HP:0003789Minicore myopathy1TNNC1 CL E G H7134154Sandhaus Ben-Ami syndromeORPHA030011943191040
HP:0003198HP:0003756Skeletal myopathy1TNNC1 CL E G H7134154Sandhaus Ben-Ami syndromeORPHA030011943191040
HP:0003198HP:0009071Inflammatory myopathy1TNNC1 CL E G H7134154Sandhaus Ben-Ami syndromeORPHA030011943191040
HP:0003198HP:0008978Necrotizing myopathy1TNNC1 CL E G H7134154Sandhaus Ben-Ami syndromeORPHA030011943191040
HP:0003198HP:0003458EMG: myopathic abnormalities1TNNC1 CL E G H7134154Sandhaus Ben-Ami syndromeORPHA030011943191040
HP:0003198HP:0003715Myofibrillar myopathy1TNNC1 CL E G H7134154Sandhaus Ben-Ami syndromeORPHA030011943191040
HP:0003198HP:0003756Skeletal myopathy1TNNI3 CL E G H7137154Sandhaus Ben-Ami syndromeORPHA065511947191044
HP:0003198HP:0003789Minicore myopathy1TNNI3 CL E G H7137154Sandhaus Ben-Ami syndromeORPHA065511947191044
HP:0003198HP:0008978Necrotizing myopathy1TNNI3 CL E G H7137154Sandhaus Ben-Ami syndromeORPHA065511947191044
HP:0003198HP:0009071Inflammatory myopathy1TNNI3 CL E G H7137154Sandhaus Ben-Ami syndromeORPHA065511947191044
HP:0003198HP:0003458EMG: myopathic abnormalities1TNNI3 CL E G H7137154Sandhaus Ben-Ami syndromeORPHA065511947191044
HP:0003198HP:0003715Myofibrillar myopathy1TNNI3 CL E G H7137154Sandhaus Ben-Ami syndromeORPHA065511947191044
HP:0003198HP:0003789Minicore myopathy1TNNT2 CL E G H7139154Sandhaus Ben-Ami syndromeORPHA081711949191045
HP:0003198HP:0003756Skeletal myopathy1TNNT2 CL E G H7139154Sandhaus Ben-Ami syndromeORPHA081711949191045
HP:0003198HP:0009071Inflammatory myopathy1TNNT2 CL E G H7139154Sandhaus Ben-Ami syndromeORPHA081711949191045
HP:0003198HP:0008978Necrotizing myopathy1TNNT2 CL E G H7139154Sandhaus Ben-Ami syndromeORPHA081711949191045
HP:0003198HP:0003458EMG: myopathic abnormalities1TNNT2 CL E G H7139154Sandhaus Ben-Ami syndromeORPHA081711949191045
HP:0003198HP:0003715Myofibrillar myopathy1TNNT2 CL E G H7139154Sandhaus Ben-Ami syndromeORPHA081711949191045
HP:0003198HP:0003789Minicore myopathy1TPM1 CL E G H7168154Sandhaus Ben-Ami syndromeORPHA076712010191010
HP:0003198HP:0003756Skeletal myopathy1TPM1 CL E G H7168154Sandhaus Ben-Ami syndromeORPHA076712010191010
HP:0003198HP:0009071Inflammatory myopathy1TPM1 CL E G H7168154Sandhaus Ben-Ami syndromeORPHA076712010191010
HP:0003198HP:0008978Necrotizing myopathy1TPM1 CL E G H7168154Sandhaus Ben-Ami syndromeORPHA076712010191010
HP:0003198HP:0003458EMG: myopathic abnormalities1TPM1 CL E G H7168154Sandhaus Ben-Ami syndromeORPHA076712010191010
HP:0003198HP:0003715Myofibrillar myopathy1TPM1 CL E G H7168154Sandhaus Ben-Ami syndromeORPHA076712010191010
HP:0003198HP:0009071Inflammatory myopathy1TPM2 CL E G H7169171436ORPHA034112011190990
HP:0003198HP:0008978Necrotizing myopathy1TPM2 CL E G H7169171436ORPHA034112011190990
HP:0003198HP:0003458EMG: myopathic abnormalities1TPM2 CL E G H7169171436ORPHA034112011190990
HP:0003198HP:0003715Myofibrillar myopathy1TPM2 CL E G H7169171436ORPHA034112011190990
HP:0003198HP:0003789Minicore myopathy1TPM2 CL E G H7169171436ORPHA034112011190990
HP:0003198HP:0003756Skeletal myopathy1TPM2 CL E G H7169171436ORPHA034112011190990
HP:0003198HP:0003789Minicore myopathy1TTN CL E G H7273154Sandhaus Ben-Ami syndromeORPHA02750312403188840
HP:0003198HP:0003756Skeletal myopathy1TTN CL E G H7273154Sandhaus Ben-Ami syndromeORPHA02750312403188840
HP:0003198HP:0009071Inflammatory myopathy1TTN CL E G H7273154Sandhaus Ben-Ami syndromeORPHA02750312403188840
HP:0003198HP:0008978Necrotizing myopathy1TTN CL E G H7273154Sandhaus Ben-Ami syndromeORPHA02750312403188840
HP:0003198HP:0003458EMG: myopathic abnormalities1TTN CL E G H7273154Sandhaus Ben-Ami syndromeORPHA02750312403188840
HP:0003198HP:0003715Myofibrillar myopathy1TTN CL E G H7273154Sandhaus Ben-Ami syndromeORPHA02750312403188840
HP:0003198HP:0003789Minicore myopathy1TXNRD2 CL E G H10587154Sandhaus Ben-Ami syndromeORPHA0106818155606448
HP:0003198HP:0003756Skeletal myopathy1TXNRD2 CL E G H10587154Sandhaus Ben-Ami syndromeORPHA0106818155606448
HP:0003198HP:0009071Inflammatory myopathy1TXNRD2 CL E G H10587154Sandhaus Ben-Ami syndromeORPHA0106818155606448
HP:0003198HP:0008978Necrotizing myopathy1TXNRD2 CL E G H10587154Sandhaus Ben-Ami syndromeORPHA0106818155606448
HP:0003198HP:0003458EMG: myopathic abnormalities1TXNRD2 CL E G H10587154Sandhaus Ben-Ami syndromeORPHA0106818155606448
HP:0003198HP:0003715Myofibrillar myopathy1TXNRD2 CL E G H10587154Sandhaus Ben-Ami syndromeORPHA0106818155606448
HP:0003198HP:0009071Inflammatory myopathy1USP8 CL E G H910196253ORPHA015812631603158
HP:0003198HP:0008978Necrotizing myopathy1USP8 CL E G H910196253ORPHA015812631603158
HP:0003198HP:0003458EMG: myopathic abnormalities1USP8 CL E G H910196253ORPHA015812631603158
HP:0003198HP:0003715Myofibrillar myopathy1USP8 CL E G H910196253ORPHA015812631603158
HP:0003198HP:0003789Minicore myopathy1USP8 CL E G H910196253ORPHA015812631603158
HP:0003198HP:0003756Skeletal myopathy1USP8 CL E G H910196253ORPHA015812631603158
HP:0003198HP:0003789Minicore myopathy1VCL CL E G H7414154Sandhaus Ben-Ami syndromeORPHA0117512665193065
HP:0003198HP:0003756Skeletal myopathy1VCL CL E G H7414154Sandhaus Ben-Ami syndromeORPHA0117512665193065
HP:0003198HP:0008978Necrotizing myopathy1VCL CL E G H7414154Sandhaus Ben-Ami syndromeORPHA0117512665193065
HP:0003198HP:0009071Inflammatory myopathy1VCL CL E G H7414154Sandhaus Ben-Ami syndromeORPHA0117512665193065
HP:0003198HP:0003715Myofibrillar myopathy1VCL CL E G H7414154Sandhaus Ben-Ami syndromeORPHA0117512665193065
HP:0003198HP:0003458EMG: myopathic abnormalities1VCL CL E G H7414154Sandhaus Ben-Ami syndromeORPHA0117512665193065
HP:0003198HP:0003458EMG: myopathic abnormalities1WFS1 CL E G H74663463ORPHA0163412762606201
HP:0003198HP:0003715Myofibrillar myopathy1WFS1 CL E G H74663463ORPHA0163412762606201
HP:0003198HP:0003756Skeletal myopathy1WFS1 CL E G H74663463ORPHA0163412762606201
HP:0003198HP:0003789Minicore myopathy1WFS1 CL E G H74663463ORPHA0163412762606201
HP:0003198HP:0009071Inflammatory myopathy1WFS1 CL E G H74663463ORPHA0163412762606201
HP:0003198HP:0008978Necrotizing myopathy1WFS1 CL E G H74663463ORPHA0163412762606201
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ABCC9 CL E G H10060154Sandhaus Ben-Ami syndromeORPHA0150760601439
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ACTA1 CL E G H58171436ORPHA0506129102610
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ACTC1 CL E G H70154Sandhaus Ben-Ami syndromeORPHA0672143102540
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ACTN2 CL E G H88154Sandhaus Ben-Ami syndromeORPHA01361164102573
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ALDOA CL E G H226611881HNSHA due to aldolase A deficiency611881C0272066OMIM0504414103850
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ANKRD1 CL E G H27063154Sandhaus Ben-Ami syndromeORPHA044215819609599
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2BAG3 CL E G H9531154Sandhaus Ben-Ami syndromeORPHA0986939603883
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA0249961605681
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2BSCL2 CL E G H26580363400ORPHA051015832606158
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CACNA1S CL E G H779170400Hypokalemic periodic paralysis 1170400C3714580OMIM018861397114208
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CDH23 CL E G H6407296253ORPHA0452213733605516
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CFL2 CL E G H1073171436ORPHA01671875601443
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CISD2 CL E G H4938563463ORPHA07124212611507
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA02292586603432
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CRYAB CL E G H1410154Sandhaus Ben-Ami syndromeORPHA02732389123590
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CSRP3 CL E G H8048154Sandhaus Ben-Ami syndromeORPHA04072472600824
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2CTNS CL E G H1497219800Nephropathic cystinosis219800C0010690OMIM07782518606272
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2DES CL E G H1674154Sandhaus Ben-Ami syndromeORPHA09762770125660
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2DMD CL E G H1756154Sandhaus Ben-Ami syndromeORPHA081842928300377
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2DOLK CL E G H22845154Sandhaus Ben-Ami syndromeORPHA052123406610746
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2DSG2 CL E G H1829154Sandhaus Ben-Ami syndromeORPHA015703049125671
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA09663327130160
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2FHL2 CL E G H2274154Sandhaus Ben-Ami syndromeORPHA02003703602633
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2FKTN CL E G H2218154Sandhaus Ben-Ami syndromeORPHA09143622607440
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2GABRD CL E G H25631606ORPHA04744084137163
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2GATAD1 CL E G H57798154Sandhaus Ben-Ami syndromeORPHA061829941614518
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA01784659601679
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA02664661604318
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2KCNAB2 CL E G H85141606ORPHA01146229601142
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2KLHL41 CL E G H10324171436ORPHA029416905607701
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2LAMA4 CL E G H3910154Sandhaus Ben-Ami syndromeORPHA016136484600133
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2LDB3 CL E G H11155154Sandhaus Ben-Ami syndromeORPHA0122615710605906
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA02326613601329
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2LMNA CL E G H40002348ORPHA018146636150330
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2LMNA CL E G H4000280365ORPHA018146636150330
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2LMNA CL E G H4000610140Heart-hand syndrome, Slovenian type610140C1857829OMIM018146636150330
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2LMOD3 CL E G H56203171436ORPHA03926649616112
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ATP6 CL E G H4508104ORPHA07414516060
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-CO1 CL E G H4512104ORPHA07419516030
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-CO3 CL E G H4514104ORPHA07422516050
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-CYB CL E G H4519104ORPHA07427516020
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND1 CL E G H4535104ORPHA07455516000
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND2 CL E G H4536104ORPHA07456516001
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND4 CL E G H4538104ORPHA07459516003
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND4L CL E G H4539104ORPHA07460516004
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND5 CL E G H4540104ORPHA07461516005
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MT-ND6 CL E G H4541104ORPHA07462516006
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM02517413156540
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MYBPC3 CL E G H4607154Sandhaus Ben-Ami syndromeORPHA033177551600958
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MYH6 CL E G H4624154Sandhaus Ben-Ami syndromeORPHA021167576160710
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MYH7 CL E G H4625154Sandhaus Ben-Ami syndromeORPHA041067577160760
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MYMK CL E G H3898271358ORPHA08633778615345
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2MYPN CL E G H84665154Sandhaus Ben-Ami syndromeORPHA0148523246608517
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2NDUFS2 CL E G H4720104ORPHA02477708602985
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2NEB CL E G H4703171436ORPHA085307720161650
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2NEBL CL E G H10529154Sandhaus Ben-Ami syndromeORPHA0101616932605491
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2NEXN CL E G H91624154Sandhaus Ben-Ami syndromeORPHA066929557613121
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PDE11A CL E G H50940189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02038773604961
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PDE8B CL E G H8622189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA02438794603390
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM03468896311800
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PLN CL E G H5350154Sandhaus Ben-Ami syndromeORPHA01789080172405
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2POMT1 CL E G H1058586812ORPHA09069202607423
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PPARG CL E G H546879083ORPHA01669236601487
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PPCS CL E G H79717154Sandhaus Ben-Ami syndromeORPHA020425686609853
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PRDM16 CL E G H639761606ORPHA0127214000605557
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PRDM16 CL E G H63976154Sandhaus Ben-Ami syndromeORPHA0127214000605557
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PRKACA CL E G H5566189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA0439380601639
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PRKAR1A CL E G H5573189439Primary pigmented nodular adrenocortical diseaseCN200645ORPHA011319388188830
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PSEN1 CL E G H5663154Sandhaus Ben-Ami syndromeORPHA05019508104311
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PSEN2 CL E G H5664154Sandhaus Ben-Ami syndromeORPHA02799509600759
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA030129588601728
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2RAF1 CL E G H5894154Sandhaus Ben-Ami syndromeORPHA09909829164760
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2RBM20 CL E G H282996154Sandhaus Ben-Ami syndromeORPHA0162327424613171
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2RERE CL E G H4731606ORPHA06599965605226
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA02009970600404
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SCN4A CL E G H6329682ORPHA0176510591603967
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SCN4A CL E G H632999734ORPHA0176510591603967
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SCN4A CL E G H6329170400Hypokalemic periodic paralysis 1170400C3714580OMIM0176510591603967
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SCN5A CL E G H6331154Sandhaus Ben-Ami syndromeORPHA0353110593600163
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SDHA CL E G H6389154Sandhaus Ben-Ami syndromeORPHA0250310680600857
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SDHD CL E G H6392100093ORPHA068610683602690
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SGCD CL E G H6444154Sandhaus Ben-Ami syndromeORPHA067310807601411
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2SKI CL E G H64971606ORPHA0106210896164780
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TAF1A CL E G H9015154Sandhaus Ben-Ami syndromeORPHA04911532604903
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TAZ CL E G H6901154Sandhaus Ben-Ami syndromeORPHA011577300394
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TBCE CL E G H69052323Triple-Negative Breast Cancer FindingC2348819ORPHA045611582604934
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA019411586605842
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TCAP CL E G H8557154Sandhaus Ben-Ami syndromeORPHA029811610604488
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TMPO CL E G H7112154Sandhaus Ben-Ami syndromeORPHA059711875188380
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TNNC1 CL E G H7134154Sandhaus Ben-Ami syndromeORPHA030011943191040
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TNNI3 CL E G H7137154Sandhaus Ben-Ami syndromeORPHA065511947191044
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TNNT2 CL E G H7139154Sandhaus Ben-Ami syndromeORPHA081711949191045
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TPM1 CL E G H7168154Sandhaus Ben-Ami syndromeORPHA076712010191010
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TPM2 CL E G H7169171436ORPHA034112011190990
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TTN CL E G H7273154Sandhaus Ben-Ami syndromeORPHA02750312403188840
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2TXNRD2 CL E G H10587154Sandhaus Ben-Ami syndromeORPHA0106818155606448
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2USP8 CL E G H910196253ORPHA015812631603158
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2VCL CL E G H7414154Sandhaus Ben-Ami syndromeORPHA0117512665193065
HP:0003198HP:0003787Type 1 and type 2 muscle fiber minicore regions2WFS1 CL E G H74663463ORPHA0163412762606201


Genes (313) :ABCC9 ABHD5 ACACA ACAD9 ACADL ACADS ACTA1 ACTC1 ACTN2 ADGRG6 ADSSL1 AGK AGL AGPAT2 AGRN AK9 AKT1 ALDOA ALG14 ALG2 ALPL ANKRD1 ANO5 AP1S2 ATP6 B3GALNT2 B4GALT1 BAG3 BAZ1B BIN1 BSCL2 C1QBP CACNA1S CAPN3 CASQ1 CAV1 CAV3 CAVIN1 CCDC174 CDH23 CDON CENPF CFL2 CHAT CHKB CHRNA1 CHRNB1 CHRND CHRNE CISD2 CLIP2 COL12A1 COL13A1 COL6A1 COL6A2 COL6A3 COLQ COX1 COX2 COX3 CPT2 CRPPA CRYAB CSRP3 CTNS CYTB DES DISP1 DLL1 DMD DNA2 DNAJB6 DNM2 DOK7 DOLK DPAGT1 DSG2 DYSF ELN EMD EPG5 ERGIC1 FGF8 FGFR1 FHL1 FHL2 FKBP14 FKRP FKTN FLAD1 FLNC FOS FOXH1 GABRD GAS1 GATAD1 GCLC GFER GFPT1 GK GLI2 GMPPB GNE GTF2I GTF2IRD1 GYG1 HACD1 HADHA HADHB HNRNPA1 HNRNPA2B1 HNRNPDL HSPG2 INPP5K ISCU ITGA7 KBTBD13 KCNAB2 KLHL40 KLHL41 KLHL9 LAMA4 LAMB2 LAMP2 LARGE1 LDB3 LIMK1 LMNA LMNB2 LMOD3 LRP4 MAP3K20 MGME1 MSTO1 MT-ATP6 MT-CO1 MT-CO2 MT-CO3 MT-CYB MT-ND1 MT-ND2 MT-ND4 MT-ND4L MT-ND5 MT-ND6 MT-RNR1 MT-TC MT-TE MT-TF MT-TH MT-TI MT-TK MT-TL1 MT-TP MT-TQ MT-TS1 MT-TS2 MT-TT MT-TV MT-TW MTAP MTMR14 MUSK MYBPC3 MYF6 MYH14 MYH2 MYH6 MYH7 MYL2 MYMK MYO18B MYO9A MYOT MYPN NARS2 ND1 ND2 ND4 ND4L ND5 ND6 NDUFA11 NDUFAF1 NDUFAF4 NDUFB3 NDUFS2 NEB NEBL NEFH NEXN NODAL NUBPL OPA1 ORAI1 PABPN1 PANK2 PDE11A PDE8B PGAM2 PGK1 PLEC PLN PNPLA2 POLG POLG2 POMGNT1 POMT1 POMT2 PPARG PPCS PRDM16 PRKACA PRKAG2 PRKAR1A PSEN1 PSEN2 PTCH1 PTEN PUS1 PYGM RAF1 RAPSN RBM20 RERE RET RFC2 RMND1 RNR1 RRM2B RYR1 SAR1B SCN4A SCN5A SDHA SDHAF1 SDHB SDHD SELENON SGCA SGCB SGCD SGCG SHH SIL1 SIX3 SKI SLC18A3 SLC22A5 SLC25A1 SLC25A3 SLC25A4 SLC5A7 SNAP25 STIM1 SUFU SYNE1 SYNE2 SYT2 TAF1A TAZ TBCE TBL2 TCAP TDGF1 TGIF1 TIA1 TK2 TMEM43 TMPO TNNC1 TNNI3 TNNT1 TNNT2 TNPO3 TPI1 TPM1 TPM2 TPM3 TRAPPC11 TRIM32 TRIP4 TRMU TRNC TRNE TRNF TRNH TRNI TRNK TRNL1 TRNP TRNQ TRNS1 TRNS2 TRNT TRNV TRNW TTN TWNK TXNRD2 UBA1 USP8 VAMP1 VCL VCP VMA21 VPS13A WFS1 XDH XK YARS2 ZBTB20 ZIC2

Diseases (225) :154 275630 613933 201470 171436 97244 616503 617030 1369 212350 366 232400 528 611881 353327 241510 85329 104 535000 551500 588 79332 607091 904 363400 617713 170400 618129 88635 616816 96253 243605 602541 616313 616314 616321 605809 3463 616471 158810 98915 603034 540000 228302 228305 219800 352470 606768 310300 242840 208100 300695 300179 614557 272 255100 614065 1606 230450 613076 307030 609015 615424 615422 609115 800 559 255125 613204 609273 2348 157973 280365 610140 79087 352447 112250 605637 1358 254940 616549 182920 616239 551 618236 618234 618237 618246 616924 618242 125250 612782 270 234200 189439 261670 300653 257 98908 610717 254886 86812 79083 261740 109 2598 368 162300 614922 613077 597 99734 682 613345 100093 119 248800 212140 91130 612783 160565 185070 2323 603 254875 605355 615512 369847 369840 1878 254864 545000 551000 611705 301830 167320 310440 2388 278300 300842 3042 98907 99901 99900 171433 97240 171439 2020 161800 98913 98914 744 206549 611307 612954 169189 255200 423 2593 488650 123320 280200 610687 75840 370980 399058 608810 601419 34516 160150 253601 98863 606612 609524 602 605820 263297 746 52430 615348 399081 300257 608840 609452 98855 98853 502423 397744 59135 437572 255160 608358 181430 98911 266 609200 399103 256030 254361 254892 157640 258450 424107 71 684 3208 608099 353 609283 302060 609560 98902 608423 609284 254110 486815 2596 178464 609 600334 608807 609286 329478 255320 602771
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.